MENU
The Electronic Scholarly Publishing Project: Providing world-wide, free access to classic scientific papers and other scholarly materials, since 1993.
More About: ESP | OUR CONTENT | THIS WEBSITE | WHAT'S NEW | WHAT'S HOT
ESP: PubMed Auto Bibliography 02 Jun 2025 at 01:49 Created:
Microbiome
It has long been known that every multicellular organism coexists with large prokaryotic ecosystems — microbiomes — that completely cover its surfaces, external and internal. Recent studies have shown that these associated microbiomes are not mere contamination, but instead have profound effects upon the function and fitness of the multicellular organism. We now know that all MCEs are actually functional composites, holobionts, composed of more prokaryotic cells than eukaryotic cells and expressing more prokaryotic genes than eukaryotic genes. A full understanding of the biology of "individual" eukaryotes will now depend on an understanding of their associated microbiomes.
Created with PubMed® Query: microbiome[tiab] NOT pmcbook NOT ispreviousversion
Citations The Papers (from PubMed®)
RevDate: 2025-05-31
CmpDate: 2025-05-31
Prebiotic supplementation in patients with type 1 diabetes: study protocol for a randomised controlled trial in Canada.
BMJ open, 15(5):e102486 pii:bmjopen-2025-102486.
INTRODUCTION: Type 1 diabetes (T1D) mellitus is caused by autoimmune destruction of insulin-producing beta-cells, requiring exogenous insulin to sustain life. Achieving near normal blood glucose levels with insulin, a primary goal of diabetes management, carries a significant risk of hypoglycaemia. There is compelling evidence that an abnormal gut microbiota or dysbiosis can increase intestinal permeability (IP) and contribute to dysglycaemia seen in T1D. Given that prebiotic fibre can mitigate dysbiosis, reduce IP and improve glycaemic control, we hypothesise that microbial changes induced by prebiotics contribute to gut and endocrine adaptations that reduce glucose fluctuations, including less hypoglycaemia. In a pilot study, we showed that in children who had T1D for at least 1 year, a 3-month course of prebiotic fibre significantly reduced the frequency of hypoglycaemia. The prebiotic group had an increase in Bifidobacterium with a moderate improvement in IP. Importantly, the prebiotic group maintained their serum C peptide level (marker of residual beta cell function) while the placebo group saw a drop. Given that preserving endogenous beta cell function in patients with T1D, particularly in the first year of diagnosis, reduces hypoglycaemia and glycaemic variability, we propose to examine the effect of prebiotic supplementation in patients with T1D.
METHODS AND ANALYSIS: This is a multicentre, randomised, double-blind, placebo-controlled study. Individuals (n=144) with T1D will be randomised 1:1 for 6 months to prebiotic (oligofructose-enriched inulin) or placebo (isocaloric maltodextrin). Participants will have three in-person study visits at baseline, 3 months and 6 months. The primary outcome, frequency of hypoglycaemia, will be determined from continuous glucose monitor (CGM) reports and patient blood glucose logs. Secondary outcomes will include glycaemic variability, time-in-range, glycated haemoglobin, stimulated C peptide, IP, serum inflammatory markers, quality of life and fear of hypoglycaemia ratings, as well as gut microbiome and metabolomics analysis. At 9 months, participant CGM data will be used to assess frequency of hypoglycaemia and glycaemic variability at 3 months postintervention.
ETHICS AND DISSEMINATION: The study received ethical approval from the University of Calgary Conjoint Health Research Ethics Board (REB21-0852). The University of Alberta subsite was granted ethical approval under the province of Alberta's research ethics reciprocity agreement as a participating site (REB21-0852; pSite00000066). The University of Saskatchewan subsite was granted ethical approval by the Biomedical Research Ethics Board (#4149). Trial findings will be disseminated through peer-reviewed publications and conference presentations.
TRIAL REGISTRATION NUMBER: clinicaltrials.gov NCT04963777.
Additional Links: PMID-40449951
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40449951,
year = {2025},
author = {Huang, C and Rosolowsky, E and Nour, MA and Butalia, S and Ho, J and Mayengbam, S and Wang, W and Pyke, S and Virtanen, H and Reimer, RA},
title = {Prebiotic supplementation in patients with type 1 diabetes: study protocol for a randomised controlled trial in Canada.},
journal = {BMJ open},
volume = {15},
number = {5},
pages = {e102486},
doi = {10.1136/bmjopen-2025-102486},
pmid = {40449951},
issn = {2044-6055},
mesh = {Humans ; *Diabetes Mellitus, Type 1/blood ; *Prebiotics/administration & dosage ; Randomized Controlled Trials as Topic ; Child ; Blood Glucose/metabolism ; Gastrointestinal Microbiome ; Canada ; Pilot Projects ; Hypoglycemia/prevention & control ; Female ; Dietary Supplements ; Male ; Dysbiosis ; Double-Blind Method ; Adolescent ; },
abstract = {INTRODUCTION: Type 1 diabetes (T1D) mellitus is caused by autoimmune destruction of insulin-producing beta-cells, requiring exogenous insulin to sustain life. Achieving near normal blood glucose levels with insulin, a primary goal of diabetes management, carries a significant risk of hypoglycaemia. There is compelling evidence that an abnormal gut microbiota or dysbiosis can increase intestinal permeability (IP) and contribute to dysglycaemia seen in T1D. Given that prebiotic fibre can mitigate dysbiosis, reduce IP and improve glycaemic control, we hypothesise that microbial changes induced by prebiotics contribute to gut and endocrine adaptations that reduce glucose fluctuations, including less hypoglycaemia. In a pilot study, we showed that in children who had T1D for at least 1 year, a 3-month course of prebiotic fibre significantly reduced the frequency of hypoglycaemia. The prebiotic group had an increase in Bifidobacterium with a moderate improvement in IP. Importantly, the prebiotic group maintained their serum C peptide level (marker of residual beta cell function) while the placebo group saw a drop. Given that preserving endogenous beta cell function in patients with T1D, particularly in the first year of diagnosis, reduces hypoglycaemia and glycaemic variability, we propose to examine the effect of prebiotic supplementation in patients with T1D.
METHODS AND ANALYSIS: This is a multicentre, randomised, double-blind, placebo-controlled study. Individuals (n=144) with T1D will be randomised 1:1 for 6 months to prebiotic (oligofructose-enriched inulin) or placebo (isocaloric maltodextrin). Participants will have three in-person study visits at baseline, 3 months and 6 months. The primary outcome, frequency of hypoglycaemia, will be determined from continuous glucose monitor (CGM) reports and patient blood glucose logs. Secondary outcomes will include glycaemic variability, time-in-range, glycated haemoglobin, stimulated C peptide, IP, serum inflammatory markers, quality of life and fear of hypoglycaemia ratings, as well as gut microbiome and metabolomics analysis. At 9 months, participant CGM data will be used to assess frequency of hypoglycaemia and glycaemic variability at 3 months postintervention.
ETHICS AND DISSEMINATION: The study received ethical approval from the University of Calgary Conjoint Health Research Ethics Board (REB21-0852). The University of Alberta subsite was granted ethical approval under the province of Alberta's research ethics reciprocity agreement as a participating site (REB21-0852; pSite00000066). The University of Saskatchewan subsite was granted ethical approval by the Biomedical Research Ethics Board (#4149). Trial findings will be disseminated through peer-reviewed publications and conference presentations.
TRIAL REGISTRATION NUMBER: clinicaltrials.gov NCT04963777.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Diabetes Mellitus, Type 1/blood
*Prebiotics/administration & dosage
Randomized Controlled Trials as Topic
Child
Blood Glucose/metabolism
Gastrointestinal Microbiome
Canada
Pilot Projects
Hypoglycemia/prevention & control
Female
Dietary Supplements
Male
Dysbiosis
Double-Blind Method
Adolescent
RevDate: 2025-05-31
Selected IEIs Associated with Severe Atopic Phenotypes: Implications for the Practicing Allergist.
Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology pii:S1081-1206(25)00266-2 [Epub ahead of print].
BACKGROUND: Food allergies and inborn errors of immunity (IEIs) were once viewed as distinct disorders-hypersensitivity versus infection susceptibility. However, IEIs are now recognized to include immune dysregulation, with autoimmunity, autoinflammation, lymphoproliferation, and severe atopy. Understanding the overlap between food allergies and IEIs is critical, as allergic inflammation often complicates immune deficiencies.
OBJECTIVE: To examine the shared immunologic mechanisms linking food allergies and IEIs, with a focus on immune dysregulation, barrier defects, microbial dysbiosis, and impaired regulatory T cell (Treg) function.
METHODS: A comprehensive literature review was conducted using PubMed applying search terms including food allergy, primary immunodeficiency, inborn errors of immunity (IEIs), Treg cells, immune dysregulation, autoimmunity, autoinflammation, epithelial barrier dysfunction, and microbiome. Particular focus was placed on identifying studies describing monogenic IEIs characterized by severe allergic phenotypes and elevated IgE levels. Articles were selected based on relevance to the themes of the review, quality of study design, and their contribution to advancing understanding in the field. Priority was given to original research articles, systematic reviews, meta-analyses, and key historical studies.
RESULTS: Allergic symptoms, including food allergy and atopic dermatitis, frequently present early in IEIs and may precede infection susceptibility. Common features include Treg dysfunction, cytokine signaling defects, epithelial barrier compromise, and microbiome alterations. Recognition of these pathways has enhanced diagnosis and led to targeted therapies such as biologics and gene therapy.
CONCLUSION: Regulatory T cells are central to maintaining immune tolerance across allergic, autoimmune, and immunodeficient states. Advances in understanding dysregulated immunity and barrier defects are driving personalized treatment strategies for patients with both food allergy and IEIs.
Additional Links: PMID-40449791
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40449791,
year = {2025},
author = {Bellanti, JA},
title = {Selected IEIs Associated with Severe Atopic Phenotypes: Implications for the Practicing Allergist.},
journal = {Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology},
volume = {},
number = {},
pages = {},
doi = {10.1016/j.anai.2025.05.024},
pmid = {40449791},
issn = {1534-4436},
abstract = {BACKGROUND: Food allergies and inborn errors of immunity (IEIs) were once viewed as distinct disorders-hypersensitivity versus infection susceptibility. However, IEIs are now recognized to include immune dysregulation, with autoimmunity, autoinflammation, lymphoproliferation, and severe atopy. Understanding the overlap between food allergies and IEIs is critical, as allergic inflammation often complicates immune deficiencies.
OBJECTIVE: To examine the shared immunologic mechanisms linking food allergies and IEIs, with a focus on immune dysregulation, barrier defects, microbial dysbiosis, and impaired regulatory T cell (Treg) function.
METHODS: A comprehensive literature review was conducted using PubMed applying search terms including food allergy, primary immunodeficiency, inborn errors of immunity (IEIs), Treg cells, immune dysregulation, autoimmunity, autoinflammation, epithelial barrier dysfunction, and microbiome. Particular focus was placed on identifying studies describing monogenic IEIs characterized by severe allergic phenotypes and elevated IgE levels. Articles were selected based on relevance to the themes of the review, quality of study design, and their contribution to advancing understanding in the field. Priority was given to original research articles, systematic reviews, meta-analyses, and key historical studies.
RESULTS: Allergic symptoms, including food allergy and atopic dermatitis, frequently present early in IEIs and may precede infection susceptibility. Common features include Treg dysfunction, cytokine signaling defects, epithelial barrier compromise, and microbiome alterations. Recognition of these pathways has enhanced diagnosis and led to targeted therapies such as biologics and gene therapy.
CONCLUSION: Regulatory T cells are central to maintaining immune tolerance across allergic, autoimmune, and immunodeficient states. Advances in understanding dysregulated immunity and barrier defects are driving personalized treatment strategies for patients with both food allergy and IEIs.},
}
RevDate: 2025-05-31
Characterization of blood and urine microbiome temporal variability in patients with acute myeloid leukemia.
Microbial pathogenesis pii:S0882-4010(25)00459-0 [Epub ahead of print].
BACKGROUND: Investigating the microbiota of blood and urine from acute myeloid leukemia (AML) patients is essential to unravel the complex role of microbiota in systemic host-microbe interactions and implications.
METHODS: We conducted a longitudinal observational study to characterize the temporal dynamics of blood and urine microbiota in 27 AML patients, utilizing metagenomic analysis pipeline for microbial identification to identify disease-associated microbial signatures.
RESULTS: The composition of blood and urine microbiota of AML was dominated by Proteobacteria phylum in blood, Firmicutes phylum in urine. The species and diversity of blood and urine microbiota did not have difference between AML patients and healthy controls. Restitution of alpha and beta diversity of blood microbiota and urine microbiota to resemble that of healthy controls occurred after cessation of treatment. Temporal variation of urine microbiome was higher than blood after treatment which was closely related to pathogenic bacteria and beneficial bacteria measured by coefficient of variation (CV) of alpha diversity. The temporal variability of urine microbiota was significantly correlated with platelet and exposure of levofloxacin. The variation of microbiome of AML patients with infection was found that the relative abundance of Burkholderia significantly enriched in blood and urine which had high accuracy and sensitivity. The correlation between blood microbiota and serum amino acid metabolites was similar to that between gut microbiota and serum metabolites.
CONCLUSION: This study represents the first comprehensive investigation to quantify the longitudinal variability of blood and urine microbiota in AML patients, revealing distinct patterns compared to gut microbiota and associations with adverse clinical outcomes. Our findings highlight the potential of leveraging stabilizing taxa as a target for microbiome restoration.
Additional Links: PMID-40449763
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40449763,
year = {2025},
author = {Liu, W and Chen, S and Yang, J and Chen, Y and Yang, Q and Lu, L and Li, J and Yang, T and Zhang, G and Hu, J},
title = {Characterization of blood and urine microbiome temporal variability in patients with acute myeloid leukemia.},
journal = {Microbial pathogenesis},
volume = {},
number = {},
pages = {107734},
doi = {10.1016/j.micpath.2025.107734},
pmid = {40449763},
issn = {1096-1208},
abstract = {BACKGROUND: Investigating the microbiota of blood and urine from acute myeloid leukemia (AML) patients is essential to unravel the complex role of microbiota in systemic host-microbe interactions and implications.
METHODS: We conducted a longitudinal observational study to characterize the temporal dynamics of blood and urine microbiota in 27 AML patients, utilizing metagenomic analysis pipeline for microbial identification to identify disease-associated microbial signatures.
RESULTS: The composition of blood and urine microbiota of AML was dominated by Proteobacteria phylum in blood, Firmicutes phylum in urine. The species and diversity of blood and urine microbiota did not have difference between AML patients and healthy controls. Restitution of alpha and beta diversity of blood microbiota and urine microbiota to resemble that of healthy controls occurred after cessation of treatment. Temporal variation of urine microbiome was higher than blood after treatment which was closely related to pathogenic bacteria and beneficial bacteria measured by coefficient of variation (CV) of alpha diversity. The temporal variability of urine microbiota was significantly correlated with platelet and exposure of levofloxacin. The variation of microbiome of AML patients with infection was found that the relative abundance of Burkholderia significantly enriched in blood and urine which had high accuracy and sensitivity. The correlation between blood microbiota and serum amino acid metabolites was similar to that between gut microbiota and serum metabolites.
CONCLUSION: This study represents the first comprehensive investigation to quantify the longitudinal variability of blood and urine microbiota in AML patients, revealing distinct patterns compared to gut microbiota and associations with adverse clinical outcomes. Our findings highlight the potential of leveraging stabilizing taxa as a target for microbiome restoration.},
}
RevDate: 2025-05-31
Bacteroides sphingolipids promote anti-inflammatory responses through the mevalonate pathway.
Cell host & microbe pii:S1931-3128(25)00186-6 [Epub ahead of print].
Sphingolipids derived from Bacteroides species are associated with changes in host inflammation and metabolic syndrome; however, the signaling mechanisms within host cells are unknown. We utilize outer membrane vesicles (OMVs) from wild-type and sphingolipid-deficient Bacteroides strains to understand how these lipids modulate host inflammation. Characterization of the lipidome of B. thetaiotaomicron OMVs revealed enrichment of dihydroceramide phosphoethanolamine (CerPE). OMVs deliver bacterial sphingolipids into host dendritic and epithelial cells, where a subset of lipids, including CerPE, stably persist. Similarly, B. thetaiotaomicron colonization results in sphingolipid persistence in murine tissues and host lipidome alterations that are not observed with the sphingolipid-deficient strain. OMVs induce a potent, sphingolipid-dependent interleukin-10 (IL-10) anti-inflammatory response in dendritic cells, which depends on mevalonate pathway activation. Adding a CerPE fraction to sphingolipid-deficient OMVs rescued IL-10 secretion, similarly dependent on mevalonate pathway activation. These data highlight the essential roles of sphingolipids in stimulating anti-inflammatory responses mediated by mevalonate pathway induction.
Additional Links: PMID-40449488
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40449488,
year = {2025},
author = {Brown, EM and Temple, ER and Jeanfavre, S and Avila-Pacheco, J and Taylor, N and Liu, K and Nguyen, PNU and Mohamed, AMT and Ung, P and Walker, RA and Graham, DB and Clish, CB and Xavier, RJ},
title = {Bacteroides sphingolipids promote anti-inflammatory responses through the mevalonate pathway.},
journal = {Cell host & microbe},
volume = {},
number = {},
pages = {},
doi = {10.1016/j.chom.2025.05.007},
pmid = {40449488},
issn = {1934-6069},
abstract = {Sphingolipids derived from Bacteroides species are associated with changes in host inflammation and metabolic syndrome; however, the signaling mechanisms within host cells are unknown. We utilize outer membrane vesicles (OMVs) from wild-type and sphingolipid-deficient Bacteroides strains to understand how these lipids modulate host inflammation. Characterization of the lipidome of B. thetaiotaomicron OMVs revealed enrichment of dihydroceramide phosphoethanolamine (CerPE). OMVs deliver bacterial sphingolipids into host dendritic and epithelial cells, where a subset of lipids, including CerPE, stably persist. Similarly, B. thetaiotaomicron colonization results in sphingolipid persistence in murine tissues and host lipidome alterations that are not observed with the sphingolipid-deficient strain. OMVs induce a potent, sphingolipid-dependent interleukin-10 (IL-10) anti-inflammatory response in dendritic cells, which depends on mevalonate pathway activation. Adding a CerPE fraction to sphingolipid-deficient OMVs rescued IL-10 secretion, similarly dependent on mevalonate pathway activation. These data highlight the essential roles of sphingolipids in stimulating anti-inflammatory responses mediated by mevalonate pathway induction.},
}
RevDate: 2025-05-31
Genome-centric metagenomics reveals the effect of organic carbon source on one-stage partial denitrification-anammox in biofilm reactors.
Journal of environmental management, 388:125972 pii:S0301-4797(25)01948-6 [Epub ahead of print].
Nitrogen removal from wastewater with anammox saves energy and resources. Partial denitrification-anammox (PDA) is a promising process alternative for municipal wastewater treatment, given that the understanding about how to control the microbiome and its activity reach sufficient level. Here, two moving bed biofilm reactors were fed with either acetate or propionate to study the role of organic carbon type for microbiome composition and nitrogen turnover during development of PDA. With acetate, 87 % of the removed nitrogen was converted via anammox during stable operation at a rate of 0.52 g N/(m[2]·d). With propionate, the anammox contribution was considerably lower (41 %), as was the rate of nitrogen removal (0.27 g N/(m[2]·d)). The microbiome composition in the acetate- and propionate-fed reactors was however similar, with an enrichment of metagenome assembled genomes (MAGs) having genes for nitrate reduction (narG, napA). A large fraction of these MAGs had the potential to accumulate nitrite since they lacked genes for nitrite reduction (nirS, nirK, nrfA). Genes for acetate utilization were common among these MAGs, but the necessary genes for propionate conversion were rare, suggesting that the genetic make-up of the individual denitrifiers had major influence on the nitrogen turnover. One anammox MAG (Ca. Brocadia sapporoensis), harboring genes for organic carbon utilization, prevailed in the PDA reactors. Another three anammox MAGs (Ca. B. fulgida, Ca. B. pituitae and a potentially new species within Ca. Brocadia), lacking genes for organic carbon utilization, decreased in abundance in the reactors, indicating the importance of metabolic versatility for anammox bacteria in PDA.
Additional Links: PMID-40449445
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40449445,
year = {2025},
author = {Zheng, Z and Gustavsson, DJI and Zheng, D and Holmin, F and Falås, P and Wilén, BM and Modin, O and Persson, F},
title = {Genome-centric metagenomics reveals the effect of organic carbon source on one-stage partial denitrification-anammox in biofilm reactors.},
journal = {Journal of environmental management},
volume = {388},
number = {},
pages = {125972},
doi = {10.1016/j.jenvman.2025.125972},
pmid = {40449445},
issn = {1095-8630},
abstract = {Nitrogen removal from wastewater with anammox saves energy and resources. Partial denitrification-anammox (PDA) is a promising process alternative for municipal wastewater treatment, given that the understanding about how to control the microbiome and its activity reach sufficient level. Here, two moving bed biofilm reactors were fed with either acetate or propionate to study the role of organic carbon type for microbiome composition and nitrogen turnover during development of PDA. With acetate, 87 % of the removed nitrogen was converted via anammox during stable operation at a rate of 0.52 g N/(m[2]·d). With propionate, the anammox contribution was considerably lower (41 %), as was the rate of nitrogen removal (0.27 g N/(m[2]·d)). The microbiome composition in the acetate- and propionate-fed reactors was however similar, with an enrichment of metagenome assembled genomes (MAGs) having genes for nitrate reduction (narG, napA). A large fraction of these MAGs had the potential to accumulate nitrite since they lacked genes for nitrite reduction (nirS, nirK, nrfA). Genes for acetate utilization were common among these MAGs, but the necessary genes for propionate conversion were rare, suggesting that the genetic make-up of the individual denitrifiers had major influence on the nitrogen turnover. One anammox MAG (Ca. Brocadia sapporoensis), harboring genes for organic carbon utilization, prevailed in the PDA reactors. Another three anammox MAGs (Ca. B. fulgida, Ca. B. pituitae and a potentially new species within Ca. Brocadia), lacking genes for organic carbon utilization, decreased in abundance in the reactors, indicating the importance of metabolic versatility for anammox bacteria in PDA.},
}
RevDate: 2025-05-31
Unveiling the hidden microbiome: a microbiological exploration of untouched burial crypts in Krakow, Poland.
Systematic and applied microbiology, 48(4):126618 pii:S0723-2020(25)00040-2 [Epub ahead of print].
Cultural heritage objects provide valuable historical information, but can also harbour biological threats. Still, little is said about the potential risks that may await unaware researchers, conservators, and archaeologists. Our work discusses the study results from the crypts in Krakow, which were opened for the first time. The human and coffin remains were examined. The number of actinomycetes, other mesophilic bacteria, bacterial spores, and xerophilic and non-xerophilic fungi was determined. In general, a low number of microbes was observed. However, scanning electron microscope (SEM) images showed many bacterial conglomerates and confirmed that microbial activity affected the fibres covering cadavers in the crypts. The most abundant were mesophilic bacteria, followed by bacterial spores and actinomycetes. They reached up to 10[7] CFU/g in fabric remains, 5.2 × 10[6] CFU/g in burial remains, and 1.6 × 10[6] CFU/g found under the coffin, and above 7.5 × 10[5] CFU/g for xerophilic and non-xerophilic fungi. NGS (Next-Generation Sequencing) results suggested that the low presence of microorganisms may be due to the dominance of unculturable or long-growing bacteria belonging to Mycobacterium, such as M. coloregonium, M. arupense, and M. pinnipedii. Moreover, other obligatory/non-obligatory pathogens, Bacteroides fragilis, Clostridium botulinum, Coxiella burnetii, Clostridium tetani, Corynebacterium diphtheriae, Enterobacter cloacae, Escherichia coli, Legionella pneumophila, Mycobacterium leprae, Rhodococcus equi, and Staphylococcus aureus have been recorded in examined samples, with the dominance in bone samples. Results indicate the risk of dangerous pathogens present in historical objects, the impact on health may be severe, and the need to use personal protective equipment and proper measures to control the physical conditions of crypts.
Additional Links: PMID-40449316
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40449316,
year = {2025},
author = {Tarnawska, P and Burkowska-But, A and Brzezińska, MS and Drążkowska, A and Osińska, A and Walczak, M},
title = {Unveiling the hidden microbiome: a microbiological exploration of untouched burial crypts in Krakow, Poland.},
journal = {Systematic and applied microbiology},
volume = {48},
number = {4},
pages = {126618},
doi = {10.1016/j.syapm.2025.126618},
pmid = {40449316},
issn = {1618-0984},
abstract = {Cultural heritage objects provide valuable historical information, but can also harbour biological threats. Still, little is said about the potential risks that may await unaware researchers, conservators, and archaeologists. Our work discusses the study results from the crypts in Krakow, which were opened for the first time. The human and coffin remains were examined. The number of actinomycetes, other mesophilic bacteria, bacterial spores, and xerophilic and non-xerophilic fungi was determined. In general, a low number of microbes was observed. However, scanning electron microscope (SEM) images showed many bacterial conglomerates and confirmed that microbial activity affected the fibres covering cadavers in the crypts. The most abundant were mesophilic bacteria, followed by bacterial spores and actinomycetes. They reached up to 10[7] CFU/g in fabric remains, 5.2 × 10[6] CFU/g in burial remains, and 1.6 × 10[6] CFU/g found under the coffin, and above 7.5 × 10[5] CFU/g for xerophilic and non-xerophilic fungi. NGS (Next-Generation Sequencing) results suggested that the low presence of microorganisms may be due to the dominance of unculturable or long-growing bacteria belonging to Mycobacterium, such as M. coloregonium, M. arupense, and M. pinnipedii. Moreover, other obligatory/non-obligatory pathogens, Bacteroides fragilis, Clostridium botulinum, Coxiella burnetii, Clostridium tetani, Corynebacterium diphtheriae, Enterobacter cloacae, Escherichia coli, Legionella pneumophila, Mycobacterium leprae, Rhodococcus equi, and Staphylococcus aureus have been recorded in examined samples, with the dominance in bone samples. Results indicate the risk of dangerous pathogens present in historical objects, the impact on health may be severe, and the need to use personal protective equipment and proper measures to control the physical conditions of crypts.},
}
RevDate: 2025-05-31
Unraveling the stress response: How low temperature and nanoparticles impact the chinese mitten crab (Eriocheir sinensis).
Journal of hazardous materials, 494:138775 pii:S0304-3894(25)01691-7 [Epub ahead of print].
The Chinese mitten crab (Eriocheir sinensis) is a freshwater crustacean of considerable economic significance. To elucidate its physiological regulatory mechanisms under environmental stressors, we examined responses to low temperature (10 °C), ambient temperature (25 °C), and polystyrene nanoparticles (PS-NPs; 0, 1, and 10 mg/L) over a 28-day period. Exposure to these stressors led to a marked increase in glutathione peroxidase (GSH-Px) and lysozyme (LZM) activity, alongside a notable suppression of superoxide dismutase (SOD). Integrative microbiome, metabolome and transcriptome analyses revealed distinct shifts in microbial composition and metabolite profiles, including elevated levels of citric acid, L-isoleucine (L-allo-Ile), and trans-cinnamic acid (t-CA). Functional enrichment of differentially expressed metabolites and microbial taxa implicated pathways involved in oxidative defense, immune regulation, and PI3K-Akt-FoxO signaling. Functional enrichment analyses of differentially expressed metabolites (DEMs) and microbial taxa pointed to coordinated disruptions in redox homeostasis, cellular defense mechanisms, and host-microbe interactions. Collectively, our findings demonstrate that prolonged exposure to low temperatures and PS-NPs imposes considerable physiological burden on E. sinensis, manifested as metabolic dysregulation, oxidative damage, and impaired immune competence. This study provides a comprehensive molecular framework for understanding how E. sinensis responds to multifactorial environmental stressors, offering valuable insights for ecological risk assessment and resilience-oriented aquaculture practices.
Additional Links: PMID-40449217
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40449217,
year = {2025},
author = {Zhou, Z and Tian, J and Si, Q and Tay, YJ and Han, M and Jiang, Q and Wang, L},
title = {Unraveling the stress response: How low temperature and nanoparticles impact the chinese mitten crab (Eriocheir sinensis).},
journal = {Journal of hazardous materials},
volume = {494},
number = {},
pages = {138775},
doi = {10.1016/j.jhazmat.2025.138775},
pmid = {40449217},
issn = {1873-3336},
abstract = {The Chinese mitten crab (Eriocheir sinensis) is a freshwater crustacean of considerable economic significance. To elucidate its physiological regulatory mechanisms under environmental stressors, we examined responses to low temperature (10 °C), ambient temperature (25 °C), and polystyrene nanoparticles (PS-NPs; 0, 1, and 10 mg/L) over a 28-day period. Exposure to these stressors led to a marked increase in glutathione peroxidase (GSH-Px) and lysozyme (LZM) activity, alongside a notable suppression of superoxide dismutase (SOD). Integrative microbiome, metabolome and transcriptome analyses revealed distinct shifts in microbial composition and metabolite profiles, including elevated levels of citric acid, L-isoleucine (L-allo-Ile), and trans-cinnamic acid (t-CA). Functional enrichment of differentially expressed metabolites and microbial taxa implicated pathways involved in oxidative defense, immune regulation, and PI3K-Akt-FoxO signaling. Functional enrichment analyses of differentially expressed metabolites (DEMs) and microbial taxa pointed to coordinated disruptions in redox homeostasis, cellular defense mechanisms, and host-microbe interactions. Collectively, our findings demonstrate that prolonged exposure to low temperatures and PS-NPs imposes considerable physiological burden on E. sinensis, manifested as metabolic dysregulation, oxidative damage, and impaired immune competence. This study provides a comprehensive molecular framework for understanding how E. sinensis responds to multifactorial environmental stressors, offering valuable insights for ecological risk assessment and resilience-oriented aquaculture practices.},
}
RevDate: 2025-05-31
Treatment of chickens with probiotics under conditions conducive to necrotic enteritis development.
Research in veterinary science, 192:105711 pii:S0034-5288(25)00185-7 [Epub ahead of print].
Necrotic enteritis (NE) poses a significant challenge to the global broiler industry, particularly with the increasing restrictions on using antibiotic growth promoters. Probiotics have emerged as a promising alternative for effective disease control. This study evaluated the efficacy of a probiotic cocktail consisting of Lactobacillus crispatus, Ligilactobacillus johnsonii, Limosilactobacillus reuteri, and 2 strains of Ligilactobacillus salivarius, under experimental conditions conducive to NE. Chickens were divided into two groups based on stocking density: high stocking density (30 birds/m[2]) and normal stocking density (15 birds/m[2]). Within each group, one subgroup received 10[8] colony-forming units (CFUs) of lactobacilli on days 1, 7, 14, and 20 of age, while the other received phosphate-buffered saline. Body weight and lesion scores were recorded on days 21 and 24, respectively. Tissues from the intestine were collected for analysis of immunoregulatory genes and lymphocyte population. Cecal contents were collected for microbiome analysis. Probiotic treatment improved body weight gain compared to non-treated controls and reduced gut lesion scoring in the birds raised under high stocking density. Probiotic treatment increased the frequency of Bu-1[+] B cells and CD3[+]CD4[+] T cells in the cecal tonsils and enhanced the relative expression of antimicrobial peptides (zonula occludens and occludin) in the ileum. However, it decreased the expression of heat shock proteins, interleukin (IL)-18, IL-1β, and interferon (IFN)-γ. Probiotics also enhanced alpha diversity and the abundance of Christensenellaceae_R-7 group, Angelakisella, and Clostridia_vadinBB60 group compared to the high stocking density control group. These findings underscore the potential of probiotics to mitigate NE in broiler chickens, particularly under conditions of high stocking density.
Additional Links: PMID-40449136
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40449136,
year = {2025},
author = {Alizadeh, M and Fletcher, C and Oladokun, S and Mallick, AI and Abdelaziz, K and St-Denis, M and Raj, S and Blake, K and Sharif, S},
title = {Treatment of chickens with probiotics under conditions conducive to necrotic enteritis development.},
journal = {Research in veterinary science},
volume = {192},
number = {},
pages = {105711},
doi = {10.1016/j.rvsc.2025.105711},
pmid = {40449136},
issn = {1532-2661},
abstract = {Necrotic enteritis (NE) poses a significant challenge to the global broiler industry, particularly with the increasing restrictions on using antibiotic growth promoters. Probiotics have emerged as a promising alternative for effective disease control. This study evaluated the efficacy of a probiotic cocktail consisting of Lactobacillus crispatus, Ligilactobacillus johnsonii, Limosilactobacillus reuteri, and 2 strains of Ligilactobacillus salivarius, under experimental conditions conducive to NE. Chickens were divided into two groups based on stocking density: high stocking density (30 birds/m[2]) and normal stocking density (15 birds/m[2]). Within each group, one subgroup received 10[8] colony-forming units (CFUs) of lactobacilli on days 1, 7, 14, and 20 of age, while the other received phosphate-buffered saline. Body weight and lesion scores were recorded on days 21 and 24, respectively. Tissues from the intestine were collected for analysis of immunoregulatory genes and lymphocyte population. Cecal contents were collected for microbiome analysis. Probiotic treatment improved body weight gain compared to non-treated controls and reduced gut lesion scoring in the birds raised under high stocking density. Probiotic treatment increased the frequency of Bu-1[+] B cells and CD3[+]CD4[+] T cells in the cecal tonsils and enhanced the relative expression of antimicrobial peptides (zonula occludens and occludin) in the ileum. However, it decreased the expression of heat shock proteins, interleukin (IL)-18, IL-1β, and interferon (IFN)-γ. Probiotics also enhanced alpha diversity and the abundance of Christensenellaceae_R-7 group, Angelakisella, and Clostridia_vadinBB60 group compared to the high stocking density control group. These findings underscore the potential of probiotics to mitigate NE in broiler chickens, particularly under conditions of high stocking density.},
}
RevDate: 2025-05-31
Bile acids enhance fat metabolism and skeletal muscle development in Zhijiang duck by modulating gut microbiota.
Poultry science, 104(8):105319 pii:S0032-5791(25)00562-0 [Epub ahead of print].
To optimize livestock production of integrated farms, dietary crude fat levels are often increased, making efficient fat utilization crucial. Bile acids are known to improve fat utilization, but their impact on growth performance and breast muscle development in Zhijiang ducks remains unclear. In this study, a total of 360 twenty-day-old Zhijiang ducks with similar body weights were divided into three groups: the control group (CN) received a basal diet; the high-fat group (FA) received the basal diet plus 1.25 % rapeseed oil; and the high-fat plus bile acids compound (BA) group (FB) received the FA diet supplemented with 250 mg/kg BA for 30 days. Results indicated that the addition of rapeseed oil and BA significantly increased (P < 0.05) average daily gain (ADG) and reduced (P < 0.05) feed conversion ratio (FCR). Slaughter data showed that BA significantly enhanced (P < 0.05) breast muscle weight and percentage while decreasing (P < 0.05) abdominal fat weight. Additionally, BA increased (P < 0.05) the cross-sectional area of breast muscle fibers, total bile acid content, and levels of insulin-like growth factors 1/2 (IGF1/2). Transcriptomic analysis further revealed that BA significantly upregulated (P < 0.05) the levels of PPARα, CPT1α, NR1H4, and CETP in breast muscle. 16S rRNA analysis showed a significant increase (P < 0.05) in the relative abundances of genera Enorma, [Eubacterium nodatum group], Rikenellaceae RC9 gut group, and SP3-e08. Additionally, the Spearman correlation suggested a positive correlation between the genera Olsenella, SP3-e08, Enorma, Rikenellaceae_RC9_gut_group, and [Eubacterium_nodatum_group] with PPARα, CETP, NR1H4, and CPT1α. In contrast, the genera Christensenellaceae_R_7_group and Sutterella exhibited negative correlations with PPARα. These findings provide new insights into the role of BA in promoting growth performance and skeletal muscle development in Zhijiang ducks fed a high-fat diet, with this effect potentially linked to changes in the gut microbiota.
Additional Links: PMID-40449103
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40449103,
year = {2025},
author = {Chen, L and Zhang, Z and Deng, W and Jiang, G and Xie, D and Cao, A},
title = {Bile acids enhance fat metabolism and skeletal muscle development in Zhijiang duck by modulating gut microbiota.},
journal = {Poultry science},
volume = {104},
number = {8},
pages = {105319},
doi = {10.1016/j.psj.2025.105319},
pmid = {40449103},
issn = {1525-3171},
abstract = {To optimize livestock production of integrated farms, dietary crude fat levels are often increased, making efficient fat utilization crucial. Bile acids are known to improve fat utilization, but their impact on growth performance and breast muscle development in Zhijiang ducks remains unclear. In this study, a total of 360 twenty-day-old Zhijiang ducks with similar body weights were divided into three groups: the control group (CN) received a basal diet; the high-fat group (FA) received the basal diet plus 1.25 % rapeseed oil; and the high-fat plus bile acids compound (BA) group (FB) received the FA diet supplemented with 250 mg/kg BA for 30 days. Results indicated that the addition of rapeseed oil and BA significantly increased (P < 0.05) average daily gain (ADG) and reduced (P < 0.05) feed conversion ratio (FCR). Slaughter data showed that BA significantly enhanced (P < 0.05) breast muscle weight and percentage while decreasing (P < 0.05) abdominal fat weight. Additionally, BA increased (P < 0.05) the cross-sectional area of breast muscle fibers, total bile acid content, and levels of insulin-like growth factors 1/2 (IGF1/2). Transcriptomic analysis further revealed that BA significantly upregulated (P < 0.05) the levels of PPARα, CPT1α, NR1H4, and CETP in breast muscle. 16S rRNA analysis showed a significant increase (P < 0.05) in the relative abundances of genera Enorma, [Eubacterium nodatum group], Rikenellaceae RC9 gut group, and SP3-e08. Additionally, the Spearman correlation suggested a positive correlation between the genera Olsenella, SP3-e08, Enorma, Rikenellaceae_RC9_gut_group, and [Eubacterium_nodatum_group] with PPARα, CETP, NR1H4, and CPT1α. In contrast, the genera Christensenellaceae_R_7_group and Sutterella exhibited negative correlations with PPARα. These findings provide new insights into the role of BA in promoting growth performance and skeletal muscle development in Zhijiang ducks fed a high-fat diet, with this effect potentially linked to changes in the gut microbiota.},
}
RevDate: 2025-05-31
A solution to the postantibiotic era: phages as precision medicine.
Current opinion in microbiology, 86:102613 pii:S1369-5274(25)00035-9 [Epub ahead of print].
Antibiotic-resistant bacterial infections pose a significant global health challenge. Phage therapy provides a promising alternative to antibiotics that enables the specific targeting of pathogenic bacteria while preserving the healthy microbiome. Recent advances in genetic engineering, synthetic biology, and artificial intelligence have rekindled interest in phage therapy, as they move phages into the realm of precision medicine. Engineered phages can be customized to have a broader host range, encode counter-defenses that overcome bacterial immune systems, or express other proteins that modulate the bacterial host to their advantage. Innovations in artificial intelligence and machine learning promise to speed up the identification of optimal phage candidates and create tailored cocktails for individualized therapies - advances that will transform phage therapy and provide a solution to the antibiotic resistance crisis.
Additional Links: PMID-40449069
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40449069,
year = {2025},
author = {Getz, LJ and Patel, PH and Maxwell, KL},
title = {A solution to the postantibiotic era: phages as precision medicine.},
journal = {Current opinion in microbiology},
volume = {86},
number = {},
pages = {102613},
doi = {10.1016/j.mib.2025.102613},
pmid = {40449069},
issn = {1879-0364},
abstract = {Antibiotic-resistant bacterial infections pose a significant global health challenge. Phage therapy provides a promising alternative to antibiotics that enables the specific targeting of pathogenic bacteria while preserving the healthy microbiome. Recent advances in genetic engineering, synthetic biology, and artificial intelligence have rekindled interest in phage therapy, as they move phages into the realm of precision medicine. Engineered phages can be customized to have a broader host range, encode counter-defenses that overcome bacterial immune systems, or express other proteins that modulate the bacterial host to their advantage. Innovations in artificial intelligence and machine learning promise to speed up the identification of optimal phage candidates and create tailored cocktails for individualized therapies - advances that will transform phage therapy and provide a solution to the antibiotic resistance crisis.},
}
RevDate: 2025-06-01
Interorgan and Transcellular Communication in Metabolic Disease: Insights from Recent CMGH Studies.
Cellular and molecular gastroenterology and hepatology pii:S2352-345X(25)00071-2 [Epub ahead of print].
The emergence of interorgan and transcellular signaling as a defining hallmark of metabolic disease has catalyzed a paradigm shift in gastroenterology and hepatology. Increasingly, the gut, liver, adipose tissue, immune system, and the nervous system are being understood as nodes in an integrated metabolic network rather than isolated organs. The gut microbiome and its metabolites, enteroendocrine signaling, bile acid regulation, and epithelial barrier functions now occupy center stage in dissecting the pathophysiology not only of gastroenterologic conditions, such as obesity, metabolically associated steatotic liver disease, and cirrhosis, but also of several disorders making up the chronic noncontagious disease epidemic. This paradigm shift is being driven by advances in molecular biology, systems biology, and computational modeling, which have enabled a holistic understanding of how communication between organs orchestrates metabolic homeostasis.[1] Key to this understanding is the realization that local perturbations in 1 organ, such as gut microbial dysbiosis, can have systemic repercussions that affect distant organs, such as the liver or brain.[2][,][3] This has redefined how researchers conceptualize disease progression and therapeutic interventions. Rather than focusing on a single tissue, there is increasing interest in identifying molecular messengers that mediate crosstalk between organ systems, such as microbial metabolites, enteroendocrine peptides, bile acids, and cytokines. In this review, we highlight 4 recent and impactful studies published in Cellular and Molecular Gastroenterology and Hepatology that exemplify these advances. Each study offers a unique window into the mechanisms by which gut-derived signals influence host metabolism and disease states. Together, they deepen the understanding of the complex dialogue between organs and open new avenues for therapeutic exploration. We conclude by discussing the implications of these findings and outlining emerging questions and future directions for the field.
Additional Links: PMID-40348017
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40348017,
year = {2025},
author = {Dong, TS and Mayer, E},
title = {Interorgan and Transcellular Communication in Metabolic Disease: Insights from Recent CMGH Studies.},
journal = {Cellular and molecular gastroenterology and hepatology},
volume = {},
number = {},
pages = {101530},
doi = {10.1016/j.jcmgh.2025.101530},
pmid = {40348017},
issn = {2352-345X},
abstract = {The emergence of interorgan and transcellular signaling as a defining hallmark of metabolic disease has catalyzed a paradigm shift in gastroenterology and hepatology. Increasingly, the gut, liver, adipose tissue, immune system, and the nervous system are being understood as nodes in an integrated metabolic network rather than isolated organs. The gut microbiome and its metabolites, enteroendocrine signaling, bile acid regulation, and epithelial barrier functions now occupy center stage in dissecting the pathophysiology not only of gastroenterologic conditions, such as obesity, metabolically associated steatotic liver disease, and cirrhosis, but also of several disorders making up the chronic noncontagious disease epidemic. This paradigm shift is being driven by advances in molecular biology, systems biology, and computational modeling, which have enabled a holistic understanding of how communication between organs orchestrates metabolic homeostasis.[1] Key to this understanding is the realization that local perturbations in 1 organ, such as gut microbial dysbiosis, can have systemic repercussions that affect distant organs, such as the liver or brain.[2][,][3] This has redefined how researchers conceptualize disease progression and therapeutic interventions. Rather than focusing on a single tissue, there is increasing interest in identifying molecular messengers that mediate crosstalk between organ systems, such as microbial metabolites, enteroendocrine peptides, bile acids, and cytokines. In this review, we highlight 4 recent and impactful studies published in Cellular and Molecular Gastroenterology and Hepatology that exemplify these advances. Each study offers a unique window into the mechanisms by which gut-derived signals influence host metabolism and disease states. Together, they deepen the understanding of the complex dialogue between organs and open new avenues for therapeutic exploration. We conclude by discussing the implications of these findings and outlining emerging questions and future directions for the field.},
}
RevDate: 2025-05-31
Biochar loaded with nicotine-degrading bacteria works synergistically with native microorganisms to efficiently degrade nicotine.
Environment international, 201:109550 pii:S0160-4120(25)00301-0 [Epub ahead of print].
Nicotine, a potential environmental pollutant that has raised increasing concerns, accumulates to significant levels in soils under long-term tobacco monoculture, posing substantial risks to both local ecosystems and human health. Addressing this challenge, the screening and utilization of nicotine-degrading bacteria have emerged as a central remediation strategy. In this study, we isolated nicotine-degrading bacteria from tobacco-cultivated soils and subsequently immobilized them onto biochar to optimize degradation efficiency. A systematic investigation was conducted to examine the synergistic effects and underlying degradation mechanisms of the biochar-bacteria complex. Notably, we successfully isolated Paenarthrobacter ureafaciens N21 (N21), a bacterial strain capable of degrading nicotine through the pyridine pathway. When immobilized on biochar (BN21), the composite maintained robust degradation capabilities in both culture media and soil environments. Compared with free N21, BN21 demonstrated a 1.4 times enhancement in nicotine degradation efficiency and significantly improved colonization capacity by the degrading bacteria (P < 0.0001). Stability assessment tests further confirmed BN21's consistent degradation performance under diverse environmental conditions. Integrated microbiomic and metabolomic analyses revealed that BN21 induced significant alterations in soil microbial community structure and metabolic profiles, while enhancing the soil's resistance to repeated nicotine disturbances. Importantly, BN21 facilitated synergistic interactions between nicotine-degrading bacteria and indigenous microorganisms, collectively mediating nicotine decomposition through coordinated pyridine and pyrrolidine pathways. The novel discovery of bacteria-loaded biochar synergistically enhancing nicotine removal highlights the potential of biochar-microbe composites for targeted pollutant elimination. This approach shows promising prospects for future applications in ecological remediation of various organic contaminants, providing innovative perspectives for developing microbiome-based green remediation strategies.
Additional Links: PMID-40449064
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40449064,
year = {2025},
author = {Zhu, X and Jia, M and Zhou, W and Zhou, P and Du, Y and Yang, H and Wang, G and Bai, Y and Wang, N},
title = {Biochar loaded with nicotine-degrading bacteria works synergistically with native microorganisms to efficiently degrade nicotine.},
journal = {Environment international},
volume = {201},
number = {},
pages = {109550},
doi = {10.1016/j.envint.2025.109550},
pmid = {40449064},
issn = {1873-6750},
abstract = {Nicotine, a potential environmental pollutant that has raised increasing concerns, accumulates to significant levels in soils under long-term tobacco monoculture, posing substantial risks to both local ecosystems and human health. Addressing this challenge, the screening and utilization of nicotine-degrading bacteria have emerged as a central remediation strategy. In this study, we isolated nicotine-degrading bacteria from tobacco-cultivated soils and subsequently immobilized them onto biochar to optimize degradation efficiency. A systematic investigation was conducted to examine the synergistic effects and underlying degradation mechanisms of the biochar-bacteria complex. Notably, we successfully isolated Paenarthrobacter ureafaciens N21 (N21), a bacterial strain capable of degrading nicotine through the pyridine pathway. When immobilized on biochar (BN21), the composite maintained robust degradation capabilities in both culture media and soil environments. Compared with free N21, BN21 demonstrated a 1.4 times enhancement in nicotine degradation efficiency and significantly improved colonization capacity by the degrading bacteria (P < 0.0001). Stability assessment tests further confirmed BN21's consistent degradation performance under diverse environmental conditions. Integrated microbiomic and metabolomic analyses revealed that BN21 induced significant alterations in soil microbial community structure and metabolic profiles, while enhancing the soil's resistance to repeated nicotine disturbances. Importantly, BN21 facilitated synergistic interactions between nicotine-degrading bacteria and indigenous microorganisms, collectively mediating nicotine decomposition through coordinated pyridine and pyrrolidine pathways. The novel discovery of bacteria-loaded biochar synergistically enhancing nicotine removal highlights the potential of biochar-microbe composites for targeted pollutant elimination. This approach shows promising prospects for future applications in ecological remediation of various organic contaminants, providing innovative perspectives for developing microbiome-based green remediation strategies.},
}
RevDate: 2025-05-31
Effects of probiotic treatment on the intestinal microbial community of Haliotis diversicolor.
AMB Express, 15(1):87.
Probiotic treatment is an effective method for enhancing growth performance and improving intestinal flora in aquaculture species. This study examined the effects of three candidate-probiotics (Bacillus, photosynthetic bacteria, and Lactobacillus) on the rate of weight gain and the intestinal flora of abalone juveniles. Haliotis diversicolor was fed a probiotic-supplemented diet for 30 days. The abalones fed with Lactobacillus showed a more significant weight gain rate than those in the Bacillus, photosynthetic bacteria, and control groups. Through 16S rRNA high-throughput sequencing, 12,490 amplicon sequence variants (ASVs) were obtained from the abalone intestinal tract microbiome. After a short feeding period (5 days), the Bacillus and photosynthetic bacteria-treated groups showed an increased abundance of Proteobacteria in the abalone digestive tract. In the Lactobacillus-treated group, the quantity of Proteobacteria decreased, and the abundance of Bacteroidota increased. After 30 days of feeding, the abundance of Proteobacteria and Bacteroidetes at the phylum level was more significant in the Bacillus-treated group and photosynthetic bacteria-treated group than in the controls. The Lactobacillus-treated group showed an increase in the quantity of Proteobacteria and Chloroflexi. The dominant flora of the three probiotic treated groups changed slightly with respect to the control group. After a short period of feeding (5 days), the abundance of Rhodobacteraceae (at the genus level) in the abalone digestive tract increased in the Bacillus- and photosynthetic bacteria-treated groups, whereas in the Lactobacillus-treated group, Rhodobacteraceae decreased, and Maribacter increased in abundance. After 30 days of feeding, Bacteroidetes and Ruegeria were higher in the Bacillus-treated group than in the control group. Marinirhabdus and Bacteroidetes increased in the photosynthetic bacteria-treated group, and Roseivivax and Ruegeria increased in the Lactobacillus-treated group. The three probiotic-treated groups had higher microbial diversity than the control group. Therefore, our findings confirmed that adding Bacillus, photosynthetic bacteria, and Lactobacillus to the abalone diet increased abalones' weight gain rate and altered their intestinal microbiome composition.
Additional Links: PMID-40448919
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40448919,
year = {2025},
author = {Wang, R and Wang, J and Tang, D and Li, B and Huang, J and Lin, X and Li, Y and Xu, W and Gao, W and Wang, J and Zhu, H},
title = {Effects of probiotic treatment on the intestinal microbial community of Haliotis diversicolor.},
journal = {AMB Express},
volume = {15},
number = {1},
pages = {87},
pmid = {40448919},
issn = {2191-0855},
support = {2022ZDZX4029//the grants from Guangdong Province university key field special grant/ ; },
abstract = {Probiotic treatment is an effective method for enhancing growth performance and improving intestinal flora in aquaculture species. This study examined the effects of three candidate-probiotics (Bacillus, photosynthetic bacteria, and Lactobacillus) on the rate of weight gain and the intestinal flora of abalone juveniles. Haliotis diversicolor was fed a probiotic-supplemented diet for 30 days. The abalones fed with Lactobacillus showed a more significant weight gain rate than those in the Bacillus, photosynthetic bacteria, and control groups. Through 16S rRNA high-throughput sequencing, 12,490 amplicon sequence variants (ASVs) were obtained from the abalone intestinal tract microbiome. After a short feeding period (5 days), the Bacillus and photosynthetic bacteria-treated groups showed an increased abundance of Proteobacteria in the abalone digestive tract. In the Lactobacillus-treated group, the quantity of Proteobacteria decreased, and the abundance of Bacteroidota increased. After 30 days of feeding, the abundance of Proteobacteria and Bacteroidetes at the phylum level was more significant in the Bacillus-treated group and photosynthetic bacteria-treated group than in the controls. The Lactobacillus-treated group showed an increase in the quantity of Proteobacteria and Chloroflexi. The dominant flora of the three probiotic treated groups changed slightly with respect to the control group. After a short period of feeding (5 days), the abundance of Rhodobacteraceae (at the genus level) in the abalone digestive tract increased in the Bacillus- and photosynthetic bacteria-treated groups, whereas in the Lactobacillus-treated group, Rhodobacteraceae decreased, and Maribacter increased in abundance. After 30 days of feeding, Bacteroidetes and Ruegeria were higher in the Bacillus-treated group than in the control group. Marinirhabdus and Bacteroidetes increased in the photosynthetic bacteria-treated group, and Roseivivax and Ruegeria increased in the Lactobacillus-treated group. The three probiotic-treated groups had higher microbial diversity than the control group. Therefore, our findings confirmed that adding Bacillus, photosynthetic bacteria, and Lactobacillus to the abalone diet increased abalones' weight gain rate and altered their intestinal microbiome composition.},
}
RevDate: 2025-05-31
DNA forensics at forty: the way forward.
International journal of legal medicine [Epub ahead of print].
Forensic DNA analysis has transformed criminal investigations since its inception in 1985. Over four decades, this field has evolved through various phases-from the early stages of exploration to today's highly sophisticated methodologies. Key advancements such as the development of rapid DNA analysis techniques, microchip-based systems, and next-generation sequencing have improved the speed, reliability, and utility of DNA forensics. However, despite these technological advances, the field still faces considerable challenges, particularly with increasing case backlogs, limited population-specific databases, and the difficulties associated with analyzing degraded or challenging samples like bones and touch DNA. Emerging technologies such as single-cell genomic analysis, lineage markers, proteomics, and human microbiome analysis offer promising solutions to these challenges. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) in forensic workflows is enhancing the ability to analyze complex DNA samples efficiently, paving the way for faster and more accurate results. As forensic DNA analysis enters its next phase, the focus will be on expanding databases, refining quality control and assurance protocols, and standardizing training for forensic professionals worldwide. The journey of forensic DNA analysis over the past 40 years demonstrates a field in continuous development. Although significant progress has been made, there remain opportunities for further innovation, particularly in overcoming the current limitations and addressing ethical and legal concerns. By doing so, forensic DNA analysis will continue to play a pivotal role in the future of criminal justice.
Additional Links: PMID-40448869
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40448869,
year = {2025},
author = {Dash, HR and Al-Snan, NR},
title = {DNA forensics at forty: the way forward.},
journal = {International journal of legal medicine},
volume = {},
number = {},
pages = {},
pmid = {40448869},
issn = {1437-1596},
abstract = {Forensic DNA analysis has transformed criminal investigations since its inception in 1985. Over four decades, this field has evolved through various phases-from the early stages of exploration to today's highly sophisticated methodologies. Key advancements such as the development of rapid DNA analysis techniques, microchip-based systems, and next-generation sequencing have improved the speed, reliability, and utility of DNA forensics. However, despite these technological advances, the field still faces considerable challenges, particularly with increasing case backlogs, limited population-specific databases, and the difficulties associated with analyzing degraded or challenging samples like bones and touch DNA. Emerging technologies such as single-cell genomic analysis, lineage markers, proteomics, and human microbiome analysis offer promising solutions to these challenges. Furthermore, the integration of artificial intelligence (AI) and machine learning (ML) in forensic workflows is enhancing the ability to analyze complex DNA samples efficiently, paving the way for faster and more accurate results. As forensic DNA analysis enters its next phase, the focus will be on expanding databases, refining quality control and assurance protocols, and standardizing training for forensic professionals worldwide. The journey of forensic DNA analysis over the past 40 years demonstrates a field in continuous development. Although significant progress has been made, there remain opportunities for further innovation, particularly in overcoming the current limitations and addressing ethical and legal concerns. By doing so, forensic DNA analysis will continue to play a pivotal role in the future of criminal justice.},
}
RevDate: 2025-05-31
Dysbiotic Microbiome-Metabolome Axis in Childhood Obesity and Metabolic Syndrome.
Journal of dental research [Epub ahead of print].
The prevalence of childhood metabolic syndrome (MetS) and obesity is rising, with emerging evidence suggesting these conditions negatively affect oral health. However, the underlying molecular determinants are unclear. This study investigated the oral microbiome, inflammatory markers, and metabolites in children with obesity and MetS to explore the interrelationships between systemic disease and oral health. We recruited 76 periodontally healthy, caries-free individuals aged 10 to 17 y into 3 groups: MetS (29), metabolically healthy obesity (MHO) (30), and normal-weight healthy (NWH) controls (17). Unstimulated saliva was collected. Bacterial DNA was isolated, V3-V4 regions amplified, and 16S sequencing performed on the Illumina MiSeq platform. Sequences were annotated against the HOMD database. Multiplex assays quantified adipokines and cytokines, with significance determined by Tukey honestly significant difference. Gas chromatography/mass spectrometry identified metabolite peaks that were annotated against the Small Molecule Pathway Database, with enrichment analysis determining significance. Integrated multiomics analysis was performed using multiblock sparse partial least squares regression discriminant analysis. The MHO and MetS groups demonstrated lower abundances of Streptococcus, Actinomyces, and Schaalia and higher levels of Aggregatibacter, Campylobacter, Alloprevotella, Prevotella, Leptotrichia, and Porphyromonas compared with NWH, despite similar clinical oral status in all cohorts. MetS and MHO also had increased leptin, tumor necrosis factor-α, interleukin (IL)-1β, and IL-15 and decreased adiponectin levels versus NWH. Disease-associated metabolites, including glutamate, cholesterol, isoleucine, tyrosine, phenylalanine, serine, and indoleacetic acid, were significantly enriched in the MetS and MHO groups. Integrated multiomic analysis identified key correlations in the saliva of subjects with metabolic health or disease. Decreases in health-associated species and increases in proinflammatory cytokines and disease-associated metabolites in the saliva of MetS and obese adolescents with clinical oral health indicate an "at-risk" environment, potentially explaining their elevated risk for oral diseases. Increased salivary leptin and decreased adiponectin levels highlight the potential of saliva as a noninvasive biomarker source for childhood MetS.
Additional Links: PMID-40448590
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40448590,
year = {2025},
author = {Salman, U and Dabdoub, SM and Reyes, A and Sidahmed, A and Weber-Gasperoni, K and Brown, R and Evans, IA and Taylor, E and Mangalam, A and Kanner, L and Curtis, V and Ganesan, SM},
title = {Dysbiotic Microbiome-Metabolome Axis in Childhood Obesity and Metabolic Syndrome.},
journal = {Journal of dental research},
volume = {},
number = {},
pages = {220345251336129},
doi = {10.1177/00220345251336129},
pmid = {40448590},
issn = {1544-0591},
abstract = {The prevalence of childhood metabolic syndrome (MetS) and obesity is rising, with emerging evidence suggesting these conditions negatively affect oral health. However, the underlying molecular determinants are unclear. This study investigated the oral microbiome, inflammatory markers, and metabolites in children with obesity and MetS to explore the interrelationships between systemic disease and oral health. We recruited 76 periodontally healthy, caries-free individuals aged 10 to 17 y into 3 groups: MetS (29), metabolically healthy obesity (MHO) (30), and normal-weight healthy (NWH) controls (17). Unstimulated saliva was collected. Bacterial DNA was isolated, V3-V4 regions amplified, and 16S sequencing performed on the Illumina MiSeq platform. Sequences were annotated against the HOMD database. Multiplex assays quantified adipokines and cytokines, with significance determined by Tukey honestly significant difference. Gas chromatography/mass spectrometry identified metabolite peaks that were annotated against the Small Molecule Pathway Database, with enrichment analysis determining significance. Integrated multiomics analysis was performed using multiblock sparse partial least squares regression discriminant analysis. The MHO and MetS groups demonstrated lower abundances of Streptococcus, Actinomyces, and Schaalia and higher levels of Aggregatibacter, Campylobacter, Alloprevotella, Prevotella, Leptotrichia, and Porphyromonas compared with NWH, despite similar clinical oral status in all cohorts. MetS and MHO also had increased leptin, tumor necrosis factor-α, interleukin (IL)-1β, and IL-15 and decreased adiponectin levels versus NWH. Disease-associated metabolites, including glutamate, cholesterol, isoleucine, tyrosine, phenylalanine, serine, and indoleacetic acid, were significantly enriched in the MetS and MHO groups. Integrated multiomic analysis identified key correlations in the saliva of subjects with metabolic health or disease. Decreases in health-associated species and increases in proinflammatory cytokines and disease-associated metabolites in the saliva of MetS and obese adolescents with clinical oral health indicate an "at-risk" environment, potentially explaining their elevated risk for oral diseases. Increased salivary leptin and decreased adiponectin levels highlight the potential of saliva as a noninvasive biomarker source for childhood MetS.},
}
RevDate: 2025-05-31
Electroactive ecosystem insights from corrosion microbiomes inform gut microbiome modulation.
The ISME journal pii:8154415 [Epub ahead of print].
Electroactive microorganisms influence environmental and host-associated ecosystems through their ability to mediate extracellular electron transfer. This review explores parallels between EAM-driven microbiologically influenced corrosion systems and the human gut microbiome. In corrosion, EAMs contribute to biofilm formation, redox cycling, and material degradation through mechanisms such as direct electron transfer and syntrophic interactions. Similarly, gut-associated EAMs regulate redox balance, drive short-chain fatty acid production, and shape host-microbe interactions. Despite differing contexts, both systems share traits like anoxic niches, biofilm formation, and metabolic adaptability. Insights from well-characterized corrosion microbiomes offer valuable frameworks to understand microbial resilience, electron transfer strategies, and interspecies cooperation in the gut. Bridging knowledge between these systems can inform microbiome engineering approaches aimed at promoting gut health, highlighting the need for further functional metagenomics and exploration of archaeal contributions to biofilm stability and redox modulation.
Additional Links: PMID-40448586
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40448586,
year = {2025},
author = {Jones, LM and El Aidy, S},
title = {Electroactive ecosystem insights from corrosion microbiomes inform gut microbiome modulation.},
journal = {The ISME journal},
volume = {},
number = {},
pages = {},
doi = {10.1093/ismejo/wraf112},
pmid = {40448586},
issn = {1751-7370},
abstract = {Electroactive microorganisms influence environmental and host-associated ecosystems through their ability to mediate extracellular electron transfer. This review explores parallels between EAM-driven microbiologically influenced corrosion systems and the human gut microbiome. In corrosion, EAMs contribute to biofilm formation, redox cycling, and material degradation through mechanisms such as direct electron transfer and syntrophic interactions. Similarly, gut-associated EAMs regulate redox balance, drive short-chain fatty acid production, and shape host-microbe interactions. Despite differing contexts, both systems share traits like anoxic niches, biofilm formation, and metabolic adaptability. Insights from well-characterized corrosion microbiomes offer valuable frameworks to understand microbial resilience, electron transfer strategies, and interspecies cooperation in the gut. Bridging knowledge between these systems can inform microbiome engineering approaches aimed at promoting gut health, highlighting the need for further functional metagenomics and exploration of archaeal contributions to biofilm stability and redox modulation.},
}
RevDate: 2025-05-31
Dehalogenating Desulfoluna spp. are Ubiquitous in Host-Specific Sponge Microbiomes of the Great Barrier Reef.
The ISME journal pii:8154414 [Epub ahead of print].
Marine sponge holobionts are important contributors to numerous biogeochemical cycles, including the natural organohalogen cycle. Sponges produce diverse brominated secondary metabolites, which select for a population of anaerobic debrominating bacteria within the sponge body. Sponge microbiomes can be host-specific, but the selection and host-specificity of debrominating bacteria are unknown currently. In this study, we used nanopore long-read sequencing of nearly full-length ribosomal RNA operons to evaluate host-specificity of the Great Barrier Reef sponge microbiomes at the strain level and to determine if host specificity extends to sponge-associated dehalogenating bacteria. Reductive debromination activity was observed in anaerobic enrichment cultures established from all Great Barrier Reef sponges. Even though other bacterial symbionts of interest, including Nitrospira spp. and Ca. Synechococcus spp. demonstrated strong host-specificity, Desulfoluna spp., a key sponge-associated dehalogenating bacterium showed no evidence of host-specificity. This suggests different modes of transmission and/or retention of different members of the sponge microbiome residing within the same host species. These findings expand our understanding of how sponge microbiomes are assembled and the relationship between the host and individual bacterial strains.
Additional Links: PMID-40448582
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40448582,
year = {2025},
author = {Hall, LA and Scott, KD and Webster, N and Kerkhof, LJ and Häggblom, MM},
title = {Dehalogenating Desulfoluna spp. are Ubiquitous in Host-Specific Sponge Microbiomes of the Great Barrier Reef.},
journal = {The ISME journal},
volume = {},
number = {},
pages = {},
doi = {10.1093/ismejo/wraf113},
pmid = {40448582},
issn = {1751-7370},
abstract = {Marine sponge holobionts are important contributors to numerous biogeochemical cycles, including the natural organohalogen cycle. Sponges produce diverse brominated secondary metabolites, which select for a population of anaerobic debrominating bacteria within the sponge body. Sponge microbiomes can be host-specific, but the selection and host-specificity of debrominating bacteria are unknown currently. In this study, we used nanopore long-read sequencing of nearly full-length ribosomal RNA operons to evaluate host-specificity of the Great Barrier Reef sponge microbiomes at the strain level and to determine if host specificity extends to sponge-associated dehalogenating bacteria. Reductive debromination activity was observed in anaerobic enrichment cultures established from all Great Barrier Reef sponges. Even though other bacterial symbionts of interest, including Nitrospira spp. and Ca. Synechococcus spp. demonstrated strong host-specificity, Desulfoluna spp., a key sponge-associated dehalogenating bacterium showed no evidence of host-specificity. This suggests different modes of transmission and/or retention of different members of the sponge microbiome residing within the same host species. These findings expand our understanding of how sponge microbiomes are assembled and the relationship between the host and individual bacterial strains.},
}
RevDate: 2025-05-31
CmpDate: 2025-05-31
Comparative Colonisation Ability of Human Faecal Microbiome Transplantation Strategies in Murine Models.
Microbial biotechnology, 18(6):e70173.
The gut microbiome plays a crucial role in maintaining intestinal homeostasis and influencing immune-mediated diseases. Human faecal microbiota transplantation (FMT) is often employed in murine models to investigate the role of human microbes in disease regulation, but methods for effective colonisation require refinement. This study aimed to assess the colonisation efficiency of human microbiota in a murine model using FMT with human faeces, focusing particularly on the impact of gut microbiota depletion via polyethylene glycol (PEG) and comparing oral-gastric gavage with enema administration routes. Our findings revealed that PEG-induced depletion enhanced human microbiome colonisation in mice. Oral-gastric gavage prolonged colonisation, while enema administration facilitated quicker resolution of dysbiosis, both inducing selective human microbial colonisation in a time-dependent manner. Notably, genera such as Bacteroides, Blautia, Medicaternibacter and Bifidobacteria were successfully colonised, whereas Roseburia, Anaerostipes, Anaerobutyricum and Faecalibacterium failed to establish in the murine gut post-FMT. These findings highlight the challenges of replicating human gut microbiota in murine models and underscore the importance of selecting appropriate FMT methods based on desired outcomes. This study provides valuable insights into the colonisation dynamics of human microbiota in mice, contributing to the development of more effective FMT strategies for disease treatment.
Additional Links: PMID-40448308
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40448308,
year = {2025},
author = {Gu, BH and Jung, HY and Rim, CY and Kim, TY and Lee, SJ and Choi, DY and Park, HK and Kim, M},
title = {Comparative Colonisation Ability of Human Faecal Microbiome Transplantation Strategies in Murine Models.},
journal = {Microbial biotechnology},
volume = {18},
number = {6},
pages = {e70173},
doi = {10.1111/1751-7915.70173},
pmid = {40448308},
issn = {1751-7915},
support = {2024-ER2113-00//the Korea National Institute of Health (KNIH) research project/ ; 20019505//the Ministry of Trade, Industry & Energy (MOTIE, Korea)/ ; },
mesh = {Animals ; *Fecal Microbiota Transplantation/methods ; Humans ; Mice ; *Gastrointestinal Microbiome ; *Feces/microbiology ; Disease Models, Animal ; *Bacteria/classification/growth & development/isolation & purification/genetics ; Dysbiosis/therapy/microbiology ; Male ; Models, Animal ; },
abstract = {The gut microbiome plays a crucial role in maintaining intestinal homeostasis and influencing immune-mediated diseases. Human faecal microbiota transplantation (FMT) is often employed in murine models to investigate the role of human microbes in disease regulation, but methods for effective colonisation require refinement. This study aimed to assess the colonisation efficiency of human microbiota in a murine model using FMT with human faeces, focusing particularly on the impact of gut microbiota depletion via polyethylene glycol (PEG) and comparing oral-gastric gavage with enema administration routes. Our findings revealed that PEG-induced depletion enhanced human microbiome colonisation in mice. Oral-gastric gavage prolonged colonisation, while enema administration facilitated quicker resolution of dysbiosis, both inducing selective human microbial colonisation in a time-dependent manner. Notably, genera such as Bacteroides, Blautia, Medicaternibacter and Bifidobacteria were successfully colonised, whereas Roseburia, Anaerostipes, Anaerobutyricum and Faecalibacterium failed to establish in the murine gut post-FMT. These findings highlight the challenges of replicating human gut microbiota in murine models and underscore the importance of selecting appropriate FMT methods based on desired outcomes. This study provides valuable insights into the colonisation dynamics of human microbiota in mice, contributing to the development of more effective FMT strategies for disease treatment.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
*Fecal Microbiota Transplantation/methods
Humans
Mice
*Gastrointestinal Microbiome
*Feces/microbiology
Disease Models, Animal
*Bacteria/classification/growth & development/isolation & purification/genetics
Dysbiosis/therapy/microbiology
Male
Models, Animal
RevDate: 2025-05-30
CmpDate: 2025-05-31
Compositional and functional gut microbiota alterations in mild cognitive impairment: links to Alzheimer's disease pathology.
Alzheimer's research & therapy, 17(1):122.
BACKGROUND: Emerging evidence highlights the bidirectional communication between the gut microbiota and the brain, suggesting a potential role for gut dysbiosis in Alzheimer's disease (AD) pathology and cognitive decline. Existing literature on gut microbiota lacks species-level insights. This study investigates gut microbiota alterations in mild cognitive impairment (MCI), focusing on their association with comprehensive AD biomarkers, including amyloid burden, tau pathology, neurodegeneration, and cognitive performance.
METHODS: We analyzed fecal samples from 119 individuals with MCI and 320 cognitively normal controls enrolled in the Taiwan Precision Medicine Initiative on Cognitive Impairment and Dementia cohort. Shotgun metagenomic sequencing was conducted with taxonomic profiling using MetaPhlAn4. Amyloid burden and plasma pTau181 were quantified via PET imaging and Simoa assays, respectively, while APOE genotyping was performed using TaqMan assays. Microbial diversity, differential abundance analysis, and correlation mapping with neuropsychological and neuroimaging measures were conducted to identify gut microbiota species signatures associated with MCI and AD biomarkers.
RESULTS: We identified 59 key microbial species linked to MCI and AD biomarkers. Notably, species within the same genera, such as Bacteroides and Ruminococcus, showed opposing effects, while Akkermansia muciniphila correlated with reduced amyloid burden, suggesting a protective role. Functional profiling revealed microbial pathways contributing to energy metabolism and neuroinflammation, mediating the relationship between gut microbes and brain health. Co-occurrence network analyses demonstrated complex microbial interactions, indicating that the collective influence of gut microbiota on neurodegeneration.
CONCLUSIONS: Our findings challenge genus-level microbiome analyses, revealing species-specific modulators of AD pathology. This study highlights gut microbial activity as a potential therapeutic target to mitigate cognitive decline and neurodegeneration.
Additional Links: PMID-40448221
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40448221,
year = {2025},
author = {Fan, KC and Lin, CC and Chiu, YL and Koh, SH and Liu, YC and Chuang, YF},
title = {Compositional and functional gut microbiota alterations in mild cognitive impairment: links to Alzheimer's disease pathology.},
journal = {Alzheimer's research & therapy},
volume = {17},
number = {1},
pages = {122},
pmid = {40448221},
issn = {1758-9193},
mesh = {Humans ; *Gastrointestinal Microbiome/physiology ; *Cognitive Dysfunction/microbiology/pathology/metabolism ; *Alzheimer Disease/microbiology/pathology/metabolism ; Male ; Female ; Aged ; Feces/microbiology ; Biomarkers ; Brain/pathology/metabolism ; Aged, 80 and over ; Dysbiosis ; tau Proteins ; Middle Aged ; },
abstract = {BACKGROUND: Emerging evidence highlights the bidirectional communication between the gut microbiota and the brain, suggesting a potential role for gut dysbiosis in Alzheimer's disease (AD) pathology and cognitive decline. Existing literature on gut microbiota lacks species-level insights. This study investigates gut microbiota alterations in mild cognitive impairment (MCI), focusing on their association with comprehensive AD biomarkers, including amyloid burden, tau pathology, neurodegeneration, and cognitive performance.
METHODS: We analyzed fecal samples from 119 individuals with MCI and 320 cognitively normal controls enrolled in the Taiwan Precision Medicine Initiative on Cognitive Impairment and Dementia cohort. Shotgun metagenomic sequencing was conducted with taxonomic profiling using MetaPhlAn4. Amyloid burden and plasma pTau181 were quantified via PET imaging and Simoa assays, respectively, while APOE genotyping was performed using TaqMan assays. Microbial diversity, differential abundance analysis, and correlation mapping with neuropsychological and neuroimaging measures were conducted to identify gut microbiota species signatures associated with MCI and AD biomarkers.
RESULTS: We identified 59 key microbial species linked to MCI and AD biomarkers. Notably, species within the same genera, such as Bacteroides and Ruminococcus, showed opposing effects, while Akkermansia muciniphila correlated with reduced amyloid burden, suggesting a protective role. Functional profiling revealed microbial pathways contributing to energy metabolism and neuroinflammation, mediating the relationship between gut microbes and brain health. Co-occurrence network analyses demonstrated complex microbial interactions, indicating that the collective influence of gut microbiota on neurodegeneration.
CONCLUSIONS: Our findings challenge genus-level microbiome analyses, revealing species-specific modulators of AD pathology. This study highlights gut microbial activity as a potential therapeutic target to mitigate cognitive decline and neurodegeneration.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Gastrointestinal Microbiome/physiology
*Cognitive Dysfunction/microbiology/pathology/metabolism
*Alzheimer Disease/microbiology/pathology/metabolism
Male
Female
Aged
Feces/microbiology
Biomarkers
Brain/pathology/metabolism
Aged, 80 and over
Dysbiosis
tau Proteins
Middle Aged
RevDate: 2025-05-30
CmpDate: 2025-05-31
Impact of toothpaste use on the subgingival microbiome: a pilot randomized clinical trial.
BMC oral health, 25(1):854.
BACKGROUND: The subgingival microbiome plays a key role in the gingivitis development, but the impact of toothbrushing with toothpaste on the subgingival microbial composition is not well understood. Therefore, this study aimed to evaluate the microbiological safety and subgingival impact of a toothpaste containing CPC and cymenol, compared to a fluoride-based toothpaste, and assessed overall subgingival microbiome changes after 6 weeks of routine toothbrushing in patients with gingival inflammation.
METHODS: A 6-week randomized clinical trial was conducted in patients with gingival inflammation allocated to the use of either a toothpaste with cetylpyridinium chloride and cymenol or a toothpaste with sodium monofluorophosphate. Subgingival samples were collected at baseline and after 6 weeks and processed using high-throughput sequencing technology (Miseq®). Diversity metrics were calculated and the microbiome composition was analyzed using PERMANOVA, ANOSIM and PERMDISP.
RESULTS: A total of 116 samples from 60 patients were analyzed. No significant changes in diversity were observed in either group after 6 weeks. Among taxa with > 1% abundance, the toothpaste with cetylpyridinium chloride and cymenol exhibited a higher reduction in Aggregatibacter (p = 0.023) and a significant decrease in Fusobacterium nucleatum (p = 0.030), while the toothpaste with sodium monofluorophosphate showed a significant increase in the phylum Firmicutes (p = 0.033). The relative abundance of Porphyromonas gingivalis, Prevotella intermedia and Tannerella forsythia were not affected by either toothpaste (p > 0.05).
CONCLUSIONS: The daily use of a CPC/cymenol toothpaste was microbiologically safe, with no negative effects on the composition of the subgingival microbiome in patients with gingival inflammation, when compared to a fluoride-based toothpaste. The overall composition of the subgingival microbiome was not significantly affected by the daily use of either toothpaste after 6 weeks. In both groups, the observed changes affected mainly the low-abundance taxa.
TRIAL REGISTRATION: Registration Number: ISRCTN17497809; Registration Date: 12/07/2023 (ISRCTN.org).
Additional Links: PMID-40448072
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40448072,
year = {2025},
author = {Iniesta, M and Vasconcelos, V and Laciar, F and Matesanz, P and Sanz, M and Herrera, D},
title = {Impact of toothpaste use on the subgingival microbiome: a pilot randomized clinical trial.},
journal = {BMC oral health},
volume = {25},
number = {1},
pages = {854},
pmid = {40448072},
issn = {1472-6831},
mesh = {Humans ; *Toothpastes/pharmacology/therapeutic use ; *Microbiota/drug effects ; Pilot Projects ; Female ; *Gingivitis/microbiology ; Male ; Adult ; Cetylpyridinium/pharmacology/therapeutic use ; Toothbrushing ; *Gingiva/microbiology ; Middle Aged ; Phosphates/pharmacology ; Fluorides/pharmacology ; },
abstract = {BACKGROUND: The subgingival microbiome plays a key role in the gingivitis development, but the impact of toothbrushing with toothpaste on the subgingival microbial composition is not well understood. Therefore, this study aimed to evaluate the microbiological safety and subgingival impact of a toothpaste containing CPC and cymenol, compared to a fluoride-based toothpaste, and assessed overall subgingival microbiome changes after 6 weeks of routine toothbrushing in patients with gingival inflammation.
METHODS: A 6-week randomized clinical trial was conducted in patients with gingival inflammation allocated to the use of either a toothpaste with cetylpyridinium chloride and cymenol or a toothpaste with sodium monofluorophosphate. Subgingival samples were collected at baseline and after 6 weeks and processed using high-throughput sequencing technology (Miseq®). Diversity metrics were calculated and the microbiome composition was analyzed using PERMANOVA, ANOSIM and PERMDISP.
RESULTS: A total of 116 samples from 60 patients were analyzed. No significant changes in diversity were observed in either group after 6 weeks. Among taxa with > 1% abundance, the toothpaste with cetylpyridinium chloride and cymenol exhibited a higher reduction in Aggregatibacter (p = 0.023) and a significant decrease in Fusobacterium nucleatum (p = 0.030), while the toothpaste with sodium monofluorophosphate showed a significant increase in the phylum Firmicutes (p = 0.033). The relative abundance of Porphyromonas gingivalis, Prevotella intermedia and Tannerella forsythia were not affected by either toothpaste (p > 0.05).
CONCLUSIONS: The daily use of a CPC/cymenol toothpaste was microbiologically safe, with no negative effects on the composition of the subgingival microbiome in patients with gingival inflammation, when compared to a fluoride-based toothpaste. The overall composition of the subgingival microbiome was not significantly affected by the daily use of either toothpaste after 6 weeks. In both groups, the observed changes affected mainly the low-abundance taxa.
TRIAL REGISTRATION: Registration Number: ISRCTN17497809; Registration Date: 12/07/2023 (ISRCTN.org).},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Toothpastes/pharmacology/therapeutic use
*Microbiota/drug effects
Pilot Projects
Female
*Gingivitis/microbiology
Male
Adult
Cetylpyridinium/pharmacology/therapeutic use
Toothbrushing
*Gingiva/microbiology
Middle Aged
Phosphates/pharmacology
Fluorides/pharmacology
RevDate: 2025-05-30
CmpDate: 2025-05-30
Integrated microbiome and metabolome analysis reveals a novel interplay between gut microbiota and metabolites in differentiated thyroid carcinoma.
BMC microbiology, 25(1):346.
BACKGROUND: Differentiated Thyroid carcinoma (DTC) is the most prevalent endocrine malignancy. The identification of novel biomarkers for thyroid carcinoma is essential for enhancing our understanding of the molecular mechanisms underlying DTC development. Notably, gut microorganisms and their metabolites play a role in the development of DTC, although their influence is modulated by the host's genetic background and environmental factors. Our study aimed to identify and classify gut microbiota and metabolites associated with DTC.
METHODS: 90 patients with a confirmed diagnosis of DTC and 33 healthy volunteers donated stool samples for our analysis. To examine the gut microbiota, we utilized 16 S rRNA gene sequencing, a technique that allows for the identification and classification of microorganisms. Additionally, we employed liquid chromatography-mass spectrometry (LC-MS) to investigate the alterations in metabolites present in thyroid carcinoma patients compared to healthy individuals.
RESULTS: The Venn diagram visualized the distribution of bacterial species, with 926 species shared by both groups and 12,225 species unique to DTC patients. Notably, the gut microbiota of DTC patients exhibited higher species richness and diversity compared to healthy individuals. LDA Effect Size (LEfSe) analysis identified Faecalibacterium and Prevotella_9 as more abundant in healthy individuals, while Oscillospiraceae, Subdoligranulum, and Actinobacteriota were significantly more prevalent in DTC patients. We successfully characterized 3255 metabolites in both groups, which were primarily associated with biosynthesis of plant secondary metabolites, neomycin, kanamycin, and gentamicin biosynthesis, bile secretion, and steroid hormone biosynthesis. Among these metabolites, 550 were differentially expressed, with 402 metabolites being highly expressed in DTC patients. Six metabolites exhibiting an area under the curve (AUC) value exceeding 0.87 were identified as potential clinical diagnostic markers for DTC. Furthermore, Spearman's rank correlations were utilized to explore the potential functional relationships between the 10 distinctive microbial species and the top 10 differential metabolites.
CONCLUSIONS: The gut microbiota and its associated metabolites may play a crucial role in the development of DTC. The identification of altered metabolites and microbiota in DTC patients suggests their potential as diagnostic markers and therapeutic targets. This offers new insights into the molecular pathogenesis of DTC, providing opportunities for early diagnosis and improved treatment strategies.
CLINICAL TRIAL NUMBER: Not applicable.
Additional Links: PMID-40448029
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40448029,
year = {2025},
author = {Jiang, X and Liu, Q and Xu, D and Pang, H and Shi, Y},
title = {Integrated microbiome and metabolome analysis reveals a novel interplay between gut microbiota and metabolites in differentiated thyroid carcinoma.},
journal = {BMC microbiology},
volume = {25},
number = {1},
pages = {346},
pmid = {40448029},
issn = {1471-2180},
support = {CBYI202105//China Baoyuan Research Fund Project/ ; Q21076//Sichuan Provincial Medical Youth Innovation Research Project/ ; CNNC2021137//Young Talent Program of China National Nuclear Corporation/ ; 2021JDRC0170//Sichuan Science and Technology Innovation and Entrepreneurship Seedling Project/ ; },
mesh = {Humans ; *Gastrointestinal Microbiome ; *Thyroid Neoplasms/microbiology/metabolism/pathology ; Male ; *Metabolome ; Feces/microbiology ; Female ; Middle Aged ; RNA, Ribosomal, 16S/genetics ; Adult ; *Bacteria/classification/genetics/metabolism/isolation & purification ; Aged ; Chromatography, Liquid ; },
abstract = {BACKGROUND: Differentiated Thyroid carcinoma (DTC) is the most prevalent endocrine malignancy. The identification of novel biomarkers for thyroid carcinoma is essential for enhancing our understanding of the molecular mechanisms underlying DTC development. Notably, gut microorganisms and their metabolites play a role in the development of DTC, although their influence is modulated by the host's genetic background and environmental factors. Our study aimed to identify and classify gut microbiota and metabolites associated with DTC.
METHODS: 90 patients with a confirmed diagnosis of DTC and 33 healthy volunteers donated stool samples for our analysis. To examine the gut microbiota, we utilized 16 S rRNA gene sequencing, a technique that allows for the identification and classification of microorganisms. Additionally, we employed liquid chromatography-mass spectrometry (LC-MS) to investigate the alterations in metabolites present in thyroid carcinoma patients compared to healthy individuals.
RESULTS: The Venn diagram visualized the distribution of bacterial species, with 926 species shared by both groups and 12,225 species unique to DTC patients. Notably, the gut microbiota of DTC patients exhibited higher species richness and diversity compared to healthy individuals. LDA Effect Size (LEfSe) analysis identified Faecalibacterium and Prevotella_9 as more abundant in healthy individuals, while Oscillospiraceae, Subdoligranulum, and Actinobacteriota were significantly more prevalent in DTC patients. We successfully characterized 3255 metabolites in both groups, which were primarily associated with biosynthesis of plant secondary metabolites, neomycin, kanamycin, and gentamicin biosynthesis, bile secretion, and steroid hormone biosynthesis. Among these metabolites, 550 were differentially expressed, with 402 metabolites being highly expressed in DTC patients. Six metabolites exhibiting an area under the curve (AUC) value exceeding 0.87 were identified as potential clinical diagnostic markers for DTC. Furthermore, Spearman's rank correlations were utilized to explore the potential functional relationships between the 10 distinctive microbial species and the top 10 differential metabolites.
CONCLUSIONS: The gut microbiota and its associated metabolites may play a crucial role in the development of DTC. The identification of altered metabolites and microbiota in DTC patients suggests their potential as diagnostic markers and therapeutic targets. This offers new insights into the molecular pathogenesis of DTC, providing opportunities for early diagnosis and improved treatment strategies.
CLINICAL TRIAL NUMBER: Not applicable.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Gastrointestinal Microbiome
*Thyroid Neoplasms/microbiology/metabolism/pathology
Male
*Metabolome
Feces/microbiology
Female
Middle Aged
RNA, Ribosomal, 16S/genetics
Adult
*Bacteria/classification/genetics/metabolism/isolation & purification
Aged
Chromatography, Liquid
RevDate: 2025-05-30
CmpDate: 2025-05-30
Association between the dietary index of gut microbiota and abnormal bowel symptoms in U.S. adults: a cross-sectional study based on NHANES 2007-2010.
BMC gastroenterology, 25(1):419.
BACKGROUND: The Dietary Index of Gut Microbiota (DI-GM) is a newly developed measure for assessing diet quality in relation to the diversity of the gut microbiome. However, whether it is associated with the risk of chronic constipation and chronic diarrhea remains unclear.
METHODS: We analyzed data from 7,943 U.S. adults aged 20 years and older who participated in the 2007-2010 National Health and Nutrition Examination Survey (NHANES). Weighted logistic regression, subgroup analysis, and restricted cubic spline (RCS) models were used to assess the association between the DI-GM and abnormal bowel symptoms.
RESULTS: A higher DI-GM score was significantly associated with a reduced risk of abnormal bowel symptoms. For each 1-point increase in the DI-GM, the risk of constipation decreased by 12.4% (OR = 0.876, 95% CI = 0.806-0.951, p = 0.002), and the risk of diarrhea decreased by 14.1% (OR = 0.859, 95% CI = 0.789-0.936, p < 0.001). Compared with the lowest DI-GM quartile, the highest quartile showed a markedly lower risk of both constipation (OR = 0.487, 95% CI = 0.340-0.696, p < 0.001) and diarrhea (OR = 0.480, 95% CI = 0.338-0.682, p < 0.001). RCS analysis indicated a significant linear association between the DI-GM and the risks of both constipation (nonlinear p = 0.686) and diarrhea (nonlinear p = 0.136).
CONCLUSIONS: The DI-GM was negatively associated with the prevalence of abnormal bowel symptoms. Further longitudinal studies are warranted to confirm these findings and to inform dietary strategies for gut health.
Additional Links: PMID-40447995
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40447995,
year = {2025},
author = {Shen, S and Feng, H and Wang, C and Yang, Y and Chen, Z and Wang, X and Li, J},
title = {Association between the dietary index of gut microbiota and abnormal bowel symptoms in U.S. adults: a cross-sectional study based on NHANES 2007-2010.},
journal = {BMC gastroenterology},
volume = {25},
number = {1},
pages = {419},
pmid = {40447995},
issn = {1471-230X},
support = {GSW2021046//Suzhou Municipal Health Commission/ ; GSW2021046//Suzhou Municipal Health Commission/ ; GSW2021046//Suzhou Municipal Health Commission/ ; GSW2021046//Suzhou Municipal Health Commission/ ; GSW2021046//Suzhou Municipal Health Commission/ ; GSW2021046//Suzhou Municipal Health Commission/ ; GSW2021046//Suzhou Municipal Health Commission/ ; BK20211085//Natural Science Foundation of Jiangsu Province/ ; BK20211085//Natural Science Foundation of Jiangsu Province/ ; BK20211085//Natural Science Foundation of Jiangsu Province/ ; BK20211085//Natural Science Foundation of Jiangsu Province/ ; BK20211085//Natural Science Foundation of Jiangsu Province/ ; BK20211085//Natural Science Foundation of Jiangsu Province/ ; BK20211085//Natural Science Foundation of Jiangsu Province/ ; SS2019073//Suzhou Municipal Science and Technology Bureau/ ; SS2019073//Suzhou Municipal Science and Technology Bureau/ ; SS2019073//Suzhou Municipal Science and Technology Bureau/ ; SS2019073//Suzhou Municipal Science and Technology Bureau/ ; SS2019073//Suzhou Municipal Science and Technology Bureau/ ; SS2019073//Suzhou Municipal Science and Technology Bureau/ ; SS2019073//Suzhou Municipal Science and Technology Bureau/ ; },
mesh = {Humans ; *Constipation/epidemiology/microbiology ; Cross-Sectional Studies ; Male ; Female ; *Gastrointestinal Microbiome ; Adult ; Middle Aged ; Nutrition Surveys ; *Diarrhea/epidemiology/microbiology ; United States/epidemiology ; *Diet ; Aged ; Young Adult ; Chronic Disease ; },
abstract = {BACKGROUND: The Dietary Index of Gut Microbiota (DI-GM) is a newly developed measure for assessing diet quality in relation to the diversity of the gut microbiome. However, whether it is associated with the risk of chronic constipation and chronic diarrhea remains unclear.
METHODS: We analyzed data from 7,943 U.S. adults aged 20 years and older who participated in the 2007-2010 National Health and Nutrition Examination Survey (NHANES). Weighted logistic regression, subgroup analysis, and restricted cubic spline (RCS) models were used to assess the association between the DI-GM and abnormal bowel symptoms.
RESULTS: A higher DI-GM score was significantly associated with a reduced risk of abnormal bowel symptoms. For each 1-point increase in the DI-GM, the risk of constipation decreased by 12.4% (OR = 0.876, 95% CI = 0.806-0.951, p = 0.002), and the risk of diarrhea decreased by 14.1% (OR = 0.859, 95% CI = 0.789-0.936, p < 0.001). Compared with the lowest DI-GM quartile, the highest quartile showed a markedly lower risk of both constipation (OR = 0.487, 95% CI = 0.340-0.696, p < 0.001) and diarrhea (OR = 0.480, 95% CI = 0.338-0.682, p < 0.001). RCS analysis indicated a significant linear association between the DI-GM and the risks of both constipation (nonlinear p = 0.686) and diarrhea (nonlinear p = 0.136).
CONCLUSIONS: The DI-GM was negatively associated with the prevalence of abnormal bowel symptoms. Further longitudinal studies are warranted to confirm these findings and to inform dietary strategies for gut health.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Constipation/epidemiology/microbiology
Cross-Sectional Studies
Male
Female
*Gastrointestinal Microbiome
Adult
Middle Aged
Nutrition Surveys
*Diarrhea/epidemiology/microbiology
United States/epidemiology
*Diet
Aged
Young Adult
Chronic Disease
RevDate: 2025-05-30
CmpDate: 2025-05-30
Fungal Infections in Transplant Recipients Pre- and Post-coronavirus Disease 2019: Results from a Single-Center Retrospective Cohort Study.
Mycopathologia, 190(3):47.
OBJECTIVES: To investigate the incidence, subtypes, and pathogens of fungal infections in transplant recipients pre- and post-coronavirus disease 2019 (COVID-19) and their prognosis.
METHODS: Data from transplant recipients with fungal infections treated at our hospital between January 2005 and April 2024 were collected. Pre- and post-COVID-19 data were compared.
RESULTS: Among 3,505 transplant recipients, 203 had fungal infections, mostly in hematopoietic stem cell recipients (178 cases, 8.4%). The pre-COVID-19 incidence of fungal infections was 5.0%, with a median time from transplantation to infection of 96.5 days. The post-COVID-19 incidence was 6.3%, with a median time of 92.5 days. Before the COVID-19 outbreak, invasive fungal infections were predominant, with Candida as the outbreak, Candida, Aspergillus, Pneumocystis jirovecii, and mixed infections became more common. In addition to the oral cavity and lungs, infection sites following the COVID-19 outbreak also included the skin, blood, and intestinal tract. Twenty-six patients were treated with monotherapy, 14 of whom were treated with voriconazole. Voriconazole, sulfamethoxazole, and caspofungin are typically used in combination or sequentially for treatment. At 180 days, 1.4% of transplant recipients were aggravated before the outbreak of COVID-19, with a mortality rate of 8.2%. The proportion of exacerbations after the outbreak was 3.1%, with a mortality rate of 6.9%.
CONCLUSIONS: Post-COVID-19, transplant recipients exhibited increased fungal infection incidence, broader pathogen diversity, and more frequent exacerbations. However, this was not accompanied by an increase in mortality, likely reflect both enhanced clinical surveillance and SARS-CoV-2-specific biological effects, such as immune dysregulation, endothelial damage and microbiome alterations.
Additional Links: PMID-40447921
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40447921,
year = {2025},
author = {Xin, T and Pan, Q and Li, J and Zhang, J and Lin, L and Choi, K and Cai, W and Lu, S and Zhang, J},
title = {Fungal Infections in Transplant Recipients Pre- and Post-coronavirus Disease 2019: Results from a Single-Center Retrospective Cohort Study.},
journal = {Mycopathologia},
volume = {190},
number = {3},
pages = {47},
pmid = {40447921},
issn = {1573-0832},
support = {2024A1515013091//Basic and Applied Basic Research Foundation of Guangdong Province/ ; },
mesh = {Humans ; *COVID-19/complications/epidemiology ; Retrospective Studies ; Female ; Male ; *Transplant Recipients/statistics & numerical data ; Middle Aged ; Adult ; *Mycoses/epidemiology/drug therapy/microbiology ; Incidence ; Aged ; SARS-CoV-2 ; Antifungal Agents/therapeutic use ; Young Adult ; },
abstract = {OBJECTIVES: To investigate the incidence, subtypes, and pathogens of fungal infections in transplant recipients pre- and post-coronavirus disease 2019 (COVID-19) and their prognosis.
METHODS: Data from transplant recipients with fungal infections treated at our hospital between January 2005 and April 2024 were collected. Pre- and post-COVID-19 data were compared.
RESULTS: Among 3,505 transplant recipients, 203 had fungal infections, mostly in hematopoietic stem cell recipients (178 cases, 8.4%). The pre-COVID-19 incidence of fungal infections was 5.0%, with a median time from transplantation to infection of 96.5 days. The post-COVID-19 incidence was 6.3%, with a median time of 92.5 days. Before the COVID-19 outbreak, invasive fungal infections were predominant, with Candida as the outbreak, Candida, Aspergillus, Pneumocystis jirovecii, and mixed infections became more common. In addition to the oral cavity and lungs, infection sites following the COVID-19 outbreak also included the skin, blood, and intestinal tract. Twenty-six patients were treated with monotherapy, 14 of whom were treated with voriconazole. Voriconazole, sulfamethoxazole, and caspofungin are typically used in combination or sequentially for treatment. At 180 days, 1.4% of transplant recipients were aggravated before the outbreak of COVID-19, with a mortality rate of 8.2%. The proportion of exacerbations after the outbreak was 3.1%, with a mortality rate of 6.9%.
CONCLUSIONS: Post-COVID-19, transplant recipients exhibited increased fungal infection incidence, broader pathogen diversity, and more frequent exacerbations. However, this was not accompanied by an increase in mortality, likely reflect both enhanced clinical surveillance and SARS-CoV-2-specific biological effects, such as immune dysregulation, endothelial damage and microbiome alterations.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*COVID-19/complications/epidemiology
Retrospective Studies
Female
Male
*Transplant Recipients/statistics & numerical data
Middle Aged
Adult
*Mycoses/epidemiology/drug therapy/microbiology
Incidence
Aged
SARS-CoV-2
Antifungal Agents/therapeutic use
Young Adult
RevDate: 2025-05-30
Noninvasive prediction of the clinical benefit of immunotherapy in hepatocellular carcinoma.
Journal of gastroenterology [Epub ahead of print].
Long-term survival following a diagnosis of hepatocellular carcinoma (HCC) is greatly diminished when transplantation and surgical resection are ruled out. Fortunately, the advent of immune checkpoint inhibitors (ICIs) has revolutionized the treatment of advanced unresectable HCC (uHCC), prolonging median survival by over a year. T lymphocytes normally eliminate neoplastic cells, but some tumors suppress this response by binding to immune checkpoint receptors. Blocking this interaction via ICIs restores immune-mediated targeting of cancer cells. While ICI-based combination immunotherapy is currently recommended as the first-line systemic therapy for uHCC, the objective radiological response rate remains limited to 20-30%, as not all tumors exploit this mechanism. Consequently, strategies are being explored to modulate the immune microenvironment into a "hot" environment more responsive to ICIs by combining local therapies such as transarterial chemoembolization, ablation, and radiation therapy. Therapeutic options have also expanded beyond ICIs, emphasizing the importance of selecting the most appropriate treatment. Therefore, the development of biomarkers capable of predicting the efficacy of immunotherapy is a priority. Direct evaluation of immune cell infiltration through biopsy is currently the most effective method but involves issues such as invasiveness and susceptibility to sampling bias. In this review, we aim to highlight promising non-invasive biomarkers and scoring systems that have the potential to improve treatment outcomes, including blood-based biomarkers such as lymphocyte ratios, cytokines, C-reactive protein, and alpha-fetoprotein; imaging biomarkers such as MRI, ultrasound, and contrast-enhanced CT; and other clinical indicators such as sarcopenia, grip strength, and diversity of the gut microbiome.
Additional Links: PMID-40447887
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40447887,
year = {2025},
author = {Ono, A and Hayes, CN and Miura, R and Kawaoka, T and Tsuge, M and Oka, S},
title = {Noninvasive prediction of the clinical benefit of immunotherapy in hepatocellular carcinoma.},
journal = {Journal of gastroenterology},
volume = {},
number = {},
pages = {},
pmid = {40447887},
issn = {1435-5922},
abstract = {Long-term survival following a diagnosis of hepatocellular carcinoma (HCC) is greatly diminished when transplantation and surgical resection are ruled out. Fortunately, the advent of immune checkpoint inhibitors (ICIs) has revolutionized the treatment of advanced unresectable HCC (uHCC), prolonging median survival by over a year. T lymphocytes normally eliminate neoplastic cells, but some tumors suppress this response by binding to immune checkpoint receptors. Blocking this interaction via ICIs restores immune-mediated targeting of cancer cells. While ICI-based combination immunotherapy is currently recommended as the first-line systemic therapy for uHCC, the objective radiological response rate remains limited to 20-30%, as not all tumors exploit this mechanism. Consequently, strategies are being explored to modulate the immune microenvironment into a "hot" environment more responsive to ICIs by combining local therapies such as transarterial chemoembolization, ablation, and radiation therapy. Therapeutic options have also expanded beyond ICIs, emphasizing the importance of selecting the most appropriate treatment. Therefore, the development of biomarkers capable of predicting the efficacy of immunotherapy is a priority. Direct evaluation of immune cell infiltration through biopsy is currently the most effective method but involves issues such as invasiveness and susceptibility to sampling bias. In this review, we aim to highlight promising non-invasive biomarkers and scoring systems that have the potential to improve treatment outcomes, including blood-based biomarkers such as lymphocyte ratios, cytokines, C-reactive protein, and alpha-fetoprotein; imaging biomarkers such as MRI, ultrasound, and contrast-enhanced CT; and other clinical indicators such as sarcopenia, grip strength, and diversity of the gut microbiome.},
}
RevDate: 2025-05-30
Antibiotics re-booted-time to kick back against drug resistance.
npj antimicrobials and resistance, 3(1):47.
After decades of neglect and a decline in antibiotic research and development, we are now finally witnessing the advent of new funding programs dedicated to new therapies. In addition to traditional new chemical entities that directly kill or arrest the growth of bacteria, alternative approaches are being identified and advanced towards proof-of-concept trials in the clinic. We briefly review the current pipeline of conventional new antibiotics and highlight in more depth promising alternatives, including potentiators of antibiotic action, bacteriophage, lysins and microbiome modulation. More innovative approaches, such as adaptive and innate immune modulators, CRISPR-Cas and diagnostic guided 'theranostics' are discussed and contrasted. Such exploratory therapies may require the development of alternative regulatory and clinical development pathways, but represent a potential circuit breaker from the current 'arms race' between bacteria and traditional antibiotics.
Additional Links: PMID-40447846
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40447846,
year = {2025},
author = {Blaskovich, MAT and Cooper, MA},
title = {Antibiotics re-booted-time to kick back against drug resistance.},
journal = {npj antimicrobials and resistance},
volume = {3},
number = {1},
pages = {47},
pmid = {40447846},
issn = {2731-8745},
abstract = {After decades of neglect and a decline in antibiotic research and development, we are now finally witnessing the advent of new funding programs dedicated to new therapies. In addition to traditional new chemical entities that directly kill or arrest the growth of bacteria, alternative approaches are being identified and advanced towards proof-of-concept trials in the clinic. We briefly review the current pipeline of conventional new antibiotics and highlight in more depth promising alternatives, including potentiators of antibiotic action, bacteriophage, lysins and microbiome modulation. More innovative approaches, such as adaptive and innate immune modulators, CRISPR-Cas and diagnostic guided 'theranostics' are discussed and contrasted. Such exploratory therapies may require the development of alternative regulatory and clinical development pathways, but represent a potential circuit breaker from the current 'arms race' between bacteria and traditional antibiotics.},
}
RevDate: 2025-05-30
CmpDate: 2025-05-30
Heavy metals, noradrenaline/adrenaline ratio, and microbiome-associated hormone precursor metabolites: biomarkers for social behaviour, ADHD symptoms, and executive function in children.
Scientific reports, 15(1):19006.
The gut microbiome significantly influences physical and mental health, including the synthesis and metabolism of hormones and the detoxification of heavy metals, which are linked to behavioural disorders. This study investigated the associations of these biological factors with the behaviour of primary school children, specifically examining the effects of heavy metals, catecholamines, and microbiome-associated metabolites of dopamine, noradrenaline, adrenaline, and thyroxine precursors. Urine samples from 87 unselected primary school children were analysed to assess heavy metal load (arsenic, cadmium, lead, mercury), noradrenaline/adrenaline ratio, and microbiome-associated metabolites of phenylalanine, tyrosine and L-dopa (3-phenylpropionic acid, p-OH-phenylacetic acid, 4-hydroxybenzoic acid, 3,4-dihydroxyphenylpropionic acid). Three months later, executive functions, ADHD symptoms (inattention, hyperactivity and impulsivity), and social behaviour were evaluated via parent and teacher questionnaires. In a path model, heavy metal load, microbiome-associated metabolites, and the noradrenaline/adrenaline ratio measured in urine accounted for 32% of social behaviours. Microbiome-associated metabolites predicted 11% of the variance in executive functions and 17% in ADHD symptoms. Executive functions shared 55% of the variance with ADHD symptoms and 17% with social behaviours. Children with the lowest social behaviours had a sixfold increase in the odds of high heavy metal loads and a 3.4-fold increase in the odds of elevated microbiome-associated metabolites. Similarly, children with the most compromised executive functions had a threefold increase in the odds of such high metabolite levels. Overall, the results indicate that children's social behaviours are influenced by heavy metal accumulation, catecholamine balance, and the microbiome-associated metabolism of amino acids, that are crucial for producing stress and thyroid hormones.
Additional Links: PMID-40447636
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40447636,
year = {2025},
author = {Krajewski, K},
title = {Heavy metals, noradrenaline/adrenaline ratio, and microbiome-associated hormone precursor metabolites: biomarkers for social behaviour, ADHD symptoms, and executive function in children.},
journal = {Scientific reports},
volume = {15},
number = {1},
pages = {19006},
pmid = {40447636},
issn = {2045-2322},
mesh = {Humans ; *Attention Deficit Disorder with Hyperactivity/urine/metabolism ; Child ; Male ; Female ; *Metals, Heavy/urine ; Biomarkers/urine ; *Norepinephrine/urine ; *Executive Function ; *Epinephrine/urine ; *Gastrointestinal Microbiome ; *Social Behavior ; },
abstract = {The gut microbiome significantly influences physical and mental health, including the synthesis and metabolism of hormones and the detoxification of heavy metals, which are linked to behavioural disorders. This study investigated the associations of these biological factors with the behaviour of primary school children, specifically examining the effects of heavy metals, catecholamines, and microbiome-associated metabolites of dopamine, noradrenaline, adrenaline, and thyroxine precursors. Urine samples from 87 unselected primary school children were analysed to assess heavy metal load (arsenic, cadmium, lead, mercury), noradrenaline/adrenaline ratio, and microbiome-associated metabolites of phenylalanine, tyrosine and L-dopa (3-phenylpropionic acid, p-OH-phenylacetic acid, 4-hydroxybenzoic acid, 3,4-dihydroxyphenylpropionic acid). Three months later, executive functions, ADHD symptoms (inattention, hyperactivity and impulsivity), and social behaviour were evaluated via parent and teacher questionnaires. In a path model, heavy metal load, microbiome-associated metabolites, and the noradrenaline/adrenaline ratio measured in urine accounted for 32% of social behaviours. Microbiome-associated metabolites predicted 11% of the variance in executive functions and 17% in ADHD symptoms. Executive functions shared 55% of the variance with ADHD symptoms and 17% with social behaviours. Children with the lowest social behaviours had a sixfold increase in the odds of high heavy metal loads and a 3.4-fold increase in the odds of elevated microbiome-associated metabolites. Similarly, children with the most compromised executive functions had a threefold increase in the odds of such high metabolite levels. Overall, the results indicate that children's social behaviours are influenced by heavy metal accumulation, catecholamine balance, and the microbiome-associated metabolism of amino acids, that are crucial for producing stress and thyroid hormones.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Attention Deficit Disorder with Hyperactivity/urine/metabolism
Child
Male
Female
*Metals, Heavy/urine
Biomarkers/urine
*Norepinephrine/urine
*Executive Function
*Epinephrine/urine
*Gastrointestinal Microbiome
*Social Behavior
RevDate: 2025-05-30
CmpDate: 2025-05-30
Stratified dietary inflammatory potential identifies oral and gut microbiota differences associated with cognitive function in older adults.
Scientific reports, 15(1):18988.
Diet is a crucial factor that shapes the composition of the microbiota throughout the life cycle. Systemic chronic inflammation and microbial imbalance may play a key role in the pathogenesis of cognitive disorders. Inflammatory diets can influence the host microbiome and inflammatory state. This study investigated the impact of the inflammatory potential of the diet on the diversity and composition of the oral-gut microbiome, as well as on cognitive performance, in older adults over 60 years of age. The Energy-adjusted Dietary Inflammatory Index (E-DII) and 16S rRNA sequencing were used to analyze dietary inflammatory properties and oral-gut microorganisms in 54 patients. The results showed that significant differences in the diversity of oral microbiota among different E-DII groups was detected (p < 0.05), whereas gut microbiota diversity didn't exhibit variations. In the anti-inflammatory diet group, the class Saccharimonadia, the order Corynebacteriaceae, the genera TM7x, Eubacterium_yurii_group, and Centipeda were more abundant in oral microbiomes, and lower abundance of Holdemanella and Haemophilus was observed in the gut microbiomes. Specific oral and gut genera were associated with MMSE, MoCA, AVLT-LR, BNT, and VFT scores (p < 0.05). These results provide insights into anti-inflammatory diets were associated with an increased abundance of beneficial microbes, and a specific oral and gut microbial composition was associated with cognition.
Additional Links: PMID-40447628
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40447628,
year = {2025},
author = {Liu, J and Zhang, Y and Li, X and Hou, Z and Wang, B and Chen, L and Chen, M},
title = {Stratified dietary inflammatory potential identifies oral and gut microbiota differences associated with cognitive function in older adults.},
journal = {Scientific reports},
volume = {15},
number = {1},
pages = {18988},
pmid = {40447628},
issn = {2045-2322},
support = {2023Y9283//Joint Funds for the innovation of science and Technology, Fujian province/ ; 2023CXA004//Medical Innovation Project of Fujian Province/ ; },
mesh = {Humans ; *Gastrointestinal Microbiome ; Aged ; Male ; Female ; *Cognition/physiology ; Middle Aged ; *Inflammation/microbiology ; *Diet/adverse effects ; RNA, Ribosomal, 16S/genetics ; *Mouth/microbiology ; Aged, 80 and over ; },
abstract = {Diet is a crucial factor that shapes the composition of the microbiota throughout the life cycle. Systemic chronic inflammation and microbial imbalance may play a key role in the pathogenesis of cognitive disorders. Inflammatory diets can influence the host microbiome and inflammatory state. This study investigated the impact of the inflammatory potential of the diet on the diversity and composition of the oral-gut microbiome, as well as on cognitive performance, in older adults over 60 years of age. The Energy-adjusted Dietary Inflammatory Index (E-DII) and 16S rRNA sequencing were used to analyze dietary inflammatory properties and oral-gut microorganisms in 54 patients. The results showed that significant differences in the diversity of oral microbiota among different E-DII groups was detected (p < 0.05), whereas gut microbiota diversity didn't exhibit variations. In the anti-inflammatory diet group, the class Saccharimonadia, the order Corynebacteriaceae, the genera TM7x, Eubacterium_yurii_group, and Centipeda were more abundant in oral microbiomes, and lower abundance of Holdemanella and Haemophilus was observed in the gut microbiomes. Specific oral and gut genera were associated with MMSE, MoCA, AVLT-LR, BNT, and VFT scores (p < 0.05). These results provide insights into anti-inflammatory diets were associated with an increased abundance of beneficial microbes, and a specific oral and gut microbial composition was associated with cognition.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Gastrointestinal Microbiome
Aged
Male
Female
*Cognition/physiology
Middle Aged
*Inflammation/microbiology
*Diet/adverse effects
RNA, Ribosomal, 16S/genetics
*Mouth/microbiology
Aged, 80 and over
RevDate: 2025-05-30
CmpDate: 2025-05-30
Bacterial microcompartments and energy metabolism drive gut colonization by Bilophila wadsworthia.
Nature communications, 16(1):5049.
High-fat diets reshape gut microbiota composition and promote the expansion of Bilophila wadsworthia, a sulfidogenic bacterium linked to inflammation and gut barrier dysfunction. The genetic basis for its colonisation and physiological effects remain poorly understood. Here, we show that B. wadsworthia colonises the gut of germ-free male mice fed a high-fat diet by relying on genes involved in microcompartment formation and anaerobic energy metabolism. Using genome-wide transposon mutagenesis, metatranscriptomics and metabolomics, we identify 34 genes essential for gut colonisation, including two clusters encoding a bacterial microcompartment (BMC), and a NADH dehydrogenase (hdrABC-flxABCD) complex. These systems enable B. wadsworthia to metabolise taurine and isethionate, producing H2S, acetate, and ethanol. We further demonstrate that B. wadsworthia can produce and consume ethanol depending on the available electron donors. While B. wadsworthia reached higher abundance and H2S production in the absence of the simplified microbiota, its co-colonisation with the defined microbial consortium exacerbated host effects, including increased gut permeability, slightly elevated liver ethanol concentrations, and hepatic macrophage infiltration. Our findings reveal how microbial interactions and metabolic flexibility -including using alternative energy sources such as formate- rather than H2S alone, shape B. wadsworthia's impact on host physiology, with implications for understanding diet-driven microbiome-host interactions.
Additional Links: PMID-40447622
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40447622,
year = {2025},
author = {Sayavedra, L and Yasir, M and Goldson, A and Brion, A and Le Gall, G and Moreno-Gonzalez, M and Altera, A and Paxhia, MD and Warren, M and Savva, GM and Turner, AK and Beraza, N and Narbad, A},
title = {Bacterial microcompartments and energy metabolism drive gut colonization by Bilophila wadsworthia.},
journal = {Nature communications},
volume = {16},
number = {1},
pages = {5049},
pmid = {40447622},
issn = {2041-1723},
support = {BB/Z514445/10//RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)/ ; Food Microbiome & Health ISP BB/X011054/1 and its constituent project BBS/E/QU/230001//RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)/ ; Food Microbiome & Health ISP BB/X011054/1 and its constituent project BBS/E/QU/230001//RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)/ ; Food Microbiome & Health ISP BB/X011054/1 and its constituent project BBS/E/QU/230001//RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)/ ; Food Microbiome & Health ISP BB/X011054/1 and its constituent project BBS/E/QU/230001//RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)/ ; Food Microbiome & Health ISP BB/X011054/1 and its constituent project BBS/E/QU/230001//RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)/ ; Food Microbiome & Health ISP BB/X011054/1 and its constituent project BBS/E/QU/230001//RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)/ ; Food Microbiome & Health ISP BB/X011054/1 and its constituent project BBS/E/QU/230001//RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)/ ; Food Microbiome & Health ISP BB/X011054/1 and its constituent project BBS/E/QU/230001//RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)/ ; Food Microbiome & Health ISP BB/X011054/1 and its constituent project BBS/E/QU/230001//RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)/ ; Food Microbiome & Health ISP BB/X011054/1 and its constituent project BBS/E/QU/230001//RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)/ ; Food Microbiome & Health ISP BB/X011054/1 and its constituent project BBS/E/QU/230001//RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)/ ; Food Microbiome & Health ISP BB/X011054/1 and its constituent project BBS/E/QU/230001//RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)/ ; Food Microbiome & Health ISP BB/X011054/1 and its constituent project BBS/E/QU/230001//RCUK | Biotechnology and Biological Sciences Research Council (BBSRC)/ ; },
mesh = {Animals ; *Energy Metabolism ; Male ; *Gastrointestinal Microbiome/genetics/physiology ; Mice ; Diet, High-Fat/adverse effects ; *Bilophila/genetics/metabolism/growth & development ; Mice, Inbred C57BL ; Ethanol/metabolism ; Taurine/metabolism ; },
abstract = {High-fat diets reshape gut microbiota composition and promote the expansion of Bilophila wadsworthia, a sulfidogenic bacterium linked to inflammation and gut barrier dysfunction. The genetic basis for its colonisation and physiological effects remain poorly understood. Here, we show that B. wadsworthia colonises the gut of germ-free male mice fed a high-fat diet by relying on genes involved in microcompartment formation and anaerobic energy metabolism. Using genome-wide transposon mutagenesis, metatranscriptomics and metabolomics, we identify 34 genes essential for gut colonisation, including two clusters encoding a bacterial microcompartment (BMC), and a NADH dehydrogenase (hdrABC-flxABCD) complex. These systems enable B. wadsworthia to metabolise taurine and isethionate, producing H2S, acetate, and ethanol. We further demonstrate that B. wadsworthia can produce and consume ethanol depending on the available electron donors. While B. wadsworthia reached higher abundance and H2S production in the absence of the simplified microbiota, its co-colonisation with the defined microbial consortium exacerbated host effects, including increased gut permeability, slightly elevated liver ethanol concentrations, and hepatic macrophage infiltration. Our findings reveal how microbial interactions and metabolic flexibility -including using alternative energy sources such as formate- rather than H2S alone, shape B. wadsworthia's impact on host physiology, with implications for understanding diet-driven microbiome-host interactions.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
*Energy Metabolism
Male
*Gastrointestinal Microbiome/genetics/physiology
Mice
Diet, High-Fat/adverse effects
*Bilophila/genetics/metabolism/growth & development
Mice, Inbred C57BL
Ethanol/metabolism
Taurine/metabolism
RevDate: 2025-05-30
Reassessing the role of the gut microbiome in bladder cancer: A review of methodological approaches and future research directions.
Urologic oncology, 43(7):436-437.
Additional Links: PMID-40447393
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40447393,
year = {2025},
author = {Zuo, J and Chen, J and Wang, J},
title = {Reassessing the role of the gut microbiome in bladder cancer: A review of methodological approaches and future research directions.},
journal = {Urologic oncology},
volume = {43},
number = {7},
pages = {436-437},
doi = {10.1016/j.urolonc.2024.12.268},
pmid = {40447393},
issn = {1873-2496},
}
RevDate: 2025-05-30
Longitudinal Analysis of Nasopharyngeal Microbial Risk Markers for Fatal Acute Febrile Illness in a Zambian Birth Cohort.
The Journal of infectious diseases pii:8154212 [Epub ahead of print].
INTRODUCTION: Fatal acute febrile illness (fAFI) is a known predecessor of many infant mortality events in low-resource settings, yet early risk markers for this condition remain poorly understood. Nasopharyngeal (NP) microbiome patterns may influence the severity of these infections.
METHODS: We analyzed longitudinal changes in the NP microbiota of Zambian infants with fAFI onset compared to healthy controls, aiming to identify microbial indicators associated with severe illness outcomes. We conducted a pooled analysis of a longitudinal nested case-control study comprised of 26 samples from 9 infants who developed fAFI compared with 69 samples from 10 healthy infants. Infants underwent nasopharyngeal sampling from 1 week through 14 weeks of age at 2-2.5-week intervals. We performed 16S rRNA gene amplicon sequencing on all infant nasopharyngeal (NP) samples and characterized NP microbiome maturation among infants with febrile acute febrile illness (fAFI(+)) and healthy controls (fAFI(-)).
RESULTS: Beta diversity measures of fAFI(-) infants were markedly higher than those of fAFI(+) infants. The fAFI(+) infant NP microbiome was marked by lower abundances of Dolosigranulum, Haemophilus, Streptococcus, and Corynebacterium, with higher relative presence of Pseudomonas.
CONCLUSIONS: Our findings suggest that specific microbial community patterns and early NP microbiome dysbiosis may be associated with increased illness risk. These findings can motivate further studies to inform foundational markers for fAFI in infants, contributing to precision pediatric care.
Additional Links: PMID-40447275
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40447275,
year = {2025},
author = {Odom, AR and Anderson, J and Gill, CJ and Pieciak, R and Ismail, A and MacLeod, WB and Johnson, WE and Lapidot, R},
title = {Longitudinal Analysis of Nasopharyngeal Microbial Risk Markers for Fatal Acute Febrile Illness in a Zambian Birth Cohort.},
journal = {The Journal of infectious diseases},
volume = {},
number = {},
pages = {},
doi = {10.1093/infdis/jiaf292},
pmid = {40447275},
issn = {1537-6613},
abstract = {INTRODUCTION: Fatal acute febrile illness (fAFI) is a known predecessor of many infant mortality events in low-resource settings, yet early risk markers for this condition remain poorly understood. Nasopharyngeal (NP) microbiome patterns may influence the severity of these infections.
METHODS: We analyzed longitudinal changes in the NP microbiota of Zambian infants with fAFI onset compared to healthy controls, aiming to identify microbial indicators associated with severe illness outcomes. We conducted a pooled analysis of a longitudinal nested case-control study comprised of 26 samples from 9 infants who developed fAFI compared with 69 samples from 10 healthy infants. Infants underwent nasopharyngeal sampling from 1 week through 14 weeks of age at 2-2.5-week intervals. We performed 16S rRNA gene amplicon sequencing on all infant nasopharyngeal (NP) samples and characterized NP microbiome maturation among infants with febrile acute febrile illness (fAFI(+)) and healthy controls (fAFI(-)).
RESULTS: Beta diversity measures of fAFI(-) infants were markedly higher than those of fAFI(+) infants. The fAFI(+) infant NP microbiome was marked by lower abundances of Dolosigranulum, Haemophilus, Streptococcus, and Corynebacterium, with higher relative presence of Pseudomonas.
CONCLUSIONS: Our findings suggest that specific microbial community patterns and early NP microbiome dysbiosis may be associated with increased illness risk. These findings can motivate further studies to inform foundational markers for fAFI in infants, contributing to precision pediatric care.},
}
RevDate: 2025-05-30
Fecal microbiota transplant is associated with resolution of recurrent urinary tract infection.
Urology pii:S0090-4295(25)00515-1 [Epub ahead of print].
OBJECTIVE: To investigate the association of fecal microbiota transplant (FMT) therapy, an effective treatment for recurrent C. difficile colitis, with resolution of recurrent UTI (rUTI).
METHODS: A prospectively accrued database of patients who underwent FMT for recurrent Clostridoides difficile colitis was retrospectively reviewed for individuals with rUTI in the two years prior to FMT. Recurrent UTI status (defined as two UTI episodes in six months or three UTI episodes in one year) and UTI frequency in the two years prior to the FMT were compared to those in the two year follow up period after FMT using the two-tailed Wilcoxin matched pairs signed rank test. A p-value <0.05 was considered statistically significant.
RESULTS: Of 11 patients who had rUTI in the two years preceding FMT, no patient had rUTI over the follow up period following FMT (p=0.001). The average number of UTIs in the two years prior to FMT was 3.7 (range 2-6), and the average number of UTIs in the follow up period was 0.27 (range 0-1) (p=0.001). The Kaplan-Meier estimate, the median time to UTI recurrence, was 19.6 months (95% CI: 15.2 - 23.9). There was no marked difference in antibiotic susceptibility profiles before and after FMT.
CONCLUSIONS: FMT was associated with resolution of rUTI and reduction in UTI frequency in this cohort. The results of this study support the hypothesis that modulation of the gut microbiome may reduce rUTI risk, and support a clinical trial to further assess the safety and efficacy of FMT for rUTI.
Additional Links: PMID-40447159
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40447159,
year = {2025},
author = {Jeong, SH and Vasavada, SP and Lashner, B and Werneburg, GT},
title = {Fecal microbiota transplant is associated with resolution of recurrent urinary tract infection.},
journal = {Urology},
volume = {},
number = {},
pages = {},
doi = {10.1016/j.urology.2025.05.052},
pmid = {40447159},
issn = {1527-9995},
abstract = {OBJECTIVE: To investigate the association of fecal microbiota transplant (FMT) therapy, an effective treatment for recurrent C. difficile colitis, with resolution of recurrent UTI (rUTI).
METHODS: A prospectively accrued database of patients who underwent FMT for recurrent Clostridoides difficile colitis was retrospectively reviewed for individuals with rUTI in the two years prior to FMT. Recurrent UTI status (defined as two UTI episodes in six months or three UTI episodes in one year) and UTI frequency in the two years prior to the FMT were compared to those in the two year follow up period after FMT using the two-tailed Wilcoxin matched pairs signed rank test. A p-value <0.05 was considered statistically significant.
RESULTS: Of 11 patients who had rUTI in the two years preceding FMT, no patient had rUTI over the follow up period following FMT (p=0.001). The average number of UTIs in the two years prior to FMT was 3.7 (range 2-6), and the average number of UTIs in the follow up period was 0.27 (range 0-1) (p=0.001). The Kaplan-Meier estimate, the median time to UTI recurrence, was 19.6 months (95% CI: 15.2 - 23.9). There was no marked difference in antibiotic susceptibility profiles before and after FMT.
CONCLUSIONS: FMT was associated with resolution of rUTI and reduction in UTI frequency in this cohort. The results of this study support the hypothesis that modulation of the gut microbiome may reduce rUTI risk, and support a clinical trial to further assess the safety and efficacy of FMT for rUTI.},
}
RevDate: 2025-05-30
Characterization of bacterial and fungal populations in retail kefirs in Ireland.
Journal of dairy science pii:S0022-0302(25)00386-8 [Epub ahead of print].
Kefir is an increasingly popular dairy- or sugar-based fermented food product. The aim of our study was to investigate the bacterial and fungal communities in 28 retail kefirs including 21 milk kefirs, including 3 thick kefir yogurt and 4 water kefir products. Full-length amplicon nanopore sequencing of both 16S rRNA (for bacteria) and intergenic spacer (for fungi) was undertaken. The diversity within and between groups was analyzed (α and β diversity) and linear discriminant analysis effect size analysis was undertaken to identify biomarkers that differentially characterize the microbial communities associated with different kefir types. The pH, lactic acid concentration, total viable counts (TVC), lactic acid bacteria (LAB), total coliform counts (TCC), and yeast counts were also investigated. The main bacterial genera (and species) were Lactococcus (cremoris) and Streptococcus (thermophilus), and other bacteria such as Lactobacillus (delbrueckii) and Lentilactobacillus (kefiri) were also detected. The fungal populations were mainly composed of Brettanomyces (anomalus), Zygotorulaspora (florentina) and Kazachstania (unispora), but with many different fungal genera/species detected. The pH ranged from 3.1 to 4.7 with a mean of 4.2 ± 0.07 and the lactic acid content ranged from 0.1 to 9 g/L with a mean of 5.6 ± 0.53. In milk kefirs the TVC, LAB, TCC, and yeast counts ranged from 3.1 to 9.1, 3.4 to 9.0, not detected (ND) to 1.6 and ND to 6.5 log10 cfu/mL or cfu/g, respectively. The corresponding counts in water kefirs were 4.1 to 7.3 (TVC), 4.1 to 7.0 (LAB), ND to 1.1 (TCC), and 3.9 to 7.0 (yeast) log10 cfu/mL or cfu/g, respectively. It was concluded that although the 28 retail kefirs analyzed had a rich diversity of bacteria and fungi the bacteriome was dominated by bacteria belonging to the Lactococcus and Streptococcus genera and the main bacterial species were Lactococcus cremoris, Streptococcus thermophiles, Streptococcus suis, Lactobacillus delbrueckii, and Streptococcus sp. HSISS1. The fungal microbiome was dominated by Zygotorulaspora and the most abundant fungal species included Zygotorulaspora florentina, Brettanomyces anomalus, and Kazachstania unispora. To the best of our knowledge, this is the first study in Ireland to use full-length nanopore sequencing to characterize both bacterial and fungal communities in retail kefirs.
Additional Links: PMID-40447085
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40447085,
year = {2025},
author = {Maughan, L and Koolman, L and Macori, G and Killian, C and Fanning, S and Whyte, P and Bolton, D},
title = {Characterization of bacterial and fungal populations in retail kefirs in Ireland.},
journal = {Journal of dairy science},
volume = {},
number = {},
pages = {},
doi = {10.3168/jds.2025-26587},
pmid = {40447085},
issn = {1525-3198},
abstract = {Kefir is an increasingly popular dairy- or sugar-based fermented food product. The aim of our study was to investigate the bacterial and fungal communities in 28 retail kefirs including 21 milk kefirs, including 3 thick kefir yogurt and 4 water kefir products. Full-length amplicon nanopore sequencing of both 16S rRNA (for bacteria) and intergenic spacer (for fungi) was undertaken. The diversity within and between groups was analyzed (α and β diversity) and linear discriminant analysis effect size analysis was undertaken to identify biomarkers that differentially characterize the microbial communities associated with different kefir types. The pH, lactic acid concentration, total viable counts (TVC), lactic acid bacteria (LAB), total coliform counts (TCC), and yeast counts were also investigated. The main bacterial genera (and species) were Lactococcus (cremoris) and Streptococcus (thermophilus), and other bacteria such as Lactobacillus (delbrueckii) and Lentilactobacillus (kefiri) were also detected. The fungal populations were mainly composed of Brettanomyces (anomalus), Zygotorulaspora (florentina) and Kazachstania (unispora), but with many different fungal genera/species detected. The pH ranged from 3.1 to 4.7 with a mean of 4.2 ± 0.07 and the lactic acid content ranged from 0.1 to 9 g/L with a mean of 5.6 ± 0.53. In milk kefirs the TVC, LAB, TCC, and yeast counts ranged from 3.1 to 9.1, 3.4 to 9.0, not detected (ND) to 1.6 and ND to 6.5 log10 cfu/mL or cfu/g, respectively. The corresponding counts in water kefirs were 4.1 to 7.3 (TVC), 4.1 to 7.0 (LAB), ND to 1.1 (TCC), and 3.9 to 7.0 (yeast) log10 cfu/mL or cfu/g, respectively. It was concluded that although the 28 retail kefirs analyzed had a rich diversity of bacteria and fungi the bacteriome was dominated by bacteria belonging to the Lactococcus and Streptococcus genera and the main bacterial species were Lactococcus cremoris, Streptococcus thermophiles, Streptococcus suis, Lactobacillus delbrueckii, and Streptococcus sp. HSISS1. The fungal microbiome was dominated by Zygotorulaspora and the most abundant fungal species included Zygotorulaspora florentina, Brettanomyces anomalus, and Kazachstania unispora. To the best of our knowledge, this is the first study in Ireland to use full-length nanopore sequencing to characterize both bacterial and fungal communities in retail kefirs.},
}
RevDate: 2025-05-30
Nanoplastics under the charge effect: Unveiling the potential threats to amphibian (Rana nigromaculata) growth, intestinal damage, and microbial ecology.
Environmental pollution (Barking, Essex : 1987) pii:S0269-7491(25)00939-X [Epub ahead of print].
Nanoplastics (NPs) are a contaminant that may be found in charged forms in the environment, capable of accumulating in aquatic organisms and affecting their health. This study compared the effects of positively charged NPs (PS-NH2, 30nm) and negatively charged NPs (PS-COOH, 30nm) at 6 and 60 mg/L on the growth and development of black-spotted frog tadpoles (Rana nigromaculata), as well as on intestinal damage, and microbial ecology. The results indicated that exposure to both types of NPs significantly reduced the survival rate of tadpoles, while significantly increasing their body weight and body length (p <0.05). Compared to PS-COOH, exposure to PS-NH2 resulted in more adverse intestinal tissue damage and induced more severe intestinal oxidative stress. Furthermore, exposure to PS-NH2 significantly reduced the abundance and diversity of the microbiome associated with gut function and nutrient absorption, indirectly leading to more severe intestinal damage and growth changes. In addition, functional prediction and gene transcription analysis showed that exposure to charged PS-NPs caused changes in genes associated with glycolysis and lipid metabolism, indicating that the glucose-lipid metabolism of tadpoles is impacted. This study demonstrated the growth differences and intestinal toxicity of NPs exposure in tadpoles, explores the potential connections between gut microbiota and glucose-lipid metabolism, and provides new perspectives on the health risks of NPs in amphibians.
Additional Links: PMID-40446899
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40446899,
year = {2025},
author = {Fang, P and Ye, S and Luo, Z and Guo, R and Jiang, Y and Liu, L and Li, S and Xiao, F},
title = {Nanoplastics under the charge effect: Unveiling the potential threats to amphibian (Rana nigromaculata) growth, intestinal damage, and microbial ecology.},
journal = {Environmental pollution (Barking, Essex : 1987)},
volume = {},
number = {},
pages = {126566},
doi = {10.1016/j.envpol.2025.126566},
pmid = {40446899},
issn = {1873-6424},
abstract = {Nanoplastics (NPs) are a contaminant that may be found in charged forms in the environment, capable of accumulating in aquatic organisms and affecting their health. This study compared the effects of positively charged NPs (PS-NH2, 30nm) and negatively charged NPs (PS-COOH, 30nm) at 6 and 60 mg/L on the growth and development of black-spotted frog tadpoles (Rana nigromaculata), as well as on intestinal damage, and microbial ecology. The results indicated that exposure to both types of NPs significantly reduced the survival rate of tadpoles, while significantly increasing their body weight and body length (p <0.05). Compared to PS-COOH, exposure to PS-NH2 resulted in more adverse intestinal tissue damage and induced more severe intestinal oxidative stress. Furthermore, exposure to PS-NH2 significantly reduced the abundance and diversity of the microbiome associated with gut function and nutrient absorption, indirectly leading to more severe intestinal damage and growth changes. In addition, functional prediction and gene transcription analysis showed that exposure to charged PS-NPs caused changes in genes associated with glycolysis and lipid metabolism, indicating that the glucose-lipid metabolism of tadpoles is impacted. This study demonstrated the growth differences and intestinal toxicity of NPs exposure in tadpoles, explores the potential connections between gut microbiota and glucose-lipid metabolism, and provides new perspectives on the health risks of NPs in amphibians.},
}
RevDate: 2025-05-30
Bacteroides fragilis promotes chemoresistance in colorectal cancer, and its elimination by phage VA7 restores chemosensitivity.
Cell host & microbe pii:S1931-3128(25)00183-0 [Epub ahead of print].
Chemoresistance is a main cause of colorectal cancer (CRC) treatment failure. We identified that Bacteroides fragilis is enriched in patients with CRC resistant to chemotherapy in two independent cohorts, and its abundance is associated with poor survival. Consistently, administration of B. fragilis to CRC xenografts and Apc[Min/+]- and AOM/DSS-induced CRC mice all significantly attenuated the antitumor efficacy of 5-FU and OXA. Mechanistically, B. fragilis colonized colon tumors and mediated its effect via its surface protein SusD/RagB binding to the Notch1 receptor in CRC cells, leading to activation of the Notch1 signaling pathway and the induction of epithelial-to-mesenchymal transition (EMT)/stemness to suppress chemotherapy-induced apoptosis. Either deletion of SusD/RagB or blockade of Notch1 signaling abrogated B. fragilis-mediated chemoresistance. Finally, B. fragilis-targeting phage VA7 selectively suppressed B. fragilis and restored chemosensitivity in preclinical CRC mouse models. Our findings have offered insights into the potential of precise gut microbiota manipulation for the clinical management of CRC.
Additional Links: PMID-40446807
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40446807,
year = {2025},
author = {Ding, X and Ting, NL and Wong, CC and Huang, P and Jiang, L and Liu, C and Lin, Y and Li, S and Liu, Y and Xie, M and Liu, W and Yuan, K and Wang, L and Zhang, X and Ding, Y and Li, Q and Sun, Y and Miao, Y and Ma, L and Gao, X and Li, W and Wu, WKK and Sung, JJY and Wong, SH and Yu, J},
title = {Bacteroides fragilis promotes chemoresistance in colorectal cancer, and its elimination by phage VA7 restores chemosensitivity.},
journal = {Cell host & microbe},
volume = {},
number = {},
pages = {},
doi = {10.1016/j.chom.2025.05.004},
pmid = {40446807},
issn = {1934-6069},
abstract = {Chemoresistance is a main cause of colorectal cancer (CRC) treatment failure. We identified that Bacteroides fragilis is enriched in patients with CRC resistant to chemotherapy in two independent cohorts, and its abundance is associated with poor survival. Consistently, administration of B. fragilis to CRC xenografts and Apc[Min/+]- and AOM/DSS-induced CRC mice all significantly attenuated the antitumor efficacy of 5-FU and OXA. Mechanistically, B. fragilis colonized colon tumors and mediated its effect via its surface protein SusD/RagB binding to the Notch1 receptor in CRC cells, leading to activation of the Notch1 signaling pathway and the induction of epithelial-to-mesenchymal transition (EMT)/stemness to suppress chemotherapy-induced apoptosis. Either deletion of SusD/RagB or blockade of Notch1 signaling abrogated B. fragilis-mediated chemoresistance. Finally, B. fragilis-targeting phage VA7 selectively suppressed B. fragilis and restored chemosensitivity in preclinical CRC mouse models. Our findings have offered insights into the potential of precise gut microbiota manipulation for the clinical management of CRC.},
}
RevDate: 2025-05-30
Drought-induced plant microbiome and metabolic enrichments improve drought resistance.
Cell host & microbe pii:S1931-3128(25)00181-7 [Epub ahead of print].
Plant-microbiome interactions are crucial in maintaining plant health and productivity under stress; however, little is known about these interactions under drought. Here, using wheat as a model, we combine genomics and culture-dependent methods to investigate the interactions between the soil, root, and rhizosphere microbiomes with rhizosphere metabolomes and plant phenotypes. We find that drought conditions promote microbial colonization in plant microbiomes, enriching Streptomyces coeruleorubidus and Leifsonia shinshuensis, while also increasing 4-oxoproline levels in the rhizosphere, potentially attracting S. coeruleorubidus. Consistently, genes facilitating microbial responses to drought, including the N-terminal acetyltransferase rimJ, are enriched, while S. coeruleorubidus and L. shinshuensis reintroduction promotes host drought resistance. Drought-legacy-effect experiments further support these benefits, with increased plant biomass and yield in the subsequent growth cycle under drought. Collectively, this study informs how drought-induced microbial and metabolite enrichments improve plant adaptation to abiotic stresses, potentially informing development of bio-based tools to mitigate drought effects. VIDEO ABSTRACT.
Additional Links: PMID-40446806
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40446806,
year = {2025},
author = {Li, J and Liu, H and Wang, J and Macdonald, CA and Singh, P and Cong, VT and Klein, M and Delgado-Baquerizo, M and Singh, BK},
title = {Drought-induced plant microbiome and metabolic enrichments improve drought resistance.},
journal = {Cell host & microbe},
volume = {},
number = {},
pages = {},
doi = {10.1016/j.chom.2025.05.002},
pmid = {40446806},
issn = {1934-6069},
abstract = {Plant-microbiome interactions are crucial in maintaining plant health and productivity under stress; however, little is known about these interactions under drought. Here, using wheat as a model, we combine genomics and culture-dependent methods to investigate the interactions between the soil, root, and rhizosphere microbiomes with rhizosphere metabolomes and plant phenotypes. We find that drought conditions promote microbial colonization in plant microbiomes, enriching Streptomyces coeruleorubidus and Leifsonia shinshuensis, while also increasing 4-oxoproline levels in the rhizosphere, potentially attracting S. coeruleorubidus. Consistently, genes facilitating microbial responses to drought, including the N-terminal acetyltransferase rimJ, are enriched, while S. coeruleorubidus and L. shinshuensis reintroduction promotes host drought resistance. Drought-legacy-effect experiments further support these benefits, with increased plant biomass and yield in the subsequent growth cycle under drought. Collectively, this study informs how drought-induced microbial and metabolite enrichments improve plant adaptation to abiotic stresses, potentially informing development of bio-based tools to mitigate drought effects. VIDEO ABSTRACT.},
}
RevDate: 2025-05-30
Embryo secretome in predicting embryo quality and IVF treatment outcome.
Reproductive biomedicine online, 51(1):104825 pii:S1472-6483(25)00032-X [Epub ahead of print].
In IVF treatment, accurate prediction of embryo quality and successful embryo implantation are critical challenges. Recent research has highlighted the importance of the embryo secretome, the collection of molecules secreted by the embryo into the culture medium, in assessing embryo quality as a non-invasive preimplantation testing platform. The secretome plays a role in many essential processes, from gamete maturation to embryonic development. Molecules such as cell-free DNA, mitochondrial DNA and small non-coding RNA, including microRNA and PIWI-interacting RNA, together with the proteome, metabolome, microbiome and extracellular vesicles, have emerged as important players in predicting IVF outcomes. These molecules, present in the culture medium, have shown correlations with embryo viability, ploidy and implantation potential. Nevertheless, extensive validation in larger cohorts and an assessment of the applicability of the identified biomarkers in clinical settings is warranted. This article summarizes the molecular markers analysed in spent embryo culture medium and their potential for assessing embryo quality and predicting success in IVF outcomes.
Additional Links: PMID-40446645
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40446645,
year = {2025},
author = {Toporcerová, S and Badovská, Z and Kriváková, E and Mikulová, V and Mareková, M and Altmäe, S and Rabajdová, M},
title = {Embryo secretome in predicting embryo quality and IVF treatment outcome.},
journal = {Reproductive biomedicine online},
volume = {51},
number = {1},
pages = {104825},
doi = {10.1016/j.rbmo.2025.104825},
pmid = {40446645},
issn = {1472-6491},
abstract = {In IVF treatment, accurate prediction of embryo quality and successful embryo implantation are critical challenges. Recent research has highlighted the importance of the embryo secretome, the collection of molecules secreted by the embryo into the culture medium, in assessing embryo quality as a non-invasive preimplantation testing platform. The secretome plays a role in many essential processes, from gamete maturation to embryonic development. Molecules such as cell-free DNA, mitochondrial DNA and small non-coding RNA, including microRNA and PIWI-interacting RNA, together with the proteome, metabolome, microbiome and extracellular vesicles, have emerged as important players in predicting IVF outcomes. These molecules, present in the culture medium, have shown correlations with embryo viability, ploidy and implantation potential. Nevertheless, extensive validation in larger cohorts and an assessment of the applicability of the identified biomarkers in clinical settings is warranted. This article summarizes the molecular markers analysed in spent embryo culture medium and their potential for assessing embryo quality and predicting success in IVF outcomes.},
}
RevDate: 2025-05-30
Gut microbiota manipulation to mitigate the toxicities of environmental pollutants.
Aquatic toxicology (Amsterdam, Netherlands), 285:107425 pii:S0166-445X(25)00190-0 [Epub ahead of print].
The gut microbiome, commonly termed as a "super organ", plays a crucial role in the modulation of various biological functions associated with metabolism, endocrinology, immunology, and neurology. However, gut microbiome is extremely susceptible to the risks of environmental pollutants, which will drive gut microbial community to dysbiosis. Simultaneously, restoring healthy gut microbiome can protect the hosts from the health hazards of pollutants. It is increasingly verified that probiotics, prebiotics, and fecal microbiota transplantation (FMT) are efficacious measures to manipulate and remediate gut microecosystem. Among various probiotic strains, lactic acid bacteria are the most extensively applied in toxicity mitigation, which is characterized by shaping gut microbiota structure and metabolism, increasing gut epithelial barrier integrity, promoting fecal elimination of pollutants, suppressing inflammation symptoms, and then improving host systemic physiology. Prebiotics are dietary fibers that cannot be digested by the host, but can be fermented by specific gut bacteria to produce short chain fatty acids, which are identified as the key effect molecules in the manifestation of prebiotic toxicity mitigation actions. In addition, by transplanting the entire community of healthy gut microbiota, FMT also shows effective performances in counteracting the adverse effects of environmental pollutants and recovering host animal health. Intriguingly, FMT from young donors is even found to inhibit the toxic disturbances in healthy aging progression. Based on current evidence, this review summarized the findings about using probiotics, prebiotics, and FMT to manipulate gut microbiota and alleviate the health impairment of environmental pollutants. Key mechanistic insights into the interactive behaviors were underlined. Furthermore, the challenges and future directions in harnessing gut microbiota manipulation as a novel therapeutic approach to mitigate pollutant-induced toxicities were postulated. This review is expected to advocate comprehensive scientific research and literally favor the application of health intervention strategies.
Additional Links: PMID-40446472
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40446472,
year = {2025},
author = {Chen, L and Ahmad, M and Li, J and Li, J and Yang, Z and Hu, C},
title = {Gut microbiota manipulation to mitigate the toxicities of environmental pollutants.},
journal = {Aquatic toxicology (Amsterdam, Netherlands)},
volume = {285},
number = {},
pages = {107425},
doi = {10.1016/j.aquatox.2025.107425},
pmid = {40446472},
issn = {1879-1514},
abstract = {The gut microbiome, commonly termed as a "super organ", plays a crucial role in the modulation of various biological functions associated with metabolism, endocrinology, immunology, and neurology. However, gut microbiome is extremely susceptible to the risks of environmental pollutants, which will drive gut microbial community to dysbiosis. Simultaneously, restoring healthy gut microbiome can protect the hosts from the health hazards of pollutants. It is increasingly verified that probiotics, prebiotics, and fecal microbiota transplantation (FMT) are efficacious measures to manipulate and remediate gut microecosystem. Among various probiotic strains, lactic acid bacteria are the most extensively applied in toxicity mitigation, which is characterized by shaping gut microbiota structure and metabolism, increasing gut epithelial barrier integrity, promoting fecal elimination of pollutants, suppressing inflammation symptoms, and then improving host systemic physiology. Prebiotics are dietary fibers that cannot be digested by the host, but can be fermented by specific gut bacteria to produce short chain fatty acids, which are identified as the key effect molecules in the manifestation of prebiotic toxicity mitigation actions. In addition, by transplanting the entire community of healthy gut microbiota, FMT also shows effective performances in counteracting the adverse effects of environmental pollutants and recovering host animal health. Intriguingly, FMT from young donors is even found to inhibit the toxic disturbances in healthy aging progression. Based on current evidence, this review summarized the findings about using probiotics, prebiotics, and FMT to manipulate gut microbiota and alleviate the health impairment of environmental pollutants. Key mechanistic insights into the interactive behaviors were underlined. Furthermore, the challenges and future directions in harnessing gut microbiota manipulation as a novel therapeutic approach to mitigate pollutant-induced toxicities were postulated. This review is expected to advocate comprehensive scientific research and literally favor the application of health intervention strategies.},
}
RevDate: 2025-05-30
A systematic review of pharmaceutical targets in the mucosal immune system for treatment of non-intestinal auto-immune diseases.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 188:118205 pii:S0753-3322(25)00399-3 [Epub ahead of print].
The mucosal immune system entails the immune cells located in the body's mucosal surfaces and their mediators. Its function is to balance immune responses to pathogens and tolerance to harmless antigens. Treatment of autoimmune diseases is complicated by adverse events caused by suppression of systemic immunity by immunosuppressive medication. Targeting the mucosal immune system specifically in treating autoimmune diseases could circumvent systemic immune suppression and thereby reduce infection risk. This systematic review aims to provide an overview of pharmaceutical targets in the mucosal immune system, as a starting point in the search for new treatments for extra-intestinal auto-immune diseases. Preclinical and clinical studies were included and categorized into eight target categories: 'immune cells', 'signal transduction', 'inflammatory mediators', 'antibodies', 'microbiome', 'tolerance and mucosal vaccination', 'intestinal barrier' and 'other'. Studies investigating the most promising targets, namely mucosal-associated invariant T cells (MAIT cells) and tolerance induction by mucosal vaccination, are described in more detail. MAIT cells have been shown to play a role in the pathophysiology of various auto-immune diseases, particularly in multiple sclerosis (MS). Although the role of these cells has not yet been established fully, mouse studies show that the antagonism of MAIT cells has the potential to be used in the treatment of auto-immune diseases. Mucosal vaccination has demonstrable effects on the immune system, but treatment regimens and antigens must be improved to demonstrate clinical effects more extensively. This systematic review was registered in PROSPERO under number CRD42023421093.
Additional Links: PMID-40446444
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40446444,
year = {2025},
author = {Eveleens Maarse, BC and Hofstede, AD and Jansen, MAA and Moerland, M},
title = {A systematic review of pharmaceutical targets in the mucosal immune system for treatment of non-intestinal auto-immune diseases.},
journal = {Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie},
volume = {188},
number = {},
pages = {118205},
doi = {10.1016/j.biopha.2025.118205},
pmid = {40446444},
issn = {1950-6007},
abstract = {The mucosal immune system entails the immune cells located in the body's mucosal surfaces and their mediators. Its function is to balance immune responses to pathogens and tolerance to harmless antigens. Treatment of autoimmune diseases is complicated by adverse events caused by suppression of systemic immunity by immunosuppressive medication. Targeting the mucosal immune system specifically in treating autoimmune diseases could circumvent systemic immune suppression and thereby reduce infection risk. This systematic review aims to provide an overview of pharmaceutical targets in the mucosal immune system, as a starting point in the search for new treatments for extra-intestinal auto-immune diseases. Preclinical and clinical studies were included and categorized into eight target categories: 'immune cells', 'signal transduction', 'inflammatory mediators', 'antibodies', 'microbiome', 'tolerance and mucosal vaccination', 'intestinal barrier' and 'other'. Studies investigating the most promising targets, namely mucosal-associated invariant T cells (MAIT cells) and tolerance induction by mucosal vaccination, are described in more detail. MAIT cells have been shown to play a role in the pathophysiology of various auto-immune diseases, particularly in multiple sclerosis (MS). Although the role of these cells has not yet been established fully, mouse studies show that the antagonism of MAIT cells has the potential to be used in the treatment of auto-immune diseases. Mucosal vaccination has demonstrable effects on the immune system, but treatment regimens and antigens must be improved to demonstrate clinical effects more extensively. This systematic review was registered in PROSPERO under number CRD42023421093.},
}
RevDate: 2025-05-30
Keystone species in microbial communities: From discovery to soil heavy metal-remediation.
Journal of hazardous materials, 494:138753 pii:S0304-3894(25)01669-3 [Epub ahead of print].
Keystone species have significant impacts on community structure and function regardless of their abundance in space and time, whether individually or collectively. They play a unique and crucial role, and their removal can lead to substantial changes in the microbiome. It is one of the necessary processes to explore key microbial functions and interactions by studying keystone species. The term "keystone species" has been proposed and developed for nearly 60 years, but in microbiology, it is often used interchangeably with similar terms, which hinders the integration and advancement of research. Here, we review similar terms for keystone species in the microbial field and suggest using "keystone species" instead of "keystone taxa". We also summarize and analyze identification approaches for keystone species, highlighting the advantages and disadvantages of each while providing recommendations for selecting appropriate approaches in the environmental field. Based on the serious soil environment problem, this review also takes the research in the field of heavy metal-contaminated soils as case studies, and summarizes and analyzes the research situation of keystone species. Finally, we discuss the current limitations in research on keystone species, offering insights into their future development and application in the microbial field, particularly in remediation for heavy metal-contaminated soils. This review aims to summarize existing research on microbial keystone species and connect the findings to the field of environmental remediation, providing a reference for developing more effective remediation strategies and enhancing our understanding of ecosystem health.
Additional Links: PMID-40446379
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40446379,
year = {2025},
author = {Jiang, G and Ruan, Z and Yin, Y and Hu, C and Tian, L and Lu, JN and Wang, S and Tang, YT and Qiu, R and Chao, Y},
title = {Keystone species in microbial communities: From discovery to soil heavy metal-remediation.},
journal = {Journal of hazardous materials},
volume = {494},
number = {},
pages = {138753},
doi = {10.1016/j.jhazmat.2025.138753},
pmid = {40446379},
issn = {1873-3336},
abstract = {Keystone species have significant impacts on community structure and function regardless of their abundance in space and time, whether individually or collectively. They play a unique and crucial role, and their removal can lead to substantial changes in the microbiome. It is one of the necessary processes to explore key microbial functions and interactions by studying keystone species. The term "keystone species" has been proposed and developed for nearly 60 years, but in microbiology, it is often used interchangeably with similar terms, which hinders the integration and advancement of research. Here, we review similar terms for keystone species in the microbial field and suggest using "keystone species" instead of "keystone taxa". We also summarize and analyze identification approaches for keystone species, highlighting the advantages and disadvantages of each while providing recommendations for selecting appropriate approaches in the environmental field. Based on the serious soil environment problem, this review also takes the research in the field of heavy metal-contaminated soils as case studies, and summarizes and analyzes the research situation of keystone species. Finally, we discuss the current limitations in research on keystone species, offering insights into their future development and application in the microbial field, particularly in remediation for heavy metal-contaminated soils. This review aims to summarize existing research on microbial keystone species and connect the findings to the field of environmental remediation, providing a reference for developing more effective remediation strategies and enhancing our understanding of ecosystem health.},
}
RevDate: 2025-05-30
CmpDate: 2025-05-30
The microbiome for clinicians.
Cell, 188(11):2836-2844.
Despite promising evidence in diagnostics and therapeutics, microbiome research is not yet implemented into clinical medicine. Several initiatives, including the standardization of microbiome research, the refinement of microbiome clinical trial design, and the development of communication between microbiome researchers and clinicians, are crucial to move microbiome science toward clinical practice.
Additional Links: PMID-40446358
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40446358,
year = {2025},
author = {Porcari, S and Ng, SC and Zitvogel, L and Sokol, H and Weersma, RK and Elinav, E and Gasbarrini, A and Cammarota, G and Tilg, H and Ianiro, G},
title = {The microbiome for clinicians.},
journal = {Cell},
volume = {188},
number = {11},
pages = {2836-2844},
doi = {10.1016/j.cell.2025.04.016},
pmid = {40446358},
issn = {1097-4172},
mesh = {Humans ; *Microbiota ; Clinical Trials as Topic ; },
abstract = {Despite promising evidence in diagnostics and therapeutics, microbiome research is not yet implemented into clinical medicine. Several initiatives, including the standardization of microbiome research, the refinement of microbiome clinical trial design, and the development of communication between microbiome researchers and clinicians, are crucial to move microbiome science toward clinical practice.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Microbiota
Clinical Trials as Topic
RevDate: 2025-05-30
CmpDate: 2025-05-30
Impact of smokeless and smoking tobacco on subgingival microbial composition: A comparative study.
Przeglad epidemiologiczny, 79(1):95-103.
BACKGROUND: Environmental perturbations such as tobacco use causes increased bacterial diversity in the subgingival microbiome. Despite the recognized impact of tobacco on oral health, there is a notable gap in the literature regarding the specific characteristics of the subgingival microbiome among Indian tobacco users.
OBJECTIVE: This study seeks to provide a comparative analysis of subgingival microbial profile of smokeless tobacco users and smokers with an otherwise healthy periodontal environment.
MATERIAL AND METHODS: This cross-sectional study at a Tertiary Dental Hospital in India recruited 118 participants: 52 non-tobacco users (Group 1), 36 smokeless tobacco users (Group 2), and 30 smokers (Group 3). Subgingival samples were collected from mesial surfaces of teeth (16, 46) using sterile paper points and analysed via the streak plate method for bacterial profiling. Clinical examinations assessed oral hygiene, gingival, and periodontal health using indices: Bleeding on Probing (BoP), Pocket Depth (PD), and Approximate Plaque Index (API). Categorical variables were analysed using the Chi-square test, and odds ratios were calculated.
RESULTS: Gender distribution was 76.3% male and 23.7% female (p < 0.05). Group 2 had a significantly higher prevalence of gram-positive cocci (100%) and gram-negative coccobacilli (94.4%) compared to Group 1, with a 12.4 times increased risk for gram-negative coccobacilli (p < 0.05). Group 2 also showed a higher occurrence of Aggregatibacter (88.9%) and a 3.5 times increased risk (p < 0.05). Group 3 exhibited significantly more gram-positive cocci and gram-negative coccobacilli than Group 1, with 3.8 times and 4.7 times increased risks, respectively (p < 0.05). Rothia species were significantly more common in smokers (13.3%) than non-tobacco users (0%) (p < 0.05).
CONCLUSIONS: Despite the absence of periodontal disease, the elevated presence of Aggregatibacter, Enterococcus, Klebsiella, and Rothia species indicates a shift towards increased bacterial diversity and a higher risk of future periodontitis.
Additional Links: PMID-40446105
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40446105,
year = {2025},
author = {Saxena, V and Datla, A and Pradhan, P and Deheriya, M and Tiwari, N and Shoukath, S},
title = {Impact of smokeless and smoking tobacco on subgingival microbial composition: A comparative study.},
journal = {Przeglad epidemiologiczny},
volume = {79},
number = {1},
pages = {95-103},
doi = {10.32394/pe/203721},
pmid = {40446105},
issn = {0033-2100},
mesh = {Humans ; Female ; Male ; Adult ; *Tobacco, Smokeless/adverse effects ; Cross-Sectional Studies ; India/epidemiology ; Middle Aged ; *Gingiva/microbiology ; *Microbiota ; *Smoking ; },
abstract = {BACKGROUND: Environmental perturbations such as tobacco use causes increased bacterial diversity in the subgingival microbiome. Despite the recognized impact of tobacco on oral health, there is a notable gap in the literature regarding the specific characteristics of the subgingival microbiome among Indian tobacco users.
OBJECTIVE: This study seeks to provide a comparative analysis of subgingival microbial profile of smokeless tobacco users and smokers with an otherwise healthy periodontal environment.
MATERIAL AND METHODS: This cross-sectional study at a Tertiary Dental Hospital in India recruited 118 participants: 52 non-tobacco users (Group 1), 36 smokeless tobacco users (Group 2), and 30 smokers (Group 3). Subgingival samples were collected from mesial surfaces of teeth (16, 46) using sterile paper points and analysed via the streak plate method for bacterial profiling. Clinical examinations assessed oral hygiene, gingival, and periodontal health using indices: Bleeding on Probing (BoP), Pocket Depth (PD), and Approximate Plaque Index (API). Categorical variables were analysed using the Chi-square test, and odds ratios were calculated.
RESULTS: Gender distribution was 76.3% male and 23.7% female (p < 0.05). Group 2 had a significantly higher prevalence of gram-positive cocci (100%) and gram-negative coccobacilli (94.4%) compared to Group 1, with a 12.4 times increased risk for gram-negative coccobacilli (p < 0.05). Group 2 also showed a higher occurrence of Aggregatibacter (88.9%) and a 3.5 times increased risk (p < 0.05). Group 3 exhibited significantly more gram-positive cocci and gram-negative coccobacilli than Group 1, with 3.8 times and 4.7 times increased risks, respectively (p < 0.05). Rothia species were significantly more common in smokers (13.3%) than non-tobacco users (0%) (p < 0.05).
CONCLUSIONS: Despite the absence of periodontal disease, the elevated presence of Aggregatibacter, Enterococcus, Klebsiella, and Rothia species indicates a shift towards increased bacterial diversity and a higher risk of future periodontitis.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
Female
Male
Adult
*Tobacco, Smokeless/adverse effects
Cross-Sectional Studies
India/epidemiology
Middle Aged
*Gingiva/microbiology
*Microbiota
*Smoking
RevDate: 2025-05-30
CmpDate: 2025-05-30
Schistosoma mansoni infection causes consistent changes to the fecal bacterial microbiota of mice across and within sites.
PloS one, 20(5):e0324638 pii:PONE-D-24-49668.
Eggs of Schistosoma mansoni are produced by adult female worms in mesenteries of infected hosts. Eggs can cross the intestinal barrier and form granulomas in the tissue or breach and exit the host through fecal excretion. These interactions may affect the host microbiome assemblages. Given the potential for schistosomal alteration of host gut microbiome and subsequent effects on the fecal bacterial composition, it is important to conduct controlled microbiome studies on model animals. While pursuing these studies, it is important to take into account the different conditions in which microbiome studies are conducted and their consequent impacts on variability and reproducibility of results. In particular, we are interested in inter-institutional effects on controlled microbiome studies, in which the study location itself may impact study outcomes. In this work, we report global changes caused by acute and chronic schistosomiasis on the fecal microbiome of mice at two different institutions and three timepoints.
Additional Links: PMID-40445957
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40445957,
year = {2025},
author = {Mhanna, MA and Gauthier, DT and Shollenberger, LM},
title = {Schistosoma mansoni infection causes consistent changes to the fecal bacterial microbiota of mice across and within sites.},
journal = {PloS one},
volume = {20},
number = {5},
pages = {e0324638},
doi = {10.1371/journal.pone.0324638},
pmid = {40445957},
issn = {1932-6203},
mesh = {Animals ; *Feces/microbiology ; *Schistosomiasis mansoni/microbiology/parasitology ; Mice ; *Schistosoma mansoni ; Female ; *Gastrointestinal Microbiome ; Male ; },
abstract = {Eggs of Schistosoma mansoni are produced by adult female worms in mesenteries of infected hosts. Eggs can cross the intestinal barrier and form granulomas in the tissue or breach and exit the host through fecal excretion. These interactions may affect the host microbiome assemblages. Given the potential for schistosomal alteration of host gut microbiome and subsequent effects on the fecal bacterial composition, it is important to conduct controlled microbiome studies on model animals. While pursuing these studies, it is important to take into account the different conditions in which microbiome studies are conducted and their consequent impacts on variability and reproducibility of results. In particular, we are interested in inter-institutional effects on controlled microbiome studies, in which the study location itself may impact study outcomes. In this work, we report global changes caused by acute and chronic schistosomiasis on the fecal microbiome of mice at two different institutions and three timepoints.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
*Feces/microbiology
*Schistosomiasis mansoni/microbiology/parasitology
Mice
*Schistosoma mansoni
Female
*Gastrointestinal Microbiome
Male
RevDate: 2025-05-30
Gut microbiome and host interactions in catfish: hybridization structures bacterial communities along catfish intestinal tract.
Additional Links: PMID-40445867
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40445867,
year = {2025},
author = {Cai, X and Zhong, L},
title = {Gut microbiome and host interactions in catfish: hybridization structures bacterial communities along catfish intestinal tract.},
journal = {Physiological genomics},
volume = {},
number = {},
pages = {},
doi = {10.1152/physiolgenomics.00058.2025},
pmid = {40445867},
issn = {1531-2267},
support = {CARS-46//China Agriculture Research System of MOF and MARA/ ; },
}
RevDate: 2025-05-30
A systematic Mendelian randomized study of the effects of the gut microbiome and immune cells on pancreatic neuroendocrine tumors.
Discover oncology, 16(1):961.
Pancreatic neuroendocrine tumors (pNETs) are a rare subset of pancreatic cancers often diagnosed late and characterized by complex behaviors. Recent evidence suggests the gut microbiome (GM) significantly influences various diseases by modulating the immune system. This study utilized a Mendelian randomization (MR) approach to investigate the causal relationship between GM and pNETs, using single nucleotide polymorphism data as instrumental variables. Two-sample MR analysis identified significant correlations between GM and immune cell types. The study found eight specific GMs affecting pNETs risk: the family Sutterellaceae (OR: 1.52, 95% CI 1.10-2.10, p = 0.01), the genus Paraprevotella (OR: 1.34, 95% CI 1.05-1.72, p = 0.02), the species Paraprevotella unclassified (OR: 1.40, 95% CI 1.08-1.81, p = 0.01), and the species Ruminococcus torques (OR: 1.45, 95% CI 1.12-1.89, p = 0.01) increased risk, while the class Gammaproteobacteria (OR: 0.75, 95% CI 0.57-0.98, p = 0.04), the family Acidaminococcaceae (OR: 0.70, 95% CI 0.52-0.94, p = 0.02), the species Paraprevotella xylaniphila (OR: 0.72, 95% CI 0.54-0.96, p = 0.03), and the species Bacteroides finegoldii (OR: 0.68, 95% CI 0.51-0.91, p = 0.01) decreased it. Mediation analysis indicated the species Ruminococcus torques mediated the effect of CD25 on CD45RA+ CD4 non-regulatory T cells on pNETs, accounting for 3.6% of the total effect. This study provides evidence suggestive of a potential causal role of specific GM compositions in pNETs progression and their mediation through immune cell signatures. However, mechanistic studies are required to further validate this relationship.
Additional Links: PMID-40445430
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40445430,
year = {2025},
author = {Chen, F and Zhou, Y and Mao, X and Lin, R and Huang, H},
title = {A systematic Mendelian randomized study of the effects of the gut microbiome and immune cells on pancreatic neuroendocrine tumors.},
journal = {Discover oncology},
volume = {16},
number = {1},
pages = {961},
pmid = {40445430},
issn = {2730-6011},
support = {No. 2020J011013//Natural Science Foundation of Fujian Province, China/ ; No. 2023Y9149//Joint Funds for the Innovation of Science and Technology, Fujian province, China/ ; No. 2021-76//Medical Minimally Invasive Center Program of Fujian Province and National Key Clinical Specialty Discipline Construction Program, China/ ; },
abstract = {Pancreatic neuroendocrine tumors (pNETs) are a rare subset of pancreatic cancers often diagnosed late and characterized by complex behaviors. Recent evidence suggests the gut microbiome (GM) significantly influences various diseases by modulating the immune system. This study utilized a Mendelian randomization (MR) approach to investigate the causal relationship between GM and pNETs, using single nucleotide polymorphism data as instrumental variables. Two-sample MR analysis identified significant correlations between GM and immune cell types. The study found eight specific GMs affecting pNETs risk: the family Sutterellaceae (OR: 1.52, 95% CI 1.10-2.10, p = 0.01), the genus Paraprevotella (OR: 1.34, 95% CI 1.05-1.72, p = 0.02), the species Paraprevotella unclassified (OR: 1.40, 95% CI 1.08-1.81, p = 0.01), and the species Ruminococcus torques (OR: 1.45, 95% CI 1.12-1.89, p = 0.01) increased risk, while the class Gammaproteobacteria (OR: 0.75, 95% CI 0.57-0.98, p = 0.04), the family Acidaminococcaceae (OR: 0.70, 95% CI 0.52-0.94, p = 0.02), the species Paraprevotella xylaniphila (OR: 0.72, 95% CI 0.54-0.96, p = 0.03), and the species Bacteroides finegoldii (OR: 0.68, 95% CI 0.51-0.91, p = 0.01) decreased it. Mediation analysis indicated the species Ruminococcus torques mediated the effect of CD25 on CD45RA+ CD4 non-regulatory T cells on pNETs, accounting for 3.6% of the total effect. This study provides evidence suggestive of a potential causal role of specific GM compositions in pNETs progression and their mediation through immune cell signatures. However, mechanistic studies are required to further validate this relationship.},
}
RevDate: 2025-05-30
Comparing Raman and NanoSIMS for heavy water labeling of single cells.
Microbiology spectrum [Epub ahead of print].
Stable isotope probing (SIP) experiments in conjunction with Raman microspectroscopy (Raman) or nano-scale secondary ion mass spectrometry (NanoSIMS) are frequently used to explore single cell metabolic activity in pure cultures as well as complex microbiomes. Despite the increasing popularity of these techniques, the comparability of isotope incorporation measurements using both Raman and NanoSIMS directly on the same cell remains largely unexplored. This knowledge gap creates uncertainty about the consistency of single-cell SIP data obtained independently from each method. Here, we conducted a comparative analysis of 543 Escherichia coli cells grown in M9 minimal medium in the absence or presence of heavy water ([2]H2O) using correlative Raman and NanoSIMS measurements to quantify the results between the two approaches. We demonstrate that Raman and NanoSIMS yield highly comparable measurements of [2]H incorporation, with varying degrees of similarity based on the mass ratios analyzed using NanoSIMS. The [12]C[2]H/[12]C[1]H and [12]C2[2]H/[12]C2[1]H mass ratios provide targeted measurements of C-H bonds but may suffer from biases and background interference, while the [2]H/[1]H ratio captures all hydrogen with lower detection limits, making it suitable for applications requiring comprehensive [2]H quantification. Importantly, despite its higher mass resolution requirements, the use of C2[2]H/C2[1]H may be a viable alternative to the use of C[2]H/C[1]H due to lower background and higher overall count rates. Furthermore, using an empirical approach in determining Raman wavenumber ranges via the second derivative improved the data equivalency of [2]H quantification between Raman and NanoSIMS, highlighting its potential for enhancing cross-technique comparability. These findings provide a robust framework for leveraging both techniques, enabling informed experimental design and data interpretation. By enhancing cross-technique comparability, this work advances SIP methodologies for investigating microbial metabolism and interactions in diverse systems.IMPORTANCEAccurate and reliable measurements of cellular properties are fundamental to understand the function and activity of microbes. This study addresses to what extent Raman microspectroscopy and nano-scale secondary ion mass spectrometry (NanoSIMS) measurements of single cell anabolic activity can be compared. Here, we study the relationship of the incorporation of a stable isotope ([2]H through incorporation of [2]H2O) as determined by the two techniques and calculate a correlation coefficient to support the use of either technique when analyzing cells incubated with [2]H2O. The ability to discern between the comparative strengths and limitations of these techniques is invaluable in refining experimental protocols, enhancing data comparability between studies, data interpretation, and ultimately advancing the quality and reliability of outcomes in microbiome research.
Additional Links: PMID-40445204
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40445204,
year = {2025},
author = {Schaible, GA and Cliff, JB and Crandall, JA and Bougoure, JJ and Mathuri, MN and Sessions, AL and Atwood, J and Hatzenpichler, R},
title = {Comparing Raman and NanoSIMS for heavy water labeling of single cells.},
journal = {Microbiology spectrum},
volume = {},
number = {},
pages = {e0165924},
doi = {10.1128/spectrum.01659-24},
pmid = {40445204},
issn = {2165-0497},
abstract = {Stable isotope probing (SIP) experiments in conjunction with Raman microspectroscopy (Raman) or nano-scale secondary ion mass spectrometry (NanoSIMS) are frequently used to explore single cell metabolic activity in pure cultures as well as complex microbiomes. Despite the increasing popularity of these techniques, the comparability of isotope incorporation measurements using both Raman and NanoSIMS directly on the same cell remains largely unexplored. This knowledge gap creates uncertainty about the consistency of single-cell SIP data obtained independently from each method. Here, we conducted a comparative analysis of 543 Escherichia coli cells grown in M9 minimal medium in the absence or presence of heavy water ([2]H2O) using correlative Raman and NanoSIMS measurements to quantify the results between the two approaches. We demonstrate that Raman and NanoSIMS yield highly comparable measurements of [2]H incorporation, with varying degrees of similarity based on the mass ratios analyzed using NanoSIMS. The [12]C[2]H/[12]C[1]H and [12]C2[2]H/[12]C2[1]H mass ratios provide targeted measurements of C-H bonds but may suffer from biases and background interference, while the [2]H/[1]H ratio captures all hydrogen with lower detection limits, making it suitable for applications requiring comprehensive [2]H quantification. Importantly, despite its higher mass resolution requirements, the use of C2[2]H/C2[1]H may be a viable alternative to the use of C[2]H/C[1]H due to lower background and higher overall count rates. Furthermore, using an empirical approach in determining Raman wavenumber ranges via the second derivative improved the data equivalency of [2]H quantification between Raman and NanoSIMS, highlighting its potential for enhancing cross-technique comparability. These findings provide a robust framework for leveraging both techniques, enabling informed experimental design and data interpretation. By enhancing cross-technique comparability, this work advances SIP methodologies for investigating microbial metabolism and interactions in diverse systems.IMPORTANCEAccurate and reliable measurements of cellular properties are fundamental to understand the function and activity of microbes. This study addresses to what extent Raman microspectroscopy and nano-scale secondary ion mass spectrometry (NanoSIMS) measurements of single cell anabolic activity can be compared. Here, we study the relationship of the incorporation of a stable isotope ([2]H through incorporation of [2]H2O) as determined by the two techniques and calculate a correlation coefficient to support the use of either technique when analyzing cells incubated with [2]H2O. The ability to discern between the comparative strengths and limitations of these techniques is invaluable in refining experimental protocols, enhancing data comparability between studies, data interpretation, and ultimately advancing the quality and reliability of outcomes in microbiome research.},
}
RevDate: 2025-05-30
CmpDate: 2025-05-30
A suite of selective pressures supports the maintenance of alleles of a Drosophila immune peptide.
eLife, 12: pii:90638.
The innate immune system provides hosts with a crucial first line of defense against pathogens. While immune genes are often among the fastest evolving genes in the genome, in Drosophila, antimicrobial peptides (AMPs) are notable exceptions. Instead, AMPs may be under balancing selection, such that over evolutionary timescales, multiple alleles are maintained in populations. In this study, we focus on the Drosophila AMP Diptericin A, which has a segregating amino acid polymorphism associated with differential survival after infection with the Gram-negative bacteria Providencia rettgeri. Diptericin A also helps control opportunistic gut infections by common Drosophila gut microbes, especially those of Lactobacillus plantarum. In addition to genotypic effects on gut immunity, we also see strong sex-specific effects that are most prominent in flies without functional diptericin A. To further characterize differences in microbiomes between different diptericin genotypes, we used 16S metagenomics to look at the microbiome composition. We used both lab-reared and wild-caught flies for our sequencing and looked at overall composition as well as the differential abundance of individual bacterial families. Overall, we find flies that are homozygous for one allele of diptericin A are better equipped to survive a systemic infection from P. rettgeri, but in general have a shorter lifespans after being fed common gut commensals. Our results suggest a possible mechanism for the maintenance of genetic variation of diptericin A through the complex interactions of sex, systemic immunity, and the maintenance of the gut microbiome.
Additional Links: PMID-40445192
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40445192,
year = {2025},
author = {Mullinax, SR and Darby, AM and Gupta, A and Chan, P and Smith, BR and Unckless, RL},
title = {A suite of selective pressures supports the maintenance of alleles of a Drosophila immune peptide.},
journal = {eLife},
volume = {12},
number = {},
pages = {},
doi = {10.7554/eLife.90638},
pmid = {40445192},
issn = {2050-084X},
support = {AI139154/NH/NIH HHS/United States ; 2330095//National Science Foundation/ ; CMADP COBRE P20-GM103638/NH/NIH HHS/United States ; },
mesh = {Animals ; *Alleles ; Female ; Male ; *Drosophila Proteins/genetics/immunology ; *Selection, Genetic ; Providencia/immunology ; *Drosophila/genetics/immunology/microbiology ; Gastrointestinal Microbiome ; *Drosophila melanogaster/genetics/immunology/microbiology ; *Antimicrobial Peptides/genetics/immunology ; },
abstract = {The innate immune system provides hosts with a crucial first line of defense against pathogens. While immune genes are often among the fastest evolving genes in the genome, in Drosophila, antimicrobial peptides (AMPs) are notable exceptions. Instead, AMPs may be under balancing selection, such that over evolutionary timescales, multiple alleles are maintained in populations. In this study, we focus on the Drosophila AMP Diptericin A, which has a segregating amino acid polymorphism associated with differential survival after infection with the Gram-negative bacteria Providencia rettgeri. Diptericin A also helps control opportunistic gut infections by common Drosophila gut microbes, especially those of Lactobacillus plantarum. In addition to genotypic effects on gut immunity, we also see strong sex-specific effects that are most prominent in flies without functional diptericin A. To further characterize differences in microbiomes between different diptericin genotypes, we used 16S metagenomics to look at the microbiome composition. We used both lab-reared and wild-caught flies for our sequencing and looked at overall composition as well as the differential abundance of individual bacterial families. Overall, we find flies that are homozygous for one allele of diptericin A are better equipped to survive a systemic infection from P. rettgeri, but in general have a shorter lifespans after being fed common gut commensals. Our results suggest a possible mechanism for the maintenance of genetic variation of diptericin A through the complex interactions of sex, systemic immunity, and the maintenance of the gut microbiome.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
*Alleles
Female
Male
*Drosophila Proteins/genetics/immunology
*Selection, Genetic
Providencia/immunology
*Drosophila/genetics/immunology/microbiology
Gastrointestinal Microbiome
*Drosophila melanogaster/genetics/immunology/microbiology
*Antimicrobial Peptides/genetics/immunology
RevDate: 2025-05-30
Experimental assessment of interactions between marine bacteria and model protists: from predator-prey relationships to bacterial-mediated lysis.
Applied and environmental microbiology [Epub ahead of print].
Bacteria in aquatic environments are a principal food source for predatory protists. Whereas interactions between bacteria and protists are recognized to determine the pathogenesis and epidemiology of several human pathogens, few studies have systematically characterized the interactions between specific aquatic bacteria and protists beyond the prey-predator relation. We, therefore, surveyed individual co-cultures between 18 different genome-sequenced marine bacteria with known virulence gene repertoires and three model protist species widely used for assessing bacteria-protist interactions. Strikingly, 10, 5, and 3 bacterial isolates were capable of lysing the protists Acanthamoeba polyphaga, Tetrahymena pyriformis, and Euglena gracilis, respectively. A majority of the bacteria were able to grow and/or maintain viable populations in the presence of viable protists. Some bacteria survived longer with viable protists but not heat-killed protists and were observed in protist vacuoles. In this respect, marine bacteria are similar to several protist-dependent human pathogens, including Legionella. Analyses of growth patterns in low-nutrient media showed that co-cultivation with A. polyphaga allowed one bacterial strain to overcome nutritional stress and obtain active growth. Five isolates depended on viable amoebae to grow, notwithstanding nutrient media status. The remarkable capability of these marine bacteria to survive encounters with, and even actively kill, model predatory protists under laboratory conditions suggests that diverse bacterial defense strategies and virulence mechanisms to access nutrients may be important in shaping microbial interactions. If verified with native marine and freshwater populations, the diversity of interactions uncovered here has implications for understanding ecological and evolutionary consequences of population dynamics in bacteria and protists.IMPORTANCEThe microbiome constitutes the base of food webs in aquatic environments. Its composition partly reflects biotic interactions, where bacteria primarily are considered prey of predatory protists. However, studies that focus on one or a few species have shown that some bacteria have abilities to escape grazing and may even be capable of lysing their protist predators. In this study, we substantially extend these findings by systematically investigating interactions among multiple taxa of both bacteria and protists. Our results show that marine bacteria display a wider and more complex range of interactions with their predators than generally recognized-from growth dependency to protist lysis. Given that such interactions play key roles in the pathogenesis and epidemiology of several human pathogens, our findings imply that bacterial virulence traits can contribute to defining the structure and ecology of aquatic microbiomes.
Additional Links: PMID-40444979
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40444979,
year = {2025},
author = {Axelsson-Olsson, D and Gubonin, N and Israelsson, S and Pinhassi, J},
title = {Experimental assessment of interactions between marine bacteria and model protists: from predator-prey relationships to bacterial-mediated lysis.},
journal = {Applied and environmental microbiology},
volume = {},
number = {},
pages = {e0092925},
doi = {10.1128/aem.00929-25},
pmid = {40444979},
issn = {1098-5336},
abstract = {Bacteria in aquatic environments are a principal food source for predatory protists. Whereas interactions between bacteria and protists are recognized to determine the pathogenesis and epidemiology of several human pathogens, few studies have systematically characterized the interactions between specific aquatic bacteria and protists beyond the prey-predator relation. We, therefore, surveyed individual co-cultures between 18 different genome-sequenced marine bacteria with known virulence gene repertoires and three model protist species widely used for assessing bacteria-protist interactions. Strikingly, 10, 5, and 3 bacterial isolates were capable of lysing the protists Acanthamoeba polyphaga, Tetrahymena pyriformis, and Euglena gracilis, respectively. A majority of the bacteria were able to grow and/or maintain viable populations in the presence of viable protists. Some bacteria survived longer with viable protists but not heat-killed protists and were observed in protist vacuoles. In this respect, marine bacteria are similar to several protist-dependent human pathogens, including Legionella. Analyses of growth patterns in low-nutrient media showed that co-cultivation with A. polyphaga allowed one bacterial strain to overcome nutritional stress and obtain active growth. Five isolates depended on viable amoebae to grow, notwithstanding nutrient media status. The remarkable capability of these marine bacteria to survive encounters with, and even actively kill, model predatory protists under laboratory conditions suggests that diverse bacterial defense strategies and virulence mechanisms to access nutrients may be important in shaping microbial interactions. If verified with native marine and freshwater populations, the diversity of interactions uncovered here has implications for understanding ecological and evolutionary consequences of population dynamics in bacteria and protists.IMPORTANCEThe microbiome constitutes the base of food webs in aquatic environments. Its composition partly reflects biotic interactions, where bacteria primarily are considered prey of predatory protists. However, studies that focus on one or a few species have shown that some bacteria have abilities to escape grazing and may even be capable of lysing their protist predators. In this study, we substantially extend these findings by systematically investigating interactions among multiple taxa of both bacteria and protists. Our results show that marine bacteria display a wider and more complex range of interactions with their predators than generally recognized-from growth dependency to protist lysis. Given that such interactions play key roles in the pathogenesis and epidemiology of several human pathogens, our findings imply that bacterial virulence traits can contribute to defining the structure and ecology of aquatic microbiomes.},
}
RevDate: 2025-05-30
Young gut microbiota transplantation improves the metabolic health of old mice.
mSystems [Epub ahead of print].
UNLABELLED: The gut microbiota evolves over a lifetime and significantly impacts the aging process. Targeting the gut microbiota represents a novel avenue to delay aging and aging-related physical and mental decline. However, the underlying mechanism by which the microbiota modulates the aging process, particularly age-related physical and behavioral changes is not completely understood. We conducted fecal microbiota transplantation (FMT) from young or old male donor mice to the old male recipients. Old recipients with young microbiota had a higher alpha diversity than the old recipients with old microbiota. Compared to FMT with old microbiota, FMT with young microbiota reduced body weight and prevented fat accumulation in the old recipients. FMT with young microbiota also lowered frailty, increased grip strength, and alleviated depression and anxiety-like behavior in the old recipients. Consistent with observed physical changes, untargeted metabolomic analysis of serum and stools revealed that FMT with young microbiota lowered age-related long-chain fatty acid levels and increased amino acid levels in the old recipients. Bulk RNAseq analysis of the amygdala of the brain showed that FMT with young microbiota downregulated inflammatory pathways and upregulated oxidative phosphorylation in the old recipients. Our results demonstrate that FMT with young microbiota has substantial positive influences on age-related body composition, frailty, and psychological behaviors. These effects are associated with changes in host lipid and amino acid metabolism in the periphery and transcriptional regulation of neuroinflammation and energy utilization in the brain.
IMPORTANCE: The gut microbiome is a key hallmark of aging. Fecal microbiota transplantation (FMT) using young microbiota represents a novel rejuvenation strategy to delay aging. Our study provides compelling evidence that transplanting microbiota from young mice significantly improved grip strength, frailty, and body composition in aged recipient mice. At the molecular level, FMT improved aging-related metabolic markers in the gut and circulation. Additionally, FMT from young microbiota rejuvenated the amygdala of the aged brain by downregulating inflammatory pathways. This study highlights the importance of metabolic reprogramming via young microbiota FMT in improving physical and metabolic health in elderly recipients.
Additional Links: PMID-40444969
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40444969,
year = {2025},
author = {Xie, J and Kim, T and Liu, Z and Panier, H and Bokoliya, S and Xu, M and Zhou, Y},
title = {Young gut microbiota transplantation improves the metabolic health of old mice.},
journal = {mSystems},
volume = {},
number = {},
pages = {e0160124},
doi = {10.1128/msystems.01601-24},
pmid = {40444969},
issn = {2379-5077},
abstract = {UNLABELLED: The gut microbiota evolves over a lifetime and significantly impacts the aging process. Targeting the gut microbiota represents a novel avenue to delay aging and aging-related physical and mental decline. However, the underlying mechanism by which the microbiota modulates the aging process, particularly age-related physical and behavioral changes is not completely understood. We conducted fecal microbiota transplantation (FMT) from young or old male donor mice to the old male recipients. Old recipients with young microbiota had a higher alpha diversity than the old recipients with old microbiota. Compared to FMT with old microbiota, FMT with young microbiota reduced body weight and prevented fat accumulation in the old recipients. FMT with young microbiota also lowered frailty, increased grip strength, and alleviated depression and anxiety-like behavior in the old recipients. Consistent with observed physical changes, untargeted metabolomic analysis of serum and stools revealed that FMT with young microbiota lowered age-related long-chain fatty acid levels and increased amino acid levels in the old recipients. Bulk RNAseq analysis of the amygdala of the brain showed that FMT with young microbiota downregulated inflammatory pathways and upregulated oxidative phosphorylation in the old recipients. Our results demonstrate that FMT with young microbiota has substantial positive influences on age-related body composition, frailty, and psychological behaviors. These effects are associated with changes in host lipid and amino acid metabolism in the periphery and transcriptional regulation of neuroinflammation and energy utilization in the brain.
IMPORTANCE: The gut microbiome is a key hallmark of aging. Fecal microbiota transplantation (FMT) using young microbiota represents a novel rejuvenation strategy to delay aging. Our study provides compelling evidence that transplanting microbiota from young mice significantly improved grip strength, frailty, and body composition in aged recipient mice. At the molecular level, FMT improved aging-related metabolic markers in the gut and circulation. Additionally, FMT from young microbiota rejuvenated the amygdala of the aged brain by downregulating inflammatory pathways. This study highlights the importance of metabolic reprogramming via young microbiota FMT in improving physical and metabolic health in elderly recipients.},
}
RevDate: 2025-05-30
Multi-omics of a model bacterial consortium deciphers details of chitin decomposition in soil.
mBio [Epub ahead of print].
UNLABELLED: Soil microorganisms interact to carry out decomposition of complex organic carbon and nitrogen compounds, such as chitin, but the high diversity and complexity of the soil microbiome and habitat have posed a challenge to elucidating such interactions. Here, we sought to address this challenge by analysis of a model soil consortium (MSC-2) consisting of eight soil bacterial species. Our aim was to elucidate the specific roles of the member species during chitin metabolism. Samples were collected from MSC-2 incubated in chitin-enriched soil over 3 months. Multi-omics was used to understand how the community composition, transcripts, proteins, and chitin decomposition shifted over time. The data clearly and consistently revealed a temporal shift during chitin decomposition with defined contributions by individual species. A Streptomyces genus member (sp001905665) was a key player in early steps of chitin decomposition, with other MSC-2 members being central in carrying out later steps. These results illustrate how multi-omics applied to a defined consortium untangles the interactions between soil microorganisms.
IMPORTANCE: Although soil microorganisms carry out decomposition of organic matter in soil, the details are unclear due to the complexity of the soil microbiome and the heterogeneity of the soil habitat. Understanding carbon decomposition is of vital importance to determine how the soil carbon cycle functions. This is especially important with regard to understanding the fertility of soils and their ability to support plant growth. To overcome these challenges, we investigated in considerable detail a model soil community during its decomposition of a typical soil organic molecule-chitin. By using a multi-omics approach, we were able to decipher community interactions during chitin breakdown. This information provides a basis for understanding how more complex soil microbial communities interact in nature.
Additional Links: PMID-40444942
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40444942,
year = {2025},
author = {McClure, R and Rivas-Ubach, A and Hixson, KK and Farris, Y and Garcia, M and Danczak, R and Davison, M and Paurus, VL and Jansson, JK},
title = {Multi-omics of a model bacterial consortium deciphers details of chitin decomposition in soil.},
journal = {mBio},
volume = {},
number = {},
pages = {e0040425},
doi = {10.1128/mbio.00404-25},
pmid = {40444942},
issn = {2150-7511},
abstract = {UNLABELLED: Soil microorganisms interact to carry out decomposition of complex organic carbon and nitrogen compounds, such as chitin, but the high diversity and complexity of the soil microbiome and habitat have posed a challenge to elucidating such interactions. Here, we sought to address this challenge by analysis of a model soil consortium (MSC-2) consisting of eight soil bacterial species. Our aim was to elucidate the specific roles of the member species during chitin metabolism. Samples were collected from MSC-2 incubated in chitin-enriched soil over 3 months. Multi-omics was used to understand how the community composition, transcripts, proteins, and chitin decomposition shifted over time. The data clearly and consistently revealed a temporal shift during chitin decomposition with defined contributions by individual species. A Streptomyces genus member (sp001905665) was a key player in early steps of chitin decomposition, with other MSC-2 members being central in carrying out later steps. These results illustrate how multi-omics applied to a defined consortium untangles the interactions between soil microorganisms.
IMPORTANCE: Although soil microorganisms carry out decomposition of organic matter in soil, the details are unclear due to the complexity of the soil microbiome and the heterogeneity of the soil habitat. Understanding carbon decomposition is of vital importance to determine how the soil carbon cycle functions. This is especially important with regard to understanding the fertility of soils and their ability to support plant growth. To overcome these challenges, we investigated in considerable detail a model soil community during its decomposition of a typical soil organic molecule-chitin. By using a multi-omics approach, we were able to decipher community interactions during chitin breakdown. This information provides a basis for understanding how more complex soil microbial communities interact in nature.},
}
RevDate: 2025-05-30
CmpDate: 2025-05-30
Balancing harm and harmony: Evolutionary dynamics between gut microbiota-derived flagellin and TLR5-mediated host immunity and metabolism.
Virulence, 16(1):2512035.
The gut microbiota maintains host health and shapes immune responses through intricate host-microbe interactions. Bacterial flagellin, a key microbe-associated molecular pattern, is recognized by Toll-like receptor 5 (TLR5) and NOD-like receptor family caspase activation and recruitment domain-containing 4 inflammasome. This dual recognition maintains the delicate balance between immune tolerance and activation, thereby influencing health and disease outcomes. Therefore, we explored the structural and functional evolution of bacterial flagellin to elucidate its role in innate and adaptive immune responses, along with its impact on metabolic processes, particularly via TLR5. In this review, we highlight the diagnostic and therapeutic potential of flagellin, including its application in vaccine development, cancer immunotherapy, and microbiome-based therapies. We integrated perspectives from structural biology, immunology, and microbiome research to elucidate the co-evolutionary dynamics between gut microbiota-derived flagellin and host immunity. Our interpretations provide a basis for the development of innovative strategies to improve health and disease management.
Additional Links: PMID-40444793
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40444793,
year = {2025},
author = {Seo, B and Lim, MY},
title = {Balancing harm and harmony: Evolutionary dynamics between gut microbiota-derived flagellin and TLR5-mediated host immunity and metabolism.},
journal = {Virulence},
volume = {16},
number = {1},
pages = {2512035},
doi = {10.1080/21505594.2025.2512035},
pmid = {40444793},
issn = {2150-5608},
mesh = {*Flagellin/immunology/genetics/metabolism/chemistry ; *Toll-Like Receptor 5/immunology/metabolism ; *Gastrointestinal Microbiome/immunology ; Humans ; Animals ; Immunity, Innate ; Adaptive Immunity ; Host Microbial Interactions/immunology ; Evolution, Molecular ; Bacteria/immunology/genetics ; },
abstract = {The gut microbiota maintains host health and shapes immune responses through intricate host-microbe interactions. Bacterial flagellin, a key microbe-associated molecular pattern, is recognized by Toll-like receptor 5 (TLR5) and NOD-like receptor family caspase activation and recruitment domain-containing 4 inflammasome. This dual recognition maintains the delicate balance between immune tolerance and activation, thereby influencing health and disease outcomes. Therefore, we explored the structural and functional evolution of bacterial flagellin to elucidate its role in innate and adaptive immune responses, along with its impact on metabolic processes, particularly via TLR5. In this review, we highlight the diagnostic and therapeutic potential of flagellin, including its application in vaccine development, cancer immunotherapy, and microbiome-based therapies. We integrated perspectives from structural biology, immunology, and microbiome research to elucidate the co-evolutionary dynamics between gut microbiota-derived flagellin and host immunity. Our interpretations provide a basis for the development of innovative strategies to improve health and disease management.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Flagellin/immunology/genetics/metabolism/chemistry
*Toll-Like Receptor 5/immunology/metabolism
*Gastrointestinal Microbiome/immunology
Humans
Animals
Immunity, Innate
Adaptive Immunity
Host Microbial Interactions/immunology
Evolution, Molecular
Bacteria/immunology/genetics
RevDate: 2025-05-30
Beyond defense: microbial modifications of plant specialized metabolites alter and expand their ecological functions.
The New phytologist [Epub ahead of print].
Plant specialized metabolites (PSMs) are compounds that are not involved in primary metabolism but instead confer other roles for the plant host, often related to ecological interactions. In the field of plant-microbe interactions, many PSMs have traditionally been considered for their roles in shaping interactions with pathogens. However, it is increasingly clear that 'defensive' PSMs have broader functions in regulating assembly and functions of plant-associated microbes, a phenomenon that is best studied in the rhizosphere. PSMs, however, are secreted throughout plants to mediate interactions with the environment. In this Tansley insight, we argue that these molecules also play outsize roles in shaping microbial community assembly and functions in the phyllosphere. Additionally, we argue that it is important to consider how microbial activity transforms PSMs, because this may shape how plants interact with the environment. Increased attention to these effects and improved strategies to understand them across scales will lead to insights into how microbial responses to PSMs shape broader plant interactions in the environment.
Additional Links: PMID-40444642
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40444642,
year = {2025},
author = {Unger, K and Agler, MT},
title = {Beyond defense: microbial modifications of plant specialized metabolites alter and expand their ecological functions.},
journal = {The New phytologist},
volume = {},
number = {},
pages = {},
doi = {10.1111/nph.70254},
pmid = {40444642},
issn = {1469-8137},
support = {//Carl-Zeiss-Stiftung/ ; 458884166//Deutsche Forschungsgemeinschaft/ ; EXC 2051, project number 390713860//Deutsche Forschungsgemeinschaft/ ; },
abstract = {Plant specialized metabolites (PSMs) are compounds that are not involved in primary metabolism but instead confer other roles for the plant host, often related to ecological interactions. In the field of plant-microbe interactions, many PSMs have traditionally been considered for their roles in shaping interactions with pathogens. However, it is increasingly clear that 'defensive' PSMs have broader functions in regulating assembly and functions of plant-associated microbes, a phenomenon that is best studied in the rhizosphere. PSMs, however, are secreted throughout plants to mediate interactions with the environment. In this Tansley insight, we argue that these molecules also play outsize roles in shaping microbial community assembly and functions in the phyllosphere. Additionally, we argue that it is important to consider how microbial activity transforms PSMs, because this may shape how plants interact with the environment. Increased attention to these effects and improved strategies to understand them across scales will lead to insights into how microbial responses to PSMs shape broader plant interactions in the environment.},
}
RevDate: 2025-05-30
Metagenomics or Metataxonomics: Best Practice Methods to Uncover the Sinus Microbiome.
International forum of allergy & rhinology [Epub ahead of print].
Additional Links: PMID-40444400
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40444400,
year = {2025},
author = {Burdon, I and Bouras, G and Fenix, K and Yeo, K and Connell, J and Cooksley, C and Barry, E and Vreugde, S and Wormald, PJ and Psaltis, AJ},
title = {Metagenomics or Metataxonomics: Best Practice Methods to Uncover the Sinus Microbiome.},
journal = {International forum of allergy & rhinology},
volume = {},
number = {},
pages = {e23617},
doi = {10.1002/alr.23617},
pmid = {40444400},
issn = {2042-6984},
support = {//Garnett Passe and Rodney Williams Memorial Foundation/ ; APP1196832//National Health and Medical Research Council/ ; },
}
RevDate: 2025-05-30
Sleep duration associated with altered oral microbiome diversity and composition in the NIH AARP cohort.
Sleep advances : a journal of the Sleep Research Society, 6(2):zpaf023.
STUDY OBJECTIVES: The microbiome is proposed as a contributor to the adverse health impacts from altered sleep. The oral microbiome is a multifaceted microbial community that influences many health functions. However, data on the relationship between sleep and the oral microbiome are limited, and no studies have incorporated lifestyle and environmental exposures.
METHODS: Within a subset (N=1,139) of the NIH-AARP cohort, we examined the association between self-reported sleep duration and the oral microbiome via 16S rRNA gene amplicon sequencing. Statistical models were adjusted for demographic characteristics. Additional models examined the role of various lifestyle and neighborhood exposures on the sleep-oral microbiome association.
RESULTS: Compared to participants reporting the recommended 7-8 hours average sleep duration (n=702), those reporting short sleep (6 or fewer hours, n=284) had consistently decreased within-sample oral microbial diversity [e.g. number of observed amplicon sequence variants difference -8.681, p-value=0.009]. Several bacterial genera were more likely to be absent in the short sleep group. We found a higher relative abundance of Streptococcus and Rothia, and lower abundance of Fusobacterium, Atopobium, and Campylobacter in the short compared to the recommended sleep duration group. Results were consistent when controlling for lifestyle and neighborhood factors.
CONCLUSIONS: Our findings provide evidence for an association of short sleep duration with oral microbial diversity and composition. This suggests that oral bacteria may play a possible mechanistic role related to sleep health. Improved understanding of physiological pathways can aid in the design of interventions that may beneficially improve overall sleep health.
Additional Links: PMID-40444264
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40444264,
year = {2025},
author = {Dalton, KR and Chang, VC and Lee, M and Maki, K and Saint-Maurice, P and Purandare, V and Hua, X and Wan, Y and Dagnall, CL and Jones, K and Hicks, BD and Hutchinson, A and Liao, LM and Gail, MH and Shi, J and Sinha, R and Abnet, CC and London, SJ and Vogtmann, E},
title = {Sleep duration associated with altered oral microbiome diversity and composition in the NIH AARP cohort.},
journal = {Sleep advances : a journal of the Sleep Research Society},
volume = {6},
number = {2},
pages = {zpaf023},
pmid = {40444264},
issn = {2632-5012},
abstract = {STUDY OBJECTIVES: The microbiome is proposed as a contributor to the adverse health impacts from altered sleep. The oral microbiome is a multifaceted microbial community that influences many health functions. However, data on the relationship between sleep and the oral microbiome are limited, and no studies have incorporated lifestyle and environmental exposures.
METHODS: Within a subset (N=1,139) of the NIH-AARP cohort, we examined the association between self-reported sleep duration and the oral microbiome via 16S rRNA gene amplicon sequencing. Statistical models were adjusted for demographic characteristics. Additional models examined the role of various lifestyle and neighborhood exposures on the sleep-oral microbiome association.
RESULTS: Compared to participants reporting the recommended 7-8 hours average sleep duration (n=702), those reporting short sleep (6 or fewer hours, n=284) had consistently decreased within-sample oral microbial diversity [e.g. number of observed amplicon sequence variants difference -8.681, p-value=0.009]. Several bacterial genera were more likely to be absent in the short sleep group. We found a higher relative abundance of Streptococcus and Rothia, and lower abundance of Fusobacterium, Atopobium, and Campylobacter in the short compared to the recommended sleep duration group. Results were consistent when controlling for lifestyle and neighborhood factors.
CONCLUSIONS: Our findings provide evidence for an association of short sleep duration with oral microbial diversity and composition. This suggests that oral bacteria may play a possible mechanistic role related to sleep health. Improved understanding of physiological pathways can aid in the design of interventions that may beneficially improve overall sleep health.},
}
RevDate: 2025-05-30
Microbiota-derived metabolites in tumorigenesis: mechanistic insights and therapeutic implications.
Frontiers in pharmacology, 16:1598009.
Intestinal microbiota is a complex ecosystem of microorganisms that perform diverse metabolic activities to maintain gastrointestinal homeostasis. These microorganisms provide energy and nutrients for growth and reproduction while producing numerous metabolites including lipopolysaccharides (LPS), Bacteroides fragilis toxin (BFT), bile acids (BAs), polyamines (PAs), and short-chain fatty acids (SCFAs). These metabolites are linked to inflammation and various metabolic diseases, such as obesity, type-2 diabetes, non-alcoholic fatty liver disease, cardiometabolic disease, and malnutrition. In addition, they may contribute to tumorigenesis. Evidence suggests that these microbes can increase the susceptibility to certain cancers and affect treatment responses. In this review, we discuss the current knowledge on how the gut microbiome and its metabolites influence tumorigenesis, highlighting the potential molecular mechanisms and prospects for basic and translational research in this emerging field.
Additional Links: PMID-40444051
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40444051,
year = {2025},
author = {Yang, SF and Chen, XC and Pan, YJ},
title = {Microbiota-derived metabolites in tumorigenesis: mechanistic insights and therapeutic implications.},
journal = {Frontiers in pharmacology},
volume = {16},
number = {},
pages = {1598009},
pmid = {40444051},
issn = {1663-9812},
abstract = {Intestinal microbiota is a complex ecosystem of microorganisms that perform diverse metabolic activities to maintain gastrointestinal homeostasis. These microorganisms provide energy and nutrients for growth and reproduction while producing numerous metabolites including lipopolysaccharides (LPS), Bacteroides fragilis toxin (BFT), bile acids (BAs), polyamines (PAs), and short-chain fatty acids (SCFAs). These metabolites are linked to inflammation and various metabolic diseases, such as obesity, type-2 diabetes, non-alcoholic fatty liver disease, cardiometabolic disease, and malnutrition. In addition, they may contribute to tumorigenesis. Evidence suggests that these microbes can increase the susceptibility to certain cancers and affect treatment responses. In this review, we discuss the current knowledge on how the gut microbiome and its metabolites influence tumorigenesis, highlighting the potential molecular mechanisms and prospects for basic and translational research in this emerging field.},
}
RevDate: 2025-05-30
Enterotype-stratified gut microbial signatures in MASLD and cirrhosis based on integrated microbiome data.
Frontiers in microbiology, 16:1568672.
INTRODUCTION: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health challenge, characterized by significant variability in progression and clinical outcomes. While the gut microbiome is increasingly recognized as a key factor in liver disease development, its role in disease progression and associated mechanisms remains unclear. This study systematically investigated the gut microbiota's role in MASLD and liver cirrhosis progression, focusing on individual bacterial strains, microbial community dynamics, and functional characteristics across different enterotypes.
METHODS: Publicly available next-generation sequencing(NGS) datasets from healthy individuals and patients with MASLD and cirrhosis were analyzed. Enterotype classification was performed using principal component analysis, with advanced bioinformatics tools, including Linear Discriminant Analysis Effect Size (LEfSe), eXtreme Gradient Boosting (XGBoost), and Deep Cross-Fusion Networks for Genome-Scale Identification of Pathogens (DCiPatho), to identify differentially abundant microbes and potential pathogens. Microbial co-occurrence networks and functional predictions via PICRUSt2 revealed distinct patterns across enterotypes.
RESULTS AND DISCUSSION: The Prevotella-dominated(ET-P) group exhibited a 33% higher cirrhosis rate than the Bacteroides-dominated(ET-B) group. Unique microbial signatures were identified: Escherichia albertii and Veillonella nakazawae were associated with cirrhosis in ET-B, while Prevotella copri was linked to MASLD. In ET-P, Prevotella hominis and Clostridium saudiense were significantly associated with cirrhosis. Functional analysis revealed reduced biosynthesis of fatty acids, proteins, and short-chain fatty acids (SCFAs), coupled with increased lipopolysaccharide(LPS) production and altered secondary bile acid metabolism in MASLD and cirrhosis patients. There were significant microbial and functional differences across enterotypes in MASLD and cirrhosis progression, providing critical insights for developing personalized microbiome-targeted interventions to mitigate liver disease progression.
Additional Links: PMID-40444006
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40444006,
year = {2025},
author = {Yuan, H and Zhou, J and Wu, X and Wang, S and Park, S},
title = {Enterotype-stratified gut microbial signatures in MASLD and cirrhosis based on integrated microbiome data.},
journal = {Frontiers in microbiology},
volume = {16},
number = {},
pages = {1568672},
pmid = {40444006},
issn = {1664-302X},
abstract = {INTRODUCTION: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a growing global health challenge, characterized by significant variability in progression and clinical outcomes. While the gut microbiome is increasingly recognized as a key factor in liver disease development, its role in disease progression and associated mechanisms remains unclear. This study systematically investigated the gut microbiota's role in MASLD and liver cirrhosis progression, focusing on individual bacterial strains, microbial community dynamics, and functional characteristics across different enterotypes.
METHODS: Publicly available next-generation sequencing(NGS) datasets from healthy individuals and patients with MASLD and cirrhosis were analyzed. Enterotype classification was performed using principal component analysis, with advanced bioinformatics tools, including Linear Discriminant Analysis Effect Size (LEfSe), eXtreme Gradient Boosting (XGBoost), and Deep Cross-Fusion Networks for Genome-Scale Identification of Pathogens (DCiPatho), to identify differentially abundant microbes and potential pathogens. Microbial co-occurrence networks and functional predictions via PICRUSt2 revealed distinct patterns across enterotypes.
RESULTS AND DISCUSSION: The Prevotella-dominated(ET-P) group exhibited a 33% higher cirrhosis rate than the Bacteroides-dominated(ET-B) group. Unique microbial signatures were identified: Escherichia albertii and Veillonella nakazawae were associated with cirrhosis in ET-B, while Prevotella copri was linked to MASLD. In ET-P, Prevotella hominis and Clostridium saudiense were significantly associated with cirrhosis. Functional analysis revealed reduced biosynthesis of fatty acids, proteins, and short-chain fatty acids (SCFAs), coupled with increased lipopolysaccharide(LPS) production and altered secondary bile acid metabolism in MASLD and cirrhosis patients. There were significant microbial and functional differences across enterotypes in MASLD and cirrhosis progression, providing critical insights for developing personalized microbiome-targeted interventions to mitigate liver disease progression.},
}
RevDate: 2025-05-30
Microbial dysbiosis in obstructive sleep apnea: a systematic review and meta-analysis.
Frontiers in microbiology, 16:1572637.
BACKGROUND: The association between the microbiota and obstructive sleep apnea (OSA) remains understudied. In this study, we conducted a comprehensive systematic review and meta-analysis of studies investigating the diversity and relative abundance of microbiota in the gut, respiratory tracts and oral cavity of patients with OSA, aiming to provide an in-depth characterization of the microbial communities associated with OSA.
METHODS: A comprehensive literature search across PubMed, the Cochrane Library, Web of Science, and Embase databases were conducted to include studies published prior to Dec 2024 that compared the gut, respiratory and oral microbiota between individuals with and without OSA. The findings regarding alpha-diversity, beta-diversity, and relative abundance of microbiota extracted from the included studies were summarized. This meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, and the study protocol was registered with PROSPERO (CRD42024525114).
RESULTS: We identified a total of 753 articles, out of which 27 studies were ultimately included in the systematic review, involving 1,381 patients with OSA and 692 non-OSA populations, including 1,215 OSA patients and 537 non-OSA populations in adults and 166 OSA patients and 155 non-OSA populations in children. The results of alpha diversity revealed a reduction in the Chao1 index (SMD = -0.40, 95% CI = -0.76 to -0.05), Observed species (SMD = -0.50, 95% CI = -0.89 to -0.12) and Shannon index (SMD = -0.27, 95% CI = -0.47 to -0.08) of the gut microbiota in patients with OSA. Beta diversity analysis indicated significant differences in the gut, respiratory and oral microbial community structure between individuals with OSA and those without in more than half of the included studies. Furthermore, in comparison to the non-OSA individuals, the gut environment of patients with OSA exhibited an increased relative abundance of phylum Firmicutes, along with elevated levels of genera Lachnospira; conversely, there was a decreased relative abundance of phylum Bacteroidetes and genus Ruminococcus and Faecalibacterium. Similarly, within the oral environment of OSA patients, there was an elevated relative abundance of phylum Actinobacteria and genera Neisseria, Rothia, and Actinomyces.
CONCLUSION: Patients with OSA exhibit reduced diversity, changes in bacterial abundance, and altered structure in the microbiota, especially in the gut microbiota. The results of this study provide basic evidence for further exploration of microbiome diagnostic markers and potential intervention strategies for OSA.
Additional Links: PMID-40444003
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40444003,
year = {2025},
author = {Guo, Y and Sun, S and Wang, Y and Chen, S and Kou, Z and Yuan, P and Han, W and Yu, X},
title = {Microbial dysbiosis in obstructive sleep apnea: a systematic review and meta-analysis.},
journal = {Frontiers in microbiology},
volume = {16},
number = {},
pages = {1572637},
pmid = {40444003},
issn = {1664-302X},
abstract = {BACKGROUND: The association between the microbiota and obstructive sleep apnea (OSA) remains understudied. In this study, we conducted a comprehensive systematic review and meta-analysis of studies investigating the diversity and relative abundance of microbiota in the gut, respiratory tracts and oral cavity of patients with OSA, aiming to provide an in-depth characterization of the microbial communities associated with OSA.
METHODS: A comprehensive literature search across PubMed, the Cochrane Library, Web of Science, and Embase databases were conducted to include studies published prior to Dec 2024 that compared the gut, respiratory and oral microbiota between individuals with and without OSA. The findings regarding alpha-diversity, beta-diversity, and relative abundance of microbiota extracted from the included studies were summarized. This meta-analysis was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, and the study protocol was registered with PROSPERO (CRD42024525114).
RESULTS: We identified a total of 753 articles, out of which 27 studies were ultimately included in the systematic review, involving 1,381 patients with OSA and 692 non-OSA populations, including 1,215 OSA patients and 537 non-OSA populations in adults and 166 OSA patients and 155 non-OSA populations in children. The results of alpha diversity revealed a reduction in the Chao1 index (SMD = -0.40, 95% CI = -0.76 to -0.05), Observed species (SMD = -0.50, 95% CI = -0.89 to -0.12) and Shannon index (SMD = -0.27, 95% CI = -0.47 to -0.08) of the gut microbiota in patients with OSA. Beta diversity analysis indicated significant differences in the gut, respiratory and oral microbial community structure between individuals with OSA and those without in more than half of the included studies. Furthermore, in comparison to the non-OSA individuals, the gut environment of patients with OSA exhibited an increased relative abundance of phylum Firmicutes, along with elevated levels of genera Lachnospira; conversely, there was a decreased relative abundance of phylum Bacteroidetes and genus Ruminococcus and Faecalibacterium. Similarly, within the oral environment of OSA patients, there was an elevated relative abundance of phylum Actinobacteria and genera Neisseria, Rothia, and Actinomyces.
CONCLUSION: Patients with OSA exhibit reduced diversity, changes in bacterial abundance, and altered structure in the microbiota, especially in the gut microbiota. The results of this study provide basic evidence for further exploration of microbiome diagnostic markers and potential intervention strategies for OSA.},
}
RevDate: 2025-05-30
The effects of a semen cuscutae flavonoids-based antidepressant treatment on microbiome and metabolome in mice.
Frontiers in microbiology, 16:1558833.
BACKGROUND: Depression is a prevalent psychiatric disorder and one of the leading causes of disability worldwide. Previous studies have shown that Semen Cuscutae flavonoids (SCFs) exert antidepressant effects by modulating the microbiota-neuroinflammation axis and ameliorating hippocampal metabolic disturbances. However, the impact of SCFs on gut microbiota and related metabolomics remains largely undefined. Given that the gut microbiota has been proven to play a significant role in the etiology of depression and serves as a promising target for its treatment in humans, this study aims to elucidate the antidepressant effects of SCFs and to investigate how they modulate microbial and metabolic pathways to alleviate depressive symptoms.
MATERIALS AND METHODS: Chronic unpredictable mild stress (CUMS)-induced mice were used as a depression model. The normal mice and CUMS-induced mice were treated with either vehicle or with SCFs. A range of standardized behavioral assays and physiological indicators were employed to evaluate the antidepressant effects of SCFs. Upon the confirmation of the effectiveness of the SCFs treatment, the composition, richness, and diversity of the fecal microbiota were assessed using 16S rRNA gene sequencing. Additionally, fecal metabolic profiling was analyzed using UHPLC-MS/MS-based metabolomics. Multivariate data analysis was subsequently performed to identify differential metabolites and characterize alterations in fecal metabolites. Furthermore, a correlation analysis between differential metabolites and key microbiota was conducted.
RESULTS: SCFs significantly ameliorated depressive behaviors and the dysregulated diversity of fecal microbiota induced by CUMS. SCFs enhanced the gut microbiota structure in the CUMS group by increasing the Firmicutes/Bacteroidota ratio, significantly elevating the abundance of Firmicutes, Lactobacillus, Limosilactobacillus, and Actinobacteria while reducing the abundance of Bacteroidota and Bacteroides in CUMS-treated mice. Fecal metabolomics analyses revealed that SCFs could modulate metabolic pathways, including aldosterone synthesis and secretion, arachidonic acid metabolism, and primary bile acid biosynthesis.
CONCLUSIONS: Mice with depression induced by CUMS exhibited disturbances in both their gut microbiota and fecal metabolism. However, SCFs restored the balance of the microbial community and corrected metabolic disturbances in feces, exerting antidepressant effects through a multifaceted mechanism.
Additional Links: PMID-40444002
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40444002,
year = {2025},
author = {Shao, Q and Zhou, S and Li, Y and Jin, L and Fu, X and Liu, T and Wang, J and Du, S and Chen, C},
title = {The effects of a semen cuscutae flavonoids-based antidepressant treatment on microbiome and metabolome in mice.},
journal = {Frontiers in microbiology},
volume = {16},
number = {},
pages = {1558833},
pmid = {40444002},
issn = {1664-302X},
abstract = {BACKGROUND: Depression is a prevalent psychiatric disorder and one of the leading causes of disability worldwide. Previous studies have shown that Semen Cuscutae flavonoids (SCFs) exert antidepressant effects by modulating the microbiota-neuroinflammation axis and ameliorating hippocampal metabolic disturbances. However, the impact of SCFs on gut microbiota and related metabolomics remains largely undefined. Given that the gut microbiota has been proven to play a significant role in the etiology of depression and serves as a promising target for its treatment in humans, this study aims to elucidate the antidepressant effects of SCFs and to investigate how they modulate microbial and metabolic pathways to alleviate depressive symptoms.
MATERIALS AND METHODS: Chronic unpredictable mild stress (CUMS)-induced mice were used as a depression model. The normal mice and CUMS-induced mice were treated with either vehicle or with SCFs. A range of standardized behavioral assays and physiological indicators were employed to evaluate the antidepressant effects of SCFs. Upon the confirmation of the effectiveness of the SCFs treatment, the composition, richness, and diversity of the fecal microbiota were assessed using 16S rRNA gene sequencing. Additionally, fecal metabolic profiling was analyzed using UHPLC-MS/MS-based metabolomics. Multivariate data analysis was subsequently performed to identify differential metabolites and characterize alterations in fecal metabolites. Furthermore, a correlation analysis between differential metabolites and key microbiota was conducted.
RESULTS: SCFs significantly ameliorated depressive behaviors and the dysregulated diversity of fecal microbiota induced by CUMS. SCFs enhanced the gut microbiota structure in the CUMS group by increasing the Firmicutes/Bacteroidota ratio, significantly elevating the abundance of Firmicutes, Lactobacillus, Limosilactobacillus, and Actinobacteria while reducing the abundance of Bacteroidota and Bacteroides in CUMS-treated mice. Fecal metabolomics analyses revealed that SCFs could modulate metabolic pathways, including aldosterone synthesis and secretion, arachidonic acid metabolism, and primary bile acid biosynthesis.
CONCLUSIONS: Mice with depression induced by CUMS exhibited disturbances in both their gut microbiota and fecal metabolism. However, SCFs restored the balance of the microbial community and corrected metabolic disturbances in feces, exerting antidepressant effects through a multifaceted mechanism.},
}
RevDate: 2025-05-30
Synthetic vs. non-synthetic sweeteners: their differential effects on gut microbiome diversity and function.
Frontiers in microbiology, 16:1531131.
The rising use of artificial sweeteners, favored for their zero-calorie content and superior sweetness, necessitates understanding their impact on the gut microbiome. This study examines the effects of five common artificial sweeteners-Acesulfame K, Rebaudioside A, Saccharin, Sucralose, and Xylitol-on gut microbiome diversity using minibioreactor arrays. Fecal samples from three healthy individuals were used to inoculate bioreactors that were subsequently supplemented with each sweetener. Over 35 days, microbial diversity and network composition were analyzed. Results revealed synthetic sweeteners like Sucralose and Saccharin significantly reduced microbial diversity, while non-synthetic sweeteners, particularly Rebaudioside A and Xylitol, were less disruptive. Acesulfame K increased diversity but disrupted network structure, suggesting potential long-term negative impacts on microbiome resilience. Sucralose enriched pathogenic families such as Enterobacteriaceae, whereas natural sweeteners promoted beneficial taxa like Lachnospiraceae. Random Matrix Theory (RMT) based analysis highlighted distinct microbial interaction patterns, with Acesulfame K causing persistent structural changes. Findings suggest non-synthetic sweeteners may be more favorable for gut health than synthetic ones, emphasizing cautious use, particularly for those with gut health concerns. This study enhances our understanding of artificial sweeteners' effects on the gut microbiome, highlighting the need for further research into their long-term health implications.
Additional Links: PMID-40443994
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40443994,
year = {2025},
author = {Kidangathazhe, A and Amponsah, T and Maji, A and Adams, S and Chettoor, M and Wang, X and Scaria, J},
title = {Synthetic vs. non-synthetic sweeteners: their differential effects on gut microbiome diversity and function.},
journal = {Frontiers in microbiology},
volume = {16},
number = {},
pages = {1531131},
pmid = {40443994},
issn = {1664-302X},
abstract = {The rising use of artificial sweeteners, favored for their zero-calorie content and superior sweetness, necessitates understanding their impact on the gut microbiome. This study examines the effects of five common artificial sweeteners-Acesulfame K, Rebaudioside A, Saccharin, Sucralose, and Xylitol-on gut microbiome diversity using minibioreactor arrays. Fecal samples from three healthy individuals were used to inoculate bioreactors that were subsequently supplemented with each sweetener. Over 35 days, microbial diversity and network composition were analyzed. Results revealed synthetic sweeteners like Sucralose and Saccharin significantly reduced microbial diversity, while non-synthetic sweeteners, particularly Rebaudioside A and Xylitol, were less disruptive. Acesulfame K increased diversity but disrupted network structure, suggesting potential long-term negative impacts on microbiome resilience. Sucralose enriched pathogenic families such as Enterobacteriaceae, whereas natural sweeteners promoted beneficial taxa like Lachnospiraceae. Random Matrix Theory (RMT) based analysis highlighted distinct microbial interaction patterns, with Acesulfame K causing persistent structural changes. Findings suggest non-synthetic sweeteners may be more favorable for gut health than synthetic ones, emphasizing cautious use, particularly for those with gut health concerns. This study enhances our understanding of artificial sweeteners' effects on the gut microbiome, highlighting the need for further research into their long-term health implications.},
}
RevDate: 2025-05-30
Nutrition, Gut Microbiota, and Epigenetics in the Modulation of Immune Response and Metabolic Health.
Cardiology and cardiovascular medicine, 9(3):111-124.
Immune system function is intricately shaped by nutritional status, dietary patterns, and gut microbiota composition. Micronutrients such as vitamins A, C, D, E, B-complex, zinc, selenium, iron, and magnesium are critical for maintaining physical barriers, supporting immune cell proliferation, and regulating inflammation. Macronutrients-including proteins, fats, and carbohydrates-also modulate immune responses through their impact on immune metabolism and the gut-immune axis. Epigenetic mechanisms, including DNA methylation, histone modifications, and microRNA expression, mediate the long-term effects of diet on immune function and tolerance. Diet-induced alterations in gut microbiota further influence immune homeostasis via microbial metabolites like short-chain fatty acids. Imbalanced diets, particularly the Western diet, contribute to immune dysregulation, chronic inflammation, and the development of metabolic disorders such as obesity and type 2 diabetes. While plant-based and Mediterranean dietary patterns have shown anti-inflammatory and immunoregulatory benefits, gaps remain in understanding the long-term epigenetic impacts of these diets. This review integrates current knowledge on how nutrition and the microbiome regulate immunity, highlighting future directions for personalized dietary strategies in preventing chronic immune-related conditions.
Additional Links: PMID-40443829
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40443829,
year = {2025},
author = {Bacaloni, S and Agrawal, DK},
title = {Nutrition, Gut Microbiota, and Epigenetics in the Modulation of Immune Response and Metabolic Health.},
journal = {Cardiology and cardiovascular medicine},
volume = {9},
number = {3},
pages = {111-124},
pmid = {40443829},
issn = {2572-9292},
abstract = {Immune system function is intricately shaped by nutritional status, dietary patterns, and gut microbiota composition. Micronutrients such as vitamins A, C, D, E, B-complex, zinc, selenium, iron, and magnesium are critical for maintaining physical barriers, supporting immune cell proliferation, and regulating inflammation. Macronutrients-including proteins, fats, and carbohydrates-also modulate immune responses through their impact on immune metabolism and the gut-immune axis. Epigenetic mechanisms, including DNA methylation, histone modifications, and microRNA expression, mediate the long-term effects of diet on immune function and tolerance. Diet-induced alterations in gut microbiota further influence immune homeostasis via microbial metabolites like short-chain fatty acids. Imbalanced diets, particularly the Western diet, contribute to immune dysregulation, chronic inflammation, and the development of metabolic disorders such as obesity and type 2 diabetes. While plant-based and Mediterranean dietary patterns have shown anti-inflammatory and immunoregulatory benefits, gaps remain in understanding the long-term epigenetic impacts of these diets. This review integrates current knowledge on how nutrition and the microbiome regulate immunity, highlighting future directions for personalized dietary strategies in preventing chronic immune-related conditions.},
}
RevDate: 2025-05-30
CmpDate: 2025-05-30
Persistent reduction of Bifidobacterium longum in the infant gut microbiome in the first year of age following intrapartum penicillin prophylaxis for maternal GBS colonization.
Frontiers in immunology, 16:1540979.
INTRODUCTION: Group B Streptococcus is a significant cause of early-onset disease in term newborns, with a global incidence of 0.41/1000 live births. Intrapartum antibiotic prophylaxis (IAP) has reduced EOD incidence by over 80%, but concerns exist about its impact on the neonatal gut microbiome and potential long-term health effects.
METHODS: This single center study examines the effects of IAP on the fecal infant microbiome in the first year of age and on the T cell phenotype in the first days after birth among 22 infants receiving IAP with penicillin due to maternal GBS colonization and 26 infants not exposed to IAP. The fecal microbiome was analyzed at birth, one month and one year of age through 16S rRNA gene sequencing. Additionally, a T cell phenotyping of peripheral blood was performed between the second and fifth day of age.
RESULTS: At one month, IAP exposed infants had a significantly lower relative abundance of Bifidobacterium longum in fecal samples, an effect which was sustained at one year. In IAP exposed infants we found a proinflammatory T-helper cell profile, characterized by higher IL-17A, RORgt, and TGF-b expression.
DISCUSSION: This study proposes a sustained impact of IAP on the neonatal microbiome and T cell repertoire.
Additional Links: PMID-40443663
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40443663,
year = {2025},
author = {Teuscher, JL and Lupatsii, M and Graspeuntner, S and Jonassen, S and Bringewatt, A and Herting, E and Stichtenoth, G and Bossung, V and Rupp, J and Härtel, C and Demmert, M},
title = {Persistent reduction of Bifidobacterium longum in the infant gut microbiome in the first year of age following intrapartum penicillin prophylaxis for maternal GBS colonization.},
journal = {Frontiers in immunology},
volume = {16},
number = {},
pages = {1540979},
pmid = {40443663},
issn = {1664-3224},
mesh = {Humans ; *Gastrointestinal Microbiome/drug effects ; Female ; Infant ; *Antibiotic Prophylaxis ; *Streptococcal Infections/prevention & control/microbiology/immunology ; Infant, Newborn ; Pregnancy ; *Streptococcus agalactiae/drug effects ; *Bifidobacterium longum ; *Penicillins/therapeutic use/administration & dosage ; Feces/microbiology ; Male ; *Anti-Bacterial Agents/therapeutic use ; Infectious Disease Transmission, Vertical/prevention & control ; RNA, Ribosomal, 16S/genetics ; },
abstract = {INTRODUCTION: Group B Streptococcus is a significant cause of early-onset disease in term newborns, with a global incidence of 0.41/1000 live births. Intrapartum antibiotic prophylaxis (IAP) has reduced EOD incidence by over 80%, but concerns exist about its impact on the neonatal gut microbiome and potential long-term health effects.
METHODS: This single center study examines the effects of IAP on the fecal infant microbiome in the first year of age and on the T cell phenotype in the first days after birth among 22 infants receiving IAP with penicillin due to maternal GBS colonization and 26 infants not exposed to IAP. The fecal microbiome was analyzed at birth, one month and one year of age through 16S rRNA gene sequencing. Additionally, a T cell phenotyping of peripheral blood was performed between the second and fifth day of age.
RESULTS: At one month, IAP exposed infants had a significantly lower relative abundance of Bifidobacterium longum in fecal samples, an effect which was sustained at one year. In IAP exposed infants we found a proinflammatory T-helper cell profile, characterized by higher IL-17A, RORgt, and TGF-b expression.
DISCUSSION: This study proposes a sustained impact of IAP on the neonatal microbiome and T cell repertoire.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Gastrointestinal Microbiome/drug effects
Female
Infant
*Antibiotic Prophylaxis
*Streptococcal Infections/prevention & control/microbiology/immunology
Infant, Newborn
Pregnancy
*Streptococcus agalactiae/drug effects
*Bifidobacterium longum
*Penicillins/therapeutic use/administration & dosage
Feces/microbiology
Male
*Anti-Bacterial Agents/therapeutic use
Infectious Disease Transmission, Vertical/prevention & control
RNA, Ribosomal, 16S/genetics
RevDate: 2025-05-30
A glutamine metabolism gene signature with prognostic and predictive value for colorectal cancer survival and immunotherapy response.
Frontiers in molecular biosciences, 12:1599141.
BACKGROUND: Colorectal cancer (CRC) remains a major cause of cancer mortality, and dysregulated glutamine metabolism has emerged as a potential therapeutic target. However, the precise role of glutamine in CRC progression and treatment response remains debated.
METHODS: The authors collected transcriptome and microbiome information, from multiple sources to construct the GLMscore, a prognostic signature in CRC. To comprehensively characterize the biological features of GLMscore groups, the integration of transcriptomic profiling, KEGG pathway enrichment analysis, immune infiltration analysis, tumor immune microenvironment characterization, microbiome analysis, and tissue imaging were applied. Furthermore, CRC patients were stratified into GLMscore high and GLMscore low groups. The robustness of GLMscore was validated in both training and validation cohorts, and the predictive value for immunotherapy response was assessed. Finally, single-cell RNA sequencing (scRNA-seq) analysis was conducted to delineate the differences between GLMscore high and GLMscore low groups.
RESULTS: High GLMscore was associated with elevated expression of pathways related to tumorigenesis, epithelial-mesenchymal transition (EMT), and angiogenesis. Furthermore, high GLMscore patients exhibited an immunosuppressive TME characterized by increased infiltration of M0 and M2 macrophages, reduced overall immune infiltration (supported by ESTIMATE and TIDE scores), and increased expression of immune exclusion and suppression pathways. Analysis of pathological whole-slide images (WSIs) revealed a lack of intratumoral tertiary lymphoid structures (TLSs) in high GLMscore patients. The GLMscore also predicted resistance to common chemotherapeutic agents (using GDSC data) and, importantly, predicted poor response to immunotherapy in the IMvigor210 cohort. Analysis of 16S rRNA gene sequencing data revealed an enrichment of potentially oncogenic microbiota, including Hungatella and Selenomonas, in high GLMscore group. Single-cell analysis further confirmed the immunosuppressive TME and identified increased cell-cell communication between inflammatory macrophages and tumor cells in high GLMscore group.
CONCLUSION: The authors innovatively constructed GLMscore, a robust scoring system in quantifying CRC patients, exploring the distinct biological features, tumor immune microenvironment and microbiome ecology, exhibiting high validity in predicting survival prognosis and clinical treatment efficacy.
Additional Links: PMID-40443528
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40443528,
year = {2025},
author = {Zhang, Y and Zhu, H and Fan, J and Zhao, J and Xia, Y and Zhang, N and Xu, H},
title = {A glutamine metabolism gene signature with prognostic and predictive value for colorectal cancer survival and immunotherapy response.},
journal = {Frontiers in molecular biosciences},
volume = {12},
number = {},
pages = {1599141},
pmid = {40443528},
issn = {2296-889X},
abstract = {BACKGROUND: Colorectal cancer (CRC) remains a major cause of cancer mortality, and dysregulated glutamine metabolism has emerged as a potential therapeutic target. However, the precise role of glutamine in CRC progression and treatment response remains debated.
METHODS: The authors collected transcriptome and microbiome information, from multiple sources to construct the GLMscore, a prognostic signature in CRC. To comprehensively characterize the biological features of GLMscore groups, the integration of transcriptomic profiling, KEGG pathway enrichment analysis, immune infiltration analysis, tumor immune microenvironment characterization, microbiome analysis, and tissue imaging were applied. Furthermore, CRC patients were stratified into GLMscore high and GLMscore low groups. The robustness of GLMscore was validated in both training and validation cohorts, and the predictive value for immunotherapy response was assessed. Finally, single-cell RNA sequencing (scRNA-seq) analysis was conducted to delineate the differences between GLMscore high and GLMscore low groups.
RESULTS: High GLMscore was associated with elevated expression of pathways related to tumorigenesis, epithelial-mesenchymal transition (EMT), and angiogenesis. Furthermore, high GLMscore patients exhibited an immunosuppressive TME characterized by increased infiltration of M0 and M2 macrophages, reduced overall immune infiltration (supported by ESTIMATE and TIDE scores), and increased expression of immune exclusion and suppression pathways. Analysis of pathological whole-slide images (WSIs) revealed a lack of intratumoral tertiary lymphoid structures (TLSs) in high GLMscore patients. The GLMscore also predicted resistance to common chemotherapeutic agents (using GDSC data) and, importantly, predicted poor response to immunotherapy in the IMvigor210 cohort. Analysis of 16S rRNA gene sequencing data revealed an enrichment of potentially oncogenic microbiota, including Hungatella and Selenomonas, in high GLMscore group. Single-cell analysis further confirmed the immunosuppressive TME and identified increased cell-cell communication between inflammatory macrophages and tumor cells in high GLMscore group.
CONCLUSION: The authors innovatively constructed GLMscore, a robust scoring system in quantifying CRC patients, exploring the distinct biological features, tumor immune microenvironment and microbiome ecology, exhibiting high validity in predicting survival prognosis and clinical treatment efficacy.},
}
RevDate: 2025-05-30
CmpDate: 2025-05-30
Human microbiota influence the immune cell composition and gene expression in the tumor environment of a murine model of glioma.
Gut microbes, 17(1):2508432.
BACKGROUND: Immunotherapy has shown success against other cancers but not glioblastoma. Previous data has revealed that microbiota influences anti-PD-1 efficacy. We have previously found that, when using gnotobiotic mice transplanted with human fecal microbiota, the gut microbial composition influenced the response to anti-PD-1 in a mouse model of glioma. However, the role of the human microbiota in influencing the mouse immune cells in the glioma microenvironment and anti-PD-1 response was largely unknown. Using two distinct humanized microbiome (HuM) lines, we used single-cell RNA sequencing (scRNA-seq) to determine how gut microbiota affect immune infiltration and gene expression in a murine glioma model.
METHODS: 16S rRNA sequencing was performed on fecal samples from HuM1 (H1) and HuM2 (H2) mice. Mice were intracranially injected with murine glioma cells (GL261), and on day 13 treated with one dose of isotype control or anti-PD1. Mice were euthanized on day 14 for analysis of all immune cells in the tumors by scRNA-seq.
RESULTS: HuM1 and HuM2 mice had different microbial populations, with HuM1 being primarily dominated via Alistipes, and HuM2 being primarily composed of Odoribacter. Sc-RNA-seq of the tumor immune cells revealed 21 clusters with significant differences between H1 and H2 samples with a larger population of M1 type macrophages in H1 samples. Gene expression analysis revealed higher expression of inflammatory markers in the M1 population in H2 mice treated with anti-PD-1.
CONCLUSIONS: Microbial gut communities influence the presence and gene activation patterns of immune cells in the brain tumors of mice both under control (isotype) and following anti-PD-1 treatment.
Additional Links: PMID-40443227
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40443227,
year = {2025},
author = {Green, GBH and Cox-Holmes, AN and Marlow, GH and Potier, ACE and Wang, Y and Zhou, L and Chen, D and Morrow, CD and McFarland, BC},
title = {Human microbiota influence the immune cell composition and gene expression in the tumor environment of a murine model of glioma.},
journal = {Gut microbes},
volume = {17},
number = {1},
pages = {2508432},
doi = {10.1080/19490976.2025.2508432},
pmid = {40443227},
issn = {1949-0984},
mesh = {Animals ; *Glioma/immunology/microbiology/genetics ; Mice ; Humans ; *Gastrointestinal Microbiome/immunology ; Disease Models, Animal ; *Tumor Microenvironment/immunology/genetics ; *Brain Neoplasms/immunology/microbiology/genetics ; Cell Line, Tumor ; Feces/microbiology ; Programmed Cell Death 1 Receptor/antagonists & inhibitors/immunology ; RNA, Ribosomal, 16S/genetics ; Bacteria/classification/genetics/isolation & purification ; Mice, Inbred C57BL ; },
abstract = {BACKGROUND: Immunotherapy has shown success against other cancers but not glioblastoma. Previous data has revealed that microbiota influences anti-PD-1 efficacy. We have previously found that, when using gnotobiotic mice transplanted with human fecal microbiota, the gut microbial composition influenced the response to anti-PD-1 in a mouse model of glioma. However, the role of the human microbiota in influencing the mouse immune cells in the glioma microenvironment and anti-PD-1 response was largely unknown. Using two distinct humanized microbiome (HuM) lines, we used single-cell RNA sequencing (scRNA-seq) to determine how gut microbiota affect immune infiltration and gene expression in a murine glioma model.
METHODS: 16S rRNA sequencing was performed on fecal samples from HuM1 (H1) and HuM2 (H2) mice. Mice were intracranially injected with murine glioma cells (GL261), and on day 13 treated with one dose of isotype control or anti-PD1. Mice were euthanized on day 14 for analysis of all immune cells in the tumors by scRNA-seq.
RESULTS: HuM1 and HuM2 mice had different microbial populations, with HuM1 being primarily dominated via Alistipes, and HuM2 being primarily composed of Odoribacter. Sc-RNA-seq of the tumor immune cells revealed 21 clusters with significant differences between H1 and H2 samples with a larger population of M1 type macrophages in H1 samples. Gene expression analysis revealed higher expression of inflammatory markers in the M1 population in H2 mice treated with anti-PD-1.
CONCLUSIONS: Microbial gut communities influence the presence and gene activation patterns of immune cells in the brain tumors of mice both under control (isotype) and following anti-PD-1 treatment.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
*Glioma/immunology/microbiology/genetics
Mice
Humans
*Gastrointestinal Microbiome/immunology
Disease Models, Animal
*Tumor Microenvironment/immunology/genetics
*Brain Neoplasms/immunology/microbiology/genetics
Cell Line, Tumor
Feces/microbiology
Programmed Cell Death 1 Receptor/antagonists & inhibitors/immunology
RNA, Ribosomal, 16S/genetics
Bacteria/classification/genetics/isolation & purification
Mice, Inbred C57BL
RevDate: 2025-05-30
CmpDate: 2025-05-30
Root Rot Disease Biocontrol and Microbiome Community Modulation by Streptomyces Strains in Soybean.
Journal of microbiology and biotechnology, 35:e2502010 pii:jmb.2502.02010.
Traditionally, phytopathogenic fungi control strategies rely primarily upon chemical fungicides, but fungicide resistance pathogen strains have appeared in the fields. Therefore, biocontrol approaches highlighted with sustainable agriculture aspects, especially the genus Streptomyces, are known to suppress numerous plant diseases. Streptomyces bacillaris S8 was isolated from turfgrass rhizosphere, and Streptomyces globisporus SP6C4 was obtained from strawberry pollen. Both strains showed excellent antifungal and antibacterial activities and suppressed various plant diseases in vitro. However, beneficial microorganisms are rarely studied and introduced to another effect on microbial communities when incompatible with the host. The present study aims to assess the potential of effective control of plant diseases by both strains in new crops and to assess the impact of endogenous microbiota. Various diseases pose significant concerns in soybean production, leading to substantial grain yield and quality losses. Root rot caused by Fusarium spp. is known to be the most problematic disease in the soybean cropping system. In the results, S. globisporus SP6C4 and S. bacillaris S8 showed antifungal activity against soybean root rot pathogen, but strain S8 had less than SP6C4. The strain SP6C4 played a role as hub-taxa in the early stage, and the strain S8 was a modulator in microbial communities. Our results demonstrate the antifungal activity of S. globisporus SP6C4 and S. bacillaris S8, which can be expected to grow and reduce the disease of soybeans. The S8 and SP6C4 can also modify the plant microbiota which may open a new dimension of crop microbiome research.
Additional Links: PMID-40443224
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40443224,
year = {2025},
author = {Kim, DR and Ko, YM and Lee, D and Kwak, YS},
title = {Root Rot Disease Biocontrol and Microbiome Community Modulation by Streptomyces Strains in Soybean.},
journal = {Journal of microbiology and biotechnology},
volume = {35},
number = {},
pages = {e2502010},
doi = {10.4014/jmb.2502.02010},
pmid = {40443224},
issn = {1738-8872},
mesh = {*Glycine max/microbiology ; *Streptomyces/physiology/isolation & purification/classification ; *Plant Diseases/microbiology/prevention & control ; *Microbiota ; *Plant Roots/microbiology ; Fusarium ; Rhizosphere ; Antibiosis ; Soil Microbiology ; Antifungal Agents/pharmacology ; Biological Control Agents ; },
abstract = {Traditionally, phytopathogenic fungi control strategies rely primarily upon chemical fungicides, but fungicide resistance pathogen strains have appeared in the fields. Therefore, biocontrol approaches highlighted with sustainable agriculture aspects, especially the genus Streptomyces, are known to suppress numerous plant diseases. Streptomyces bacillaris S8 was isolated from turfgrass rhizosphere, and Streptomyces globisporus SP6C4 was obtained from strawberry pollen. Both strains showed excellent antifungal and antibacterial activities and suppressed various plant diseases in vitro. However, beneficial microorganisms are rarely studied and introduced to another effect on microbial communities when incompatible with the host. The present study aims to assess the potential of effective control of plant diseases by both strains in new crops and to assess the impact of endogenous microbiota. Various diseases pose significant concerns in soybean production, leading to substantial grain yield and quality losses. Root rot caused by Fusarium spp. is known to be the most problematic disease in the soybean cropping system. In the results, S. globisporus SP6C4 and S. bacillaris S8 showed antifungal activity against soybean root rot pathogen, but strain S8 had less than SP6C4. The strain SP6C4 played a role as hub-taxa in the early stage, and the strain S8 was a modulator in microbial communities. Our results demonstrate the antifungal activity of S. globisporus SP6C4 and S. bacillaris S8, which can be expected to grow and reduce the disease of soybeans. The S8 and SP6C4 can also modify the plant microbiota which may open a new dimension of crop microbiome research.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Glycine max/microbiology
*Streptomyces/physiology/isolation & purification/classification
*Plant Diseases/microbiology/prevention & control
*Microbiota
*Plant Roots/microbiology
Fusarium
Rhizosphere
Antibiosis
Soil Microbiology
Antifungal Agents/pharmacology
Biological Control Agents
RevDate: 2025-05-30
CmpDate: 2025-05-30
Impact of Ginger on Gut Microbiota Composition and Function in a Bacteroides-Dominant Enterotype.
Journal of microbiology and biotechnology, 35:e2503032 pii:jmb.2503.03032.
Ginger (Zingiber officinale) has been used worldwide for centuries, valued for both its culinary applications and potential therapeutic properties. Its bioactive compounds exhibit antioxidant, anti-inflammatory, and metabolic regulatory effects, providing physiological benefits to the human body. However, its influence on the gut microbiota remains poorly understood. In this study, we investigated the impact of ginger on gut microbiota using an in vitro fecal incubation model. To minimize interindividual variability, we classified participants into enterotypes based on gut microbial composition, focusing on the Bacteroides-dominant enterotype. While ginger treatment did not significantly affect microbial alpha diversity, it induced distinct shifts in bacterial structure, suggesting compositional changes in the microbiota. At the phylum level, taxonomic analysis revealed a lower relative abundance of Bacteroidota and a higher relative abundance of Proteobacteria in the ginger-treated group compared to the control. Consistently, genus-level analysis showed an increased relative abundance of Acinetobacter and Enterobacteriaceae, both belonging to Proteobacteria, in the ginger-treated group. Predicted functional pathway analysis further revealed that ginger treatment enriched pathways related to linoleic acid metabolism, beta-alanine metabolism, geraniol degradation, and tetracycline biosynthesis. These findings suggest that ginger modulates gut microbiota composition, particularly by increasing the abundance of Proteobacteria-associated genera. This enterotype-based study provides a structured framework for evaluating dietary effects and may support the development of personalized dietary strategies targeting gut microbiome modulation.
Additional Links: PMID-40443219
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40443219,
year = {2025},
author = {Kim, J and Ha, J and Kim, S and Kim, G and Shin, H},
title = {Impact of Ginger on Gut Microbiota Composition and Function in a Bacteroides-Dominant Enterotype.},
journal = {Journal of microbiology and biotechnology},
volume = {35},
number = {},
pages = {e2503032},
doi = {10.4014/jmb.2503.03032},
pmid = {40443219},
issn = {1738-8872},
mesh = {*Zingiber officinale/chemistry ; *Gastrointestinal Microbiome/drug effects ; Humans ; Feces/microbiology ; *Bacteroides/classification/isolation & purification/genetics/drug effects ; Bacteria/classification/genetics/isolation & purification ; Male ; Adult ; RNA, Ribosomal, 16S/genetics ; Proteobacteria/classification/isolation & purification/genetics ; Female ; Plant Extracts/pharmacology ; },
abstract = {Ginger (Zingiber officinale) has been used worldwide for centuries, valued for both its culinary applications and potential therapeutic properties. Its bioactive compounds exhibit antioxidant, anti-inflammatory, and metabolic regulatory effects, providing physiological benefits to the human body. However, its influence on the gut microbiota remains poorly understood. In this study, we investigated the impact of ginger on gut microbiota using an in vitro fecal incubation model. To minimize interindividual variability, we classified participants into enterotypes based on gut microbial composition, focusing on the Bacteroides-dominant enterotype. While ginger treatment did not significantly affect microbial alpha diversity, it induced distinct shifts in bacterial structure, suggesting compositional changes in the microbiota. At the phylum level, taxonomic analysis revealed a lower relative abundance of Bacteroidota and a higher relative abundance of Proteobacteria in the ginger-treated group compared to the control. Consistently, genus-level analysis showed an increased relative abundance of Acinetobacter and Enterobacteriaceae, both belonging to Proteobacteria, in the ginger-treated group. Predicted functional pathway analysis further revealed that ginger treatment enriched pathways related to linoleic acid metabolism, beta-alanine metabolism, geraniol degradation, and tetracycline biosynthesis. These findings suggest that ginger modulates gut microbiota composition, particularly by increasing the abundance of Proteobacteria-associated genera. This enterotype-based study provides a structured framework for evaluating dietary effects and may support the development of personalized dietary strategies targeting gut microbiome modulation.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Zingiber officinale/chemistry
*Gastrointestinal Microbiome/drug effects
Humans
Feces/microbiology
*Bacteroides/classification/isolation & purification/genetics/drug effects
Bacteria/classification/genetics/isolation & purification
Male
Adult
RNA, Ribosomal, 16S/genetics
Proteobacteria/classification/isolation & purification/genetics
Female
Plant Extracts/pharmacology
RevDate: 2025-05-30
Continuity of interstitial spaces within and outside the human lung.
Journal of anatomy [Epub ahead of print].
There is a body-wide network of interstitial spaces that includes three components: a large-scale fascial network made up of fluid-filled spaces containing collagens and other extracellular matrix components like hyaluronic acid (HA), the peri-vascular/capillary interstitium, and intercellular interstitial spaces. Staining for HA within the colon, skin, and liver has demonstrated spatial continuity of the fascial interstitium across tissue layers and between organs, while continuity of HA staining between perineurial and adventitial sheathes beyond organ boundaries confirmed that they also participate in this body-wide network. We asked whether the pulmonary interstitium comprises a continuous organ-wide network that also connects to the body-wide interstitium via routes along nerves and the vasculature. We studied archival lung lobectomy specimens containing normal tissues inclusive of all lung anatomical units from six females and three males (mean age 53+/- 16.5 years). For comparison, we also studied normal mouse lung. Multiplex immunohistochemical cocktails were used to identify: (1) HA, CD34, and vimentin - highlighting interstitium; (2) HA, CD34, and podoplanin (D2-40) - highlighting relationships between the interstitium, vasculature, and lymphatics. Sizes of extracellular APP were measured. Tissues from nine patients (six females, three males, mean age 53+/- 16.5 years) were studied. HA staining was continuous throughout the five major anatomic compartments of the lung: alveolar walls, subpleural connective tissue, centrilobular peribronchovascular compartment, interlobular septal compartment, and axial peribronchovascular of the hilum, with similar findings in murine lung tissue. Continuity with interstitial spaces of the perineurium and adventitia was confirmed. The distribution of APP corresponded to known routes of lymphatic drainage, superficial and deep. APP within perineurium and perivascular adventitia further demonstrated continuity between intra- and extrapulmonary interstitium. To conclude, all segments of the lung interstitium are connected and are linked along nerves and the vascular tree to a body-wide communication network. These findings have significant implications for understanding lung physiology and pathobiology, suggesting routes of passage for inflammatory cells and mediators, malignant cells, and infectious agents. Interstitial spaces may be important in microbiome signaling within and beyond the lung and may be a component of the lung-brain axis.
Additional Links: PMID-40442920
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40442920,
year = {2025},
author = {Ordner, J and Narula, N and Chiriboga, L and Zeck, B and Majd, M and Gupta, K and Gaglia, R and Zhou, F and Moreira, A and Iman, R and Ko, JP and Le, L and Wells, RG and Theise, ND},
title = {Continuity of interstitial spaces within and outside the human lung.},
journal = {Journal of anatomy},
volume = {},
number = {},
pages = {},
doi = {10.1111/joa.14280},
pmid = {40442920},
issn = {1469-7580},
abstract = {There is a body-wide network of interstitial spaces that includes three components: a large-scale fascial network made up of fluid-filled spaces containing collagens and other extracellular matrix components like hyaluronic acid (HA), the peri-vascular/capillary interstitium, and intercellular interstitial spaces. Staining for HA within the colon, skin, and liver has demonstrated spatial continuity of the fascial interstitium across tissue layers and between organs, while continuity of HA staining between perineurial and adventitial sheathes beyond organ boundaries confirmed that they also participate in this body-wide network. We asked whether the pulmonary interstitium comprises a continuous organ-wide network that also connects to the body-wide interstitium via routes along nerves and the vasculature. We studied archival lung lobectomy specimens containing normal tissues inclusive of all lung anatomical units from six females and three males (mean age 53+/- 16.5 years). For comparison, we also studied normal mouse lung. Multiplex immunohistochemical cocktails were used to identify: (1) HA, CD34, and vimentin - highlighting interstitium; (2) HA, CD34, and podoplanin (D2-40) - highlighting relationships between the interstitium, vasculature, and lymphatics. Sizes of extracellular APP were measured. Tissues from nine patients (six females, three males, mean age 53+/- 16.5 years) were studied. HA staining was continuous throughout the five major anatomic compartments of the lung: alveolar walls, subpleural connective tissue, centrilobular peribronchovascular compartment, interlobular septal compartment, and axial peribronchovascular of the hilum, with similar findings in murine lung tissue. Continuity with interstitial spaces of the perineurium and adventitia was confirmed. The distribution of APP corresponded to known routes of lymphatic drainage, superficial and deep. APP within perineurium and perivascular adventitia further demonstrated continuity between intra- and extrapulmonary interstitium. To conclude, all segments of the lung interstitium are connected and are linked along nerves and the vascular tree to a body-wide communication network. These findings have significant implications for understanding lung physiology and pathobiology, suggesting routes of passage for inflammatory cells and mediators, malignant cells, and infectious agents. Interstitial spaces may be important in microbiome signaling within and beyond the lung and may be a component of the lung-brain axis.},
}
RevDate: 2025-05-30
Early-Life Microbiome and Neurodevelopmental Disorders: A Systematic Review and Meta-Analysis.
Current neuropharmacology pii:CN-EPUB-148587 [Epub ahead of print].
BACKGROUND AND OBJECTIVES: This systematic review intends to find out how neurodevelopmental disorders, including Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD), are influenced by the gut microbiota throughout early childhood. The study looks at the variety and types of microbes that a child is exposed to, the particular microbiome profiles associated with neurodevelopmental outcomes, and the molecular processes that underlie these relationships.
METHODS: We performed a thorough search of PubMed, Scopus, the WHO Global Health Library (GHL), and ISI Web of Science. After screening 2,744 original studies based on predetermined eligibility criteria, 19 studies were included. Microbial groupings, presence (high/low), and related neurodevelopmental disorders were among the primary areas of data extraction. The methodological quality of the studies was assessed using the Newcastle-Ottawa Quality Assessment Scale (NOS).
RESULTS: The investigated literature repeatedly showed a strong correlation between dysbiosis of the gut microbiota and neurodevelopmental disorders. Cases of ASD were associated with both a high number of Clostridium species and a low number of Bifidobacterium species. On the other hand, a Low number of E. coli and a high number of the class Clostridia, phylum Firmicute, genus Bifidobacterium, and Akkermansia, as well as the species Listeria monocytogenes, Toxoplasma gondii, Streptococcus mutans, and Mycobacterium tuberculosis have been linked to ADHD. The NOS evaluation showed variation in the quality of the methodology; some studies had high scores, suggesting sound technique, while other studies had lower scores, indicating serious methodological flaws.
CONCLUSION: The results highlight the potential impact of the gut microbiome throughout early life on neurodevelopmental outcomes, indicating that microbial imbalances may play a role in the onset of disorders like ASD and ADHD. However, to improve the quality of data, larger-scale longitudinal studies would be required.
Additional Links: PMID-40442917
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40442917,
year = {2025},
author = {Fakruddin, M and Amin, T and Shishir, MA and Jameel, RM and Bari, MM and Shameem, NF and Hossain, A and Jerin, N and Bin Mannan, S and Sultana Jime, J and Bulbul, N},
title = {Early-Life Microbiome and Neurodevelopmental Disorders: A Systematic Review and Meta-Analysis.},
journal = {Current neuropharmacology},
volume = {},
number = {},
pages = {},
doi = {10.2174/011570159X360129250508113618},
pmid = {40442917},
issn = {1875-6190},
abstract = {BACKGROUND AND OBJECTIVES: This systematic review intends to find out how neurodevelopmental disorders, including Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD), are influenced by the gut microbiota throughout early childhood. The study looks at the variety and types of microbes that a child is exposed to, the particular microbiome profiles associated with neurodevelopmental outcomes, and the molecular processes that underlie these relationships.
METHODS: We performed a thorough search of PubMed, Scopus, the WHO Global Health Library (GHL), and ISI Web of Science. After screening 2,744 original studies based on predetermined eligibility criteria, 19 studies were included. Microbial groupings, presence (high/low), and related neurodevelopmental disorders were among the primary areas of data extraction. The methodological quality of the studies was assessed using the Newcastle-Ottawa Quality Assessment Scale (NOS).
RESULTS: The investigated literature repeatedly showed a strong correlation between dysbiosis of the gut microbiota and neurodevelopmental disorders. Cases of ASD were associated with both a high number of Clostridium species and a low number of Bifidobacterium species. On the other hand, a Low number of E. coli and a high number of the class Clostridia, phylum Firmicute, genus Bifidobacterium, and Akkermansia, as well as the species Listeria monocytogenes, Toxoplasma gondii, Streptococcus mutans, and Mycobacterium tuberculosis have been linked to ADHD. The NOS evaluation showed variation in the quality of the methodology; some studies had high scores, suggesting sound technique, while other studies had lower scores, indicating serious methodological flaws.
CONCLUSION: The results highlight the potential impact of the gut microbiome throughout early life on neurodevelopmental outcomes, indicating that microbial imbalances may play a role in the onset of disorders like ASD and ADHD. However, to improve the quality of data, larger-scale longitudinal studies would be required.},
}
RevDate: 2025-05-29
Clinical study of intelligent tongue diagnosis and oral microbiome for classifying TCM syndromes in MASLD.
Chinese medicine, 20(1):78.
BACKGROUND: This study aimed to analyze the tongue image features and oral microbial markers in different TCM syndromes related to metabolic dysfunction-associated steatotic liver disease (MASLD).
METHODS: This study involved 34 healthy volunteers and 66 MASLD patients [36 with Dampness-Heat (DH) and 30 with Qi-Deficiency (QD) syndrome]. Oral microbiome analysis was conducted through 16S rRNA sequencing. Tongue image feature extraction used the Uncertainty Augmented Context Attention Network (UACANet), while syndrome classification was performed using five different machine learning methods based on tongue features and oral microbiota.
RESULTS: Significant differences in tongue color, coating, and oral microbiota were noted between DH band QD syndromes in MASLD patients. DH patients exhibited a red-crimson tongue color with a greasy coating and enriched Streptococcus and Rothia on the tongue. In contrast, QD patients displayed a pale tongue with higher abundances of Neisseria, Fusobacterium, Porphyromonas and Haemophilus. Combining tongue image characteristics with oral microbiota differentiated DH and QD syndromes with an AUC of 0.939 and an accuracy of 85%.
CONCLUSION: This study suggests that tongue characteristics are related to microbial metabolism, and different MASLD syndromes possess distinct biomarkers, supporting syndrome classification.
Additional Links: PMID-40442807
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40442807,
year = {2025},
author = {Deng, J and Dai, S and Liu, S and Tu, L and Cui, J and Hu, X and Qiu, X and Lu, H and Jiang, T and Xu, J},
title = {Clinical study of intelligent tongue diagnosis and oral microbiome for classifying TCM syndromes in MASLD.},
journal = {Chinese medicine},
volume = {20},
number = {1},
pages = {78},
pmid = {40442807},
issn = {1749-8546},
support = {82104738//Innovative Research Group Project of the National Natural Science Foundation of China/ ; 2023M732337//China Postdoctoral Science Foundation/ ; ZYYZDXK-2023069//State Administration of Traditional Chinese Medicine of the People's Republic of China/ ; 20244Y0129//Shanghai Municipal Health Commission/ ; 2022509//Intelligence Community Postdoctoral Research Fellowship Program/ ; },
abstract = {BACKGROUND: This study aimed to analyze the tongue image features and oral microbial markers in different TCM syndromes related to metabolic dysfunction-associated steatotic liver disease (MASLD).
METHODS: This study involved 34 healthy volunteers and 66 MASLD patients [36 with Dampness-Heat (DH) and 30 with Qi-Deficiency (QD) syndrome]. Oral microbiome analysis was conducted through 16S rRNA sequencing. Tongue image feature extraction used the Uncertainty Augmented Context Attention Network (UACANet), while syndrome classification was performed using five different machine learning methods based on tongue features and oral microbiota.
RESULTS: Significant differences in tongue color, coating, and oral microbiota were noted between DH band QD syndromes in MASLD patients. DH patients exhibited a red-crimson tongue color with a greasy coating and enriched Streptococcus and Rothia on the tongue. In contrast, QD patients displayed a pale tongue with higher abundances of Neisseria, Fusobacterium, Porphyromonas and Haemophilus. Combining tongue image characteristics with oral microbiota differentiated DH and QD syndromes with an AUC of 0.939 and an accuracy of 85%.
CONCLUSION: This study suggests that tongue characteristics are related to microbial metabolism, and different MASLD syndromes possess distinct biomarkers, supporting syndrome classification.},
}
RevDate: 2025-05-29
CmpDate: 2025-05-30
Viable bacterial communities in freshly pumped human milk and their changes during cold storage conditions.
International breastfeeding journal, 20(1):44.
BACKGROUND: Human milk harbors diverse bacterial communities that contribute to infant health. Although pumping and storing milk is a common practice, the viable bacterial composition of pumped milk and the impact of storage practice on these bacteria remains under-explored. This metagenomic observational study aimed to characterize viable bacterial communities in freshly pumped human milk and its changes under different storage conditions.
METHODS: In 2023, twelve lactating mothers from the CELSPAC: TNG cohort (Czech Republic) provided freshly pumped milk samples. These samples were stored under various conditions (refrigeration for 24 h, 48 h, or freezing for six weeks) and treated with propidium monoazide (PMA) to selectively identify viable cells. The DNA extracted from individual samples was subsequently analyzed using 16S rRNA amplicon sequencing on the Illumina platform.
RESULTS: The genera Streptococcus, Staphylococcus, Diaphorobacter, Cutibacterium, and Corynebacterium were the most common viable bacteria in fresh human milk. The median sequencing depth and Shannon index of fresh human milk samples treated with PMA (+ PMA) were significantly lower than in untreated (-PMA) samples (p < 0.05 for all), which was true also for each time point. Also, significant changes in these parameters were observed between fresh human milk samples and their paired frozen samples (p < 0.05), while no differences were found between fresh human milk samples and those refrigerated for up to 48 h (p > 0.05). Of specific genera, only + PMA frozen human milk samples showed a significant decrease in the central log-ratio transformed relative abundances of the genera Diaphorobacter and Cutibacterium (p < 0.05) in comparison to + PMA fresh human milk samples.
CONCLUSIONS: The study demonstrated that the bacterial profiles significantly differed between human milk samples treated with PMA, which represent only viable bacteria, and those untreated. While storage at 4 °C for up to 48 h did not significantly alter the overall diversity and composition of viable bacteria in human milk, freezing notably affected both the viability and relative abundances of some bacterial genera.
Additional Links: PMID-40442718
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40442718,
year = {2025},
author = {Pivrncova, E and Bohm, J and Barton, V and Klanova, J and Borilova Linhartova, P},
title = {Viable bacterial communities in freshly pumped human milk and their changes during cold storage conditions.},
journal = {International breastfeeding journal},
volume = {20},
number = {1},
pages = {44},
pmid = {40442718},
issn = {1746-4358},
support = {LM2023069//Ministerstvo Školství, Mládeže a Tělovýchovy/ ; 857560//Horizon 2020 Framework Programme/ ; },
mesh = {Humans ; *Milk, Human/microbiology ; Female ; *Bacteria/isolation & purification/genetics/classification ; *Food Storage/methods ; Adult ; RNA, Ribosomal, 16S ; *Microbiota ; Freezing ; Refrigeration ; Azides ; Propidium/analogs & derivatives ; },
abstract = {BACKGROUND: Human milk harbors diverse bacterial communities that contribute to infant health. Although pumping and storing milk is a common practice, the viable bacterial composition of pumped milk and the impact of storage practice on these bacteria remains under-explored. This metagenomic observational study aimed to characterize viable bacterial communities in freshly pumped human milk and its changes under different storage conditions.
METHODS: In 2023, twelve lactating mothers from the CELSPAC: TNG cohort (Czech Republic) provided freshly pumped milk samples. These samples were stored under various conditions (refrigeration for 24 h, 48 h, or freezing for six weeks) and treated with propidium monoazide (PMA) to selectively identify viable cells. The DNA extracted from individual samples was subsequently analyzed using 16S rRNA amplicon sequencing on the Illumina platform.
RESULTS: The genera Streptococcus, Staphylococcus, Diaphorobacter, Cutibacterium, and Corynebacterium were the most common viable bacteria in fresh human milk. The median sequencing depth and Shannon index of fresh human milk samples treated with PMA (+ PMA) were significantly lower than in untreated (-PMA) samples (p < 0.05 for all), which was true also for each time point. Also, significant changes in these parameters were observed between fresh human milk samples and their paired frozen samples (p < 0.05), while no differences were found between fresh human milk samples and those refrigerated for up to 48 h (p > 0.05). Of specific genera, only + PMA frozen human milk samples showed a significant decrease in the central log-ratio transformed relative abundances of the genera Diaphorobacter and Cutibacterium (p < 0.05) in comparison to + PMA fresh human milk samples.
CONCLUSIONS: The study demonstrated that the bacterial profiles significantly differed between human milk samples treated with PMA, which represent only viable bacteria, and those untreated. While storage at 4 °C for up to 48 h did not significantly alter the overall diversity and composition of viable bacteria in human milk, freezing notably affected both the viability and relative abundances of some bacterial genera.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Milk, Human/microbiology
Female
*Bacteria/isolation & purification/genetics/classification
*Food Storage/methods
Adult
RNA, Ribosomal, 16S
*Microbiota
Freezing
Refrigeration
Azides
Propidium/analogs & derivatives
RevDate: 2025-05-29
CmpDate: 2025-05-30
Berries and Steps: a protocol of a randomized, placebo-controlled pilot study testing freeze-dried blueberry powder in sedentary older adults with mild depressive symptoms.
Nutrition journal, 24(1):87.
BACKGROUND: Older adults spend the majority of their day engaging in sedentary behavior, which increases risk of mortality by 22%. Despite the well-established health benefits of physical activity, a large portion of older adults remain sedentary. Recent evidence suggests that inflammation contributes to lack of motivation, which is a critical barrier to overcoming sedentary behavior in older adults. Given that inflammation is highly modifiable by diet, an anti-inflammatory dietary strategy may be a viable way to improve inflammation-driven lack of motivation and ultimately increase physical activity in sedentary older adults. However, interventions targeting such a pathway are scarce. We propose a study intervention protocol, which aims to determine the feasibility and preliminary efficacy of daily supplementation of freeze-dried blueberries. Supplementation with blueberries provides 2 anti-inflammatory nutrients (fiber and anthocyanins) to theoretically reduce inflammation-driven lack of motivation and thereby enhance physical activity in older adults with sedentary behavior and mild depressive symptoms.
METHODS: The current study is planned as a single-site, randomized, double-blind, parallel pilot study in 40 older adults with sedentary behavior and mild depressive symptoms. Individuals with depressive symptoms often lack motivation and have increased levels of inflammatory cytokines, representing an ideal population for an anti-inflammatory dietary intervention to improve motivation. Participants will be randomized to consume either 48 g of freeze-dried blueberry powder (~ 600 mg of anthocyanins and ~ 8 g of fiber) or a nutritionally matched placebo powder (without any known amounts of anthocyanins and fiber) each day for a total of 12 weeks.
DISCUSSION: Identification of a dietary intervention to target the inflammatory pathways may offer a novel and feasible approach to increase motivation and engagement of physical activity in older adults. If feasible and effective, such a strategy would help avoid the plethora of health consequences associated with sedentary behavior and physical inactivity.
TRIAL REGISTRATION: The current study is approved by the Advarra IRB (#Pro00064749) and registered at Clinicaltrials.gov (Identifier: NCT05735587).
Additional Links: PMID-40442715
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40442715,
year = {2025},
author = {Millar, CL and Wolfe, A and Baldyga, K and Dufour, AB and Lipsitz, LA},
title = {Berries and Steps: a protocol of a randomized, placebo-controlled pilot study testing freeze-dried blueberry powder in sedentary older adults with mild depressive symptoms.},
journal = {Nutrition journal},
volume = {24},
number = {1},
pages = {87},
pmid = {40442715},
issn = {1475-2891},
support = {P30AG048785//NIA and Boston Roybal Center/ ; P30AG048785//NIA and Boston Roybal Center/ ; P30AG048785//NIA and Boston Roybal Center/ ; 2022-09412//USDA NIFA/ ; 2022-09412//USDA NIFA/ ; 2022-09412//USDA NIFA/ ; },
mesh = {Humans ; *Blueberry Plants/chemistry ; Pilot Projects ; Aged ; *Sedentary Behavior ; Freeze Drying ; Male ; Female ; Double-Blind Method ; *Fruit/chemistry ; *Depression/diet therapy ; Dietary Supplements ; Powders ; Anthocyanins/administration & dosage ; Dietary Fiber/administration & dosage ; Inflammation ; Motivation ; Middle Aged ; },
abstract = {BACKGROUND: Older adults spend the majority of their day engaging in sedentary behavior, which increases risk of mortality by 22%. Despite the well-established health benefits of physical activity, a large portion of older adults remain sedentary. Recent evidence suggests that inflammation contributes to lack of motivation, which is a critical barrier to overcoming sedentary behavior in older adults. Given that inflammation is highly modifiable by diet, an anti-inflammatory dietary strategy may be a viable way to improve inflammation-driven lack of motivation and ultimately increase physical activity in sedentary older adults. However, interventions targeting such a pathway are scarce. We propose a study intervention protocol, which aims to determine the feasibility and preliminary efficacy of daily supplementation of freeze-dried blueberries. Supplementation with blueberries provides 2 anti-inflammatory nutrients (fiber and anthocyanins) to theoretically reduce inflammation-driven lack of motivation and thereby enhance physical activity in older adults with sedentary behavior and mild depressive symptoms.
METHODS: The current study is planned as a single-site, randomized, double-blind, parallel pilot study in 40 older adults with sedentary behavior and mild depressive symptoms. Individuals with depressive symptoms often lack motivation and have increased levels of inflammatory cytokines, representing an ideal population for an anti-inflammatory dietary intervention to improve motivation. Participants will be randomized to consume either 48 g of freeze-dried blueberry powder (~ 600 mg of anthocyanins and ~ 8 g of fiber) or a nutritionally matched placebo powder (without any known amounts of anthocyanins and fiber) each day for a total of 12 weeks.
DISCUSSION: Identification of a dietary intervention to target the inflammatory pathways may offer a novel and feasible approach to increase motivation and engagement of physical activity in older adults. If feasible and effective, such a strategy would help avoid the plethora of health consequences associated with sedentary behavior and physical inactivity.
TRIAL REGISTRATION: The current study is approved by the Advarra IRB (#Pro00064749) and registered at Clinicaltrials.gov (Identifier: NCT05735587).},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Blueberry Plants/chemistry
Pilot Projects
Aged
*Sedentary Behavior
Freeze Drying
Male
Female
Double-Blind Method
*Fruit/chemistry
*Depression/diet therapy
Dietary Supplements
Powders
Anthocyanins/administration & dosage
Dietary Fiber/administration & dosage
Inflammation
Motivation
Middle Aged
RevDate: 2025-05-29
Dentures and the oral microbiome: Unraveling the hidden impact on edentulous and partially edentulous patients - a systematic review and meta-analysis.
Evidence-based dentistry [Epub ahead of print].
OBJECTIVE: This systematic review and meta-analysis evaluate the impact of edentulism and denture use on the oral microbiome, focusing on microbial diversity, colonization and biofilm formation in completely and partially edentulous patients.
METHODS: A comprehensive search was conducted across five databases (PubMed-Medline, Scopus, Embase, Lilacs, and Google Scholar) until June 1, 2024. Randomized and non-randomized clinical trials, observational studies, and cohort studies were included. Data extraction and risk of bias assessment followed PRISMA guidelines. Meta-analysis was performed using STATA and R software with a random effects maximum likelihood model. Microbial co-occurrence networks, heatmaps, and longitudinal trends were analyzed, with heterogeneity assessed using Higgin's I² (substantial heterogeneity defined as I² > 50%).
RESULTS: Thirty-two studies met the inclusion criteria. The oral microbiome in edentulous patients differed significantly from dentate individuals, influenced by denture materials, design, and time. Veillonella abundance in acrylic complete dentures was 13.63% (95% CI = -0.04, 27.29), I² = 90.98%, compared to 49.10% (95% CI = -29.62, 115.81), I² = 99.47% in dentate patients. Candida albicans increased over time in acrylic dentures, from 63.13% (95% CI = 48.93, 77.33), I² = 99.84% after insertion to 344.72 CFU/ml × 10² (95% CI = 139.19, 550.24), I² = 98.30% at nine months. Streptococcus mutans in CAD/CAM dentures increased from 45.54 CFU/ml × 10² (95% CI = 33.82, 57.25), I² = 87.26% at three months to 125.22 CFU/ml × 10² (95% CI = 38.25, 212.18), I² = 97.89% at nine months. Co-occurrence networks revealed strong Candida albicans-Streptococcus mutans synergy, while Fusobacterium nucleatum showed antagonistic interactions. Heatmaps demonstrated microbial dysbiosis in denture stomatitis cases, with increased Porphyromonas gingivalis and Candida albicans and reduced commensals. Longitudinal analyses highlighted the progressive dominance of opportunistic pathogens, emphasizing the need for early and consistent hygiene interventions.
CONCLUSION: Denture wearers exhibit distinct microbial communities influenced by biofilm formation, denture materials, and hygiene practices. Findings highlight the importance of antimicrobial denture materials and effective cleaning protocols in managing microbial colonization. Given high heterogeneity, standardized methodologies are essential for future research. Frequent professional cleaning and individualized hygiene strategies are necessary to prevent denture-associated infections and maintain oral health.
Additional Links: PMID-40442493
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40442493,
year = {2025},
author = {Madhan Kumar, S and Natarajan, S and Ks, S and Sundarajan, SK and Natarajan, P and Arockiam, AS},
title = {Dentures and the oral microbiome: Unraveling the hidden impact on edentulous and partially edentulous patients - a systematic review and meta-analysis.},
journal = {Evidence-based dentistry},
volume = {},
number = {},
pages = {},
pmid = {40442493},
issn = {1476-5446},
abstract = {OBJECTIVE: This systematic review and meta-analysis evaluate the impact of edentulism and denture use on the oral microbiome, focusing on microbial diversity, colonization and biofilm formation in completely and partially edentulous patients.
METHODS: A comprehensive search was conducted across five databases (PubMed-Medline, Scopus, Embase, Lilacs, and Google Scholar) until June 1, 2024. Randomized and non-randomized clinical trials, observational studies, and cohort studies were included. Data extraction and risk of bias assessment followed PRISMA guidelines. Meta-analysis was performed using STATA and R software with a random effects maximum likelihood model. Microbial co-occurrence networks, heatmaps, and longitudinal trends were analyzed, with heterogeneity assessed using Higgin's I² (substantial heterogeneity defined as I² > 50%).
RESULTS: Thirty-two studies met the inclusion criteria. The oral microbiome in edentulous patients differed significantly from dentate individuals, influenced by denture materials, design, and time. Veillonella abundance in acrylic complete dentures was 13.63% (95% CI = -0.04, 27.29), I² = 90.98%, compared to 49.10% (95% CI = -29.62, 115.81), I² = 99.47% in dentate patients. Candida albicans increased over time in acrylic dentures, from 63.13% (95% CI = 48.93, 77.33), I² = 99.84% after insertion to 344.72 CFU/ml × 10² (95% CI = 139.19, 550.24), I² = 98.30% at nine months. Streptococcus mutans in CAD/CAM dentures increased from 45.54 CFU/ml × 10² (95% CI = 33.82, 57.25), I² = 87.26% at three months to 125.22 CFU/ml × 10² (95% CI = 38.25, 212.18), I² = 97.89% at nine months. Co-occurrence networks revealed strong Candida albicans-Streptococcus mutans synergy, while Fusobacterium nucleatum showed antagonistic interactions. Heatmaps demonstrated microbial dysbiosis in denture stomatitis cases, with increased Porphyromonas gingivalis and Candida albicans and reduced commensals. Longitudinal analyses highlighted the progressive dominance of opportunistic pathogens, emphasizing the need for early and consistent hygiene interventions.
CONCLUSION: Denture wearers exhibit distinct microbial communities influenced by biofilm formation, denture materials, and hygiene practices. Findings highlight the importance of antimicrobial denture materials and effective cleaning protocols in managing microbial colonization. Given high heterogeneity, standardized methodologies are essential for future research. Frequent professional cleaning and individualized hygiene strategies are necessary to prevent denture-associated infections and maintain oral health.},
}
RevDate: 2025-05-29
CmpDate: 2025-05-30
Microbiome: A Key Regulator of Body-Brain Interactions.
Advances in experimental medicine and biology, 1477:139-203.
The gut microbiota, consisting of trillions of microorganisms, plays a critical role in regulating host physiology, including metabolism, immune responses, and brain function. This chapter examines the microbiota-gut-brain axis, a multifaceted bidirectional communication system connecting gut microbial activity with central nervous system processes through immune pathways, metabolic byproducts, and neural circuits like the vagus nerve. The evolution of the gut microbiota throughout an individual's life-from early developmental influences like birth mode and antibiotic use to changes associated with aging and neurodegenerative conditions-highlights its dynamic nature. The chapter reviews experimental approaches and microbiome-based interventions to demonstrate the influence of gut microbiota on neurological conditions such as autism spectrum disorder, anxiety, and Alzheimer's disease. Finally, it emphasises the importance of advancing microbiome-targeted therapies, integrating emerging technologies, and clinical trials to develop personalised strategies for enhancing brain health through gut microbiome modulation.
Additional Links: PMID-40442386
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40442386,
year = {2025},
author = {O'Riordan, KJ and Aburto, MR and Nagpal, J and Clarke, G and Cryan, JF},
title = {Microbiome: A Key Regulator of Body-Brain Interactions.},
journal = {Advances in experimental medicine and biology},
volume = {1477},
number = {},
pages = {139-203},
pmid = {40442386},
issn = {0065-2598},
mesh = {Humans ; *Gastrointestinal Microbiome/physiology ; *Brain/physiology/microbiology ; Animals ; *Brain-Gut Axis/physiology ; },
abstract = {The gut microbiota, consisting of trillions of microorganisms, plays a critical role in regulating host physiology, including metabolism, immune responses, and brain function. This chapter examines the microbiota-gut-brain axis, a multifaceted bidirectional communication system connecting gut microbial activity with central nervous system processes through immune pathways, metabolic byproducts, and neural circuits like the vagus nerve. The evolution of the gut microbiota throughout an individual's life-from early developmental influences like birth mode and antibiotic use to changes associated with aging and neurodegenerative conditions-highlights its dynamic nature. The chapter reviews experimental approaches and microbiome-based interventions to demonstrate the influence of gut microbiota on neurological conditions such as autism spectrum disorder, anxiety, and Alzheimer's disease. Finally, it emphasises the importance of advancing microbiome-targeted therapies, integrating emerging technologies, and clinical trials to develop personalised strategies for enhancing brain health through gut microbiome modulation.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Gastrointestinal Microbiome/physiology
*Brain/physiology/microbiology
Animals
*Brain-Gut Axis/physiology
RevDate: 2025-05-29
CmpDate: 2025-05-29
Association between post-stroke cognitive impairment and gut microbiota in patients with ischemic stroke.
Scientific reports, 15(1):18849.
More than half of stroke survivors have post-stroke cognitive impairment (PSCI). The role of gut microbiota, which can communicate with the brain through the gut-brain axis and affect inflammation, has been receiving increased attention. This cross-sectional study aimed to investigate the association of PSCI, gut microbiota, and inflammatory markers. Patients with first ischemic stroke and complete 3-month and 1-year follow-up data were included and divided into PSCI and non-PSCI groups according to the Montreal Cognitive Assessment (MoCA) score at the above time points. PSCI was defined as having a MoCA less than 23 at either 3 months or 1 year, or a decrease of more than 2 points at both time points. Gut microbiota was assessed by 16 S rRNA gene sequencing and Next Generation Sequencing analysis. The inflammatory markers included interleukins (ILs), eotaxin, G-CSF, TNF-α, IFNγ, sCD40L, and MCP-1. There were 95 ischemic stroke patients (mean age, 60.5 ± 12.1 years; male, 68.4%), including 30 with PSCI and 65 with non-PSCI. In gut microbiota analysis, the PSCI group had a higher abundance of Bacteroidaceae and Clostridiaceae, and the non-PSCI group had a higher abundance of Prevotellaceae, Ruminococcaceae, Oscillibacter, and Faecalibacterium. Ruminococcaceae family under the Oscillospirales order remains significantly different in the two groups in logistic regression model adjusting confounding variables (p = 0.044). In an analysis of inflammatory markers, the plasma levels of eotaxin (p = 0.041) and IL-12p40 (p = 0.031) were significantly higher in the PSCI group than those in the non-PSCI group, and the plasma level of eotaxin was significantly positively correlated with the amount of Clostridiaceae (rho = 0.389, p = 0.045). The study found that PSCI was associated with certain gut microbiota, and these gut microbiotas correlated with the pro-inflammatory marker eotaxin. This suggests that gut microbiota might play a role in the development of cognitive impairment after ischemic stroke.
Additional Links: PMID-40442236
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40442236,
year = {2025},
author = {Jeng, TM and Hsieh, YC and Chang, PY and Li, YL and Tang, SC and Jeng, JS and Hu, CJ and Chiou, HY},
title = {Association between post-stroke cognitive impairment and gut microbiota in patients with ischemic stroke.},
journal = {Scientific reports},
volume = {15},
number = {1},
pages = {18849},
pmid = {40442236},
issn = {2045-2322},
support = {NSTC107-2314-B-038-070-MY3//National Science and Technology Council/ ; },
mesh = {Humans ; *Gastrointestinal Microbiome ; Male ; Female ; Middle Aged ; *Cognitive Dysfunction/microbiology/etiology ; *Ischemic Stroke/complications/microbiology ; Aged ; Cross-Sectional Studies ; Biomarkers ; Inflammation ; *Stroke/complications/microbiology ; },
abstract = {More than half of stroke survivors have post-stroke cognitive impairment (PSCI). The role of gut microbiota, which can communicate with the brain through the gut-brain axis and affect inflammation, has been receiving increased attention. This cross-sectional study aimed to investigate the association of PSCI, gut microbiota, and inflammatory markers. Patients with first ischemic stroke and complete 3-month and 1-year follow-up data were included and divided into PSCI and non-PSCI groups according to the Montreal Cognitive Assessment (MoCA) score at the above time points. PSCI was defined as having a MoCA less than 23 at either 3 months or 1 year, or a decrease of more than 2 points at both time points. Gut microbiota was assessed by 16 S rRNA gene sequencing and Next Generation Sequencing analysis. The inflammatory markers included interleukins (ILs), eotaxin, G-CSF, TNF-α, IFNγ, sCD40L, and MCP-1. There were 95 ischemic stroke patients (mean age, 60.5 ± 12.1 years; male, 68.4%), including 30 with PSCI and 65 with non-PSCI. In gut microbiota analysis, the PSCI group had a higher abundance of Bacteroidaceae and Clostridiaceae, and the non-PSCI group had a higher abundance of Prevotellaceae, Ruminococcaceae, Oscillibacter, and Faecalibacterium. Ruminococcaceae family under the Oscillospirales order remains significantly different in the two groups in logistic regression model adjusting confounding variables (p = 0.044). In an analysis of inflammatory markers, the plasma levels of eotaxin (p = 0.041) and IL-12p40 (p = 0.031) were significantly higher in the PSCI group than those in the non-PSCI group, and the plasma level of eotaxin was significantly positively correlated with the amount of Clostridiaceae (rho = 0.389, p = 0.045). The study found that PSCI was associated with certain gut microbiota, and these gut microbiotas correlated with the pro-inflammatory marker eotaxin. This suggests that gut microbiota might play a role in the development of cognitive impairment after ischemic stroke.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Gastrointestinal Microbiome
Male
Female
Middle Aged
*Cognitive Dysfunction/microbiology/etiology
*Ischemic Stroke/complications/microbiology
Aged
Cross-Sectional Studies
Biomarkers
Inflammation
*Stroke/complications/microbiology
RevDate: 2025-05-29
CmpDate: 2025-05-29
Integrated multi-omics reveals different host crosstalk of atopic dermatitis-enriched Bifidobacterium longum Strains.
NPJ biofilms and microbiomes, 11(1):91.
The infant gut microbiome is essential for long-term health and is linked to atopic dermatitis (AD), although the underlying mechanisms are not fully understood. This study investigated gut microbiome-host interactions in 31 infants with AD and 29 healthy controls using multi-omics approaches, including metagenomic, host transcriptomic, and metabolomic analyses. Microbial diversity was significantly altered in AD, with Bifidobacterium longum and Clostridium innocuum associated with these changes. At the strain-level, only B. longum differed significantly between groups, with pangenome analyses identifying genetic variations potentially affecting amino acid and lipid metabolites. Notably, B. longum subclade I, which was more prevalent in healthy controls, correlated with host transcriptomic pathways involved in phosphatidylinositol 3-kinase-AKT signaling and neuroactive ligand-receptor pathways, as well as specific metabolites, including tetrahydrocortisol and ornithine. These findings highlight the role of B. longum strain-level variation in infants, offering new insights into microbiome-host interactions related to AD.
Additional Links: PMID-40442154
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40442154,
year = {2025},
author = {Seong, HJ and Park, YM and Kim, BS and Yoo, HJ and Kim, T and Yoon, SM and Kim, JH and Lee, SY and Lee, YK and Lee, DW and Nam, MH and Hong, SJ},
title = {Integrated multi-omics reveals different host crosstalk of atopic dermatitis-enriched Bifidobacterium longum Strains.},
journal = {NPJ biofilms and microbiomes},
volume = {11},
number = {1},
pages = {91},
pmid = {40442154},
issn = {2055-5008},
mesh = {Humans ; *Dermatitis, Atopic/microbiology ; *Gastrointestinal Microbiome ; Infant ; *Bifidobacterium longum/genetics/isolation & purification/classification/metabolism ; Female ; Male ; Metabolomics ; Metagenomics/methods ; Feces/microbiology ; *Host Microbial Interactions ; Clostridium/genetics/isolation & purification ; Transcriptome ; Multiomics ; },
abstract = {The infant gut microbiome is essential for long-term health and is linked to atopic dermatitis (AD), although the underlying mechanisms are not fully understood. This study investigated gut microbiome-host interactions in 31 infants with AD and 29 healthy controls using multi-omics approaches, including metagenomic, host transcriptomic, and metabolomic analyses. Microbial diversity was significantly altered in AD, with Bifidobacterium longum and Clostridium innocuum associated with these changes. At the strain-level, only B. longum differed significantly between groups, with pangenome analyses identifying genetic variations potentially affecting amino acid and lipid metabolites. Notably, B. longum subclade I, which was more prevalent in healthy controls, correlated with host transcriptomic pathways involved in phosphatidylinositol 3-kinase-AKT signaling and neuroactive ligand-receptor pathways, as well as specific metabolites, including tetrahydrocortisol and ornithine. These findings highlight the role of B. longum strain-level variation in infants, offering new insights into microbiome-host interactions related to AD.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Dermatitis, Atopic/microbiology
*Gastrointestinal Microbiome
Infant
*Bifidobacterium longum/genetics/isolation & purification/classification/metabolism
Female
Male
Metabolomics
Metagenomics/methods
Feces/microbiology
*Host Microbial Interactions
Clostridium/genetics/isolation & purification
Transcriptome
Multiomics
RevDate: 2025-05-29
Bridging the bench-to-bedside divide in microbiome research.
Clinical and translational medicine, 15(5):e70358.
Additional Links: PMID-40442038
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40442038,
year = {2025},
author = {Turjeman, S and Koren, O},
title = {Bridging the bench-to-bedside divide in microbiome research.},
journal = {Clinical and translational medicine},
volume = {15},
number = {5},
pages = {e70358},
doi = {10.1002/ctm2.70358},
pmid = {40442038},
issn = {2001-1326},
support = {ERC-2020-COG no. 101001355//HORIZON EUROPE European Research Council/ ; 1527/21//Israel Science Foundation/ ; },
}
RevDate: 2025-05-29
CmpDate: 2025-05-29
I-SVVS: integrative stochastic variational variable selection to explore joint patterns of multi-omics microbiome data.
Briefings in bioinformatics, 26(3):.
High-dimensional multi-omics microbiome data play an important role in elucidating microbial community interactions with their hosts and environment in critical diseases and ecological changes. Although Bayesian clustering methods have recently been used for the integrated analysis of multi-omics data, no method designed to analyze multi-omics microbiome data has been proposed. In this study, we propose a novel framework called integrative stochastic variational variable selection (I-SVVS), which is an extension of stochastic variational variable selection for high-dimensional microbiome data. The I-SVVS approach addresses a specific Bayesian mixture model for each type of omics data, such as an infinite Dirichlet multinomial mixture model for microbiome data and an infinite Gaussian mixture model for metabolomic data. This approach is expected to reduce the computational time of the clustering process and improve the accuracy of the clustering results. Additionally, I-SVVS identifies a critical set of representative variables in multi-omics microbiome data. Three datasets from soybean, mice, and humans (each set integrated microbiome and metabolome) were used to demonstrate the potential of I-SVVS. The results indicate that I-SVVS achieved improved accuracy and faster computation compared to existing methods across all test datasets. It effectively identified key microbiome species and metabolites characterizing each cluster. For instance, the computational analysis of the soybean dataset, including 377 samples with 16 943 microbiome species and 265 metabolome features, was completed in 2.18 hours using I-SVVS, compared to 2.35 days with Clusternomics and 1.12 days with iClusterPlus. The software for this analysis, written in Python, is freely available at https://github.com/tungtokyo1108/I-SVVS.
Additional Links: PMID-40441709
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40441709,
year = {2025},
author = {Dang, T and Fuji, Y and Kumaishi, K and Usui, E and Kobori, S and Sato, T and Narukawa, M and Toda, Y and Sakurai, K and Yamasaki, Y and Tsujimoto, H and Hirai, MY and Ichihashi, Y and Iwata, H},
title = {I-SVVS: integrative stochastic variational variable selection to explore joint patterns of multi-omics microbiome data.},
journal = {Briefings in bioinformatics},
volume = {26},
number = {3},
pages = {},
doi = {10.1093/bib/bbaf132},
pmid = {40441709},
issn = {1477-4054},
support = {JP21J21850//JSPS KAKENHI/ ; JPMJCR1602//JST-CREST Program/ ; JPMJMI120C7//JST-Mirai Program/ ; JPMJAN23D1//JST ALCA-Next Program/ ; },
mesh = {*Microbiota ; Mice ; Animals ; Humans ; Stochastic Processes ; Bayes Theorem ; Glycine max/microbiology ; *Metabolomics/methods ; Algorithms ; *Computational Biology/methods ; Metabolome ; Cluster Analysis ; Multiomics ; },
abstract = {High-dimensional multi-omics microbiome data play an important role in elucidating microbial community interactions with their hosts and environment in critical diseases and ecological changes. Although Bayesian clustering methods have recently been used for the integrated analysis of multi-omics data, no method designed to analyze multi-omics microbiome data has been proposed. In this study, we propose a novel framework called integrative stochastic variational variable selection (I-SVVS), which is an extension of stochastic variational variable selection for high-dimensional microbiome data. The I-SVVS approach addresses a specific Bayesian mixture model for each type of omics data, such as an infinite Dirichlet multinomial mixture model for microbiome data and an infinite Gaussian mixture model for metabolomic data. This approach is expected to reduce the computational time of the clustering process and improve the accuracy of the clustering results. Additionally, I-SVVS identifies a critical set of representative variables in multi-omics microbiome data. Three datasets from soybean, mice, and humans (each set integrated microbiome and metabolome) were used to demonstrate the potential of I-SVVS. The results indicate that I-SVVS achieved improved accuracy and faster computation compared to existing methods across all test datasets. It effectively identified key microbiome species and metabolites characterizing each cluster. For instance, the computational analysis of the soybean dataset, including 377 samples with 16 943 microbiome species and 265 metabolome features, was completed in 2.18 hours using I-SVVS, compared to 2.35 days with Clusternomics and 1.12 days with iClusterPlus. The software for this analysis, written in Python, is freely available at https://github.com/tungtokyo1108/I-SVVS.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Microbiota
Mice
Animals
Humans
Stochastic Processes
Bayes Theorem
Glycine max/microbiology
*Metabolomics/methods
Algorithms
*Computational Biology/methods
Metabolome
Cluster Analysis
Multiomics
RevDate: 2025-05-29
Normalizing body weight with a dietary strategy mitigates obesity-accelerated pancreatic carcinogenesis in mice.
The Journal of nutrition pii:S0022-3166(25)00322-0 [Epub ahead of print].
BACKGROUND: Obesity is a modifiable risk factor for pancreatic cancer, but the impact of dietary changes leading to weight loss in pancreatic carcinogenesis remains unknown.
OBJECTIVE: To determine the effects of weight normalization via dietary switch on pancreatic carcinogenesis and associated mechanisms.
METHODS: Five-week-old male and female LSL-Kras[G12D/+]; p48[Cre/+] (KC) mice (8-12/diet group/sex) were fed a high-fat, diet-induced obesity diet (DIO; 60% kcal from fat) or a low-fat, control diet (CD; 11% kcal from fat) for 21 weeks. A subset of mice was fed the DIO for 8 weeks, then switched to CD for 13 additional weeks (DIO→CD). Cancer incidence was evaluated by histology. Lipidomics and RNAseq followed by bioinformatic analysis identified potential mechanisms. The gut microbiome was characterized using 16s rRNA amplicon sequencing. Data were analyzed using one-way analysis of variance.
RESULTS: After 21 weeks, DIO-fed mice had 1.7-fold higher body weight gain, and 60% increase (p<0.05 DIO vs. CD) in pancreatic acinar-to-ductal metaplasia, compared to the other 2 groups. None of the 21 mice fed a CD developed cancer, while 2 out of 21 DIO-fed male mice did. Switching from a DIO to a CD normalized body weight and composition to CD levels, slowed acinar-to-ductal metaplasia and prevented cancer incidence, with no mice developing cancer. Mechanistically, DIO affected gene expression related to cellular metabolism, pancreatic secretions, immune function, and cell-signaling, while CD and DIO→CD had similar global gene expression. Moreover, DIO increased epoxy metabolites of linoleic acid, which were mitigated by the dietary switch. Finally, compared to a CD, DIO altered the gut microbiome and switching from a DIO to a CD restored the gut microbiome profile to resemble that of CD-fed mice.
CONCLUSIONS: Body weight normalization slowed obesity-accelerated pancreatic carcinogenesis, in part, by affecting inflammatory and cell signaling pathways, reducing epoxy metabolites, and modulating the gut microbiome.
Additional Links: PMID-40441385
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40441385,
year = {2025},
author = {Wirkus, J and Ead, AS and Krga, I and Wang, Y and Pontifex, MG and Muller, M and Vauzour, D and Matsukuma, KE and Zhang, G and Mackenzie, GG},
title = {Normalizing body weight with a dietary strategy mitigates obesity-accelerated pancreatic carcinogenesis in mice.},
journal = {The Journal of nutrition},
volume = {},
number = {},
pages = {},
doi = {10.1016/j.tjnut.2025.05.039},
pmid = {40441385},
issn = {1541-6100},
abstract = {BACKGROUND: Obesity is a modifiable risk factor for pancreatic cancer, but the impact of dietary changes leading to weight loss in pancreatic carcinogenesis remains unknown.
OBJECTIVE: To determine the effects of weight normalization via dietary switch on pancreatic carcinogenesis and associated mechanisms.
METHODS: Five-week-old male and female LSL-Kras[G12D/+]; p48[Cre/+] (KC) mice (8-12/diet group/sex) were fed a high-fat, diet-induced obesity diet (DIO; 60% kcal from fat) or a low-fat, control diet (CD; 11% kcal from fat) for 21 weeks. A subset of mice was fed the DIO for 8 weeks, then switched to CD for 13 additional weeks (DIO→CD). Cancer incidence was evaluated by histology. Lipidomics and RNAseq followed by bioinformatic analysis identified potential mechanisms. The gut microbiome was characterized using 16s rRNA amplicon sequencing. Data were analyzed using one-way analysis of variance.
RESULTS: After 21 weeks, DIO-fed mice had 1.7-fold higher body weight gain, and 60% increase (p<0.05 DIO vs. CD) in pancreatic acinar-to-ductal metaplasia, compared to the other 2 groups. None of the 21 mice fed a CD developed cancer, while 2 out of 21 DIO-fed male mice did. Switching from a DIO to a CD normalized body weight and composition to CD levels, slowed acinar-to-ductal metaplasia and prevented cancer incidence, with no mice developing cancer. Mechanistically, DIO affected gene expression related to cellular metabolism, pancreatic secretions, immune function, and cell-signaling, while CD and DIO→CD had similar global gene expression. Moreover, DIO increased epoxy metabolites of linoleic acid, which were mitigated by the dietary switch. Finally, compared to a CD, DIO altered the gut microbiome and switching from a DIO to a CD restored the gut microbiome profile to resemble that of CD-fed mice.
CONCLUSIONS: Body weight normalization slowed obesity-accelerated pancreatic carcinogenesis, in part, by affecting inflammatory and cell signaling pathways, reducing epoxy metabolites, and modulating the gut microbiome.},
}
RevDate: 2025-05-29
Impact of metabolic surgery on cardiovascular disease outcomes.
The Canadian journal of cardiology pii:S0828-282X(25)00372-1 [Epub ahead of print].
Obesity is strongly associated with a range of cardiovascular conditions, including coronary artery disease, heart failure, atrial fibrillation, and stroke. Metabolic surgery has emerged as one of the most effective interventions for individuals with severe obesity, not only by promoting substantial and durable weight loss but also by improving cardiovascular risk factors and outcomes. Cardiovascular benefits may also be mediated via weight independent mechanisms involving insulin sensitivity, gastrointestinal hormones, bile acid dynamics, and gut microbiome. Long-term cohort studies have documented that metabolic surgery is associated with a reduction in all-cause mortality and major adverse cardiovascular events in this population. This narrative review examines the role of metabolic surgery in the prevention and management of cardiovascular disease associated with severe obesity. It provides an overview of the most common metabolic surgery procedures, including sleeve gastrectomy, Roux-en-Y gastric bypass and biliopancreatic diversion with duodenal switch as well as newer procedures like single-anastomosis duodenal switch. This review also evaluates the impact of these interventions on key cardiovascular risk factors such as type 2 diabetes, hypertension, dyslipidemia, and obstructive sleep apnea, as well as their effects on cardiac structure and function. Metabolic surgery is associated with reductions in all-cause mortality and cardiovascular events, including myocardial infarction and heart failure, especially in individuals with obesity and pre-existing cardiovascular disease. The current evidence supporting the link between metabolic surgery and cardiovascular outcomes is reviewed. Notably, randomized trials specifically focusing on cardiovascular outcomes after metabolic surgery are lacking highlighting an important knowledge gap and their crucial need. Addressing this gap is essential for guiding future clinical practice and optimizing patient care.
Additional Links: PMID-40441298
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40441298,
year = {2025},
author = {Piché, ME and Poirier, P and Wong, JA},
title = {Impact of metabolic surgery on cardiovascular disease outcomes.},
journal = {The Canadian journal of cardiology},
volume = {},
number = {},
pages = {},
doi = {10.1016/j.cjca.2025.05.013},
pmid = {40441298},
issn = {1916-7075},
abstract = {Obesity is strongly associated with a range of cardiovascular conditions, including coronary artery disease, heart failure, atrial fibrillation, and stroke. Metabolic surgery has emerged as one of the most effective interventions for individuals with severe obesity, not only by promoting substantial and durable weight loss but also by improving cardiovascular risk factors and outcomes. Cardiovascular benefits may also be mediated via weight independent mechanisms involving insulin sensitivity, gastrointestinal hormones, bile acid dynamics, and gut microbiome. Long-term cohort studies have documented that metabolic surgery is associated with a reduction in all-cause mortality and major adverse cardiovascular events in this population. This narrative review examines the role of metabolic surgery in the prevention and management of cardiovascular disease associated with severe obesity. It provides an overview of the most common metabolic surgery procedures, including sleeve gastrectomy, Roux-en-Y gastric bypass and biliopancreatic diversion with duodenal switch as well as newer procedures like single-anastomosis duodenal switch. This review also evaluates the impact of these interventions on key cardiovascular risk factors such as type 2 diabetes, hypertension, dyslipidemia, and obstructive sleep apnea, as well as their effects on cardiac structure and function. Metabolic surgery is associated with reductions in all-cause mortality and cardiovascular events, including myocardial infarction and heart failure, especially in individuals with obesity and pre-existing cardiovascular disease. The current evidence supporting the link between metabolic surgery and cardiovascular outcomes is reviewed. Notably, randomized trials specifically focusing on cardiovascular outcomes after metabolic surgery are lacking highlighting an important knowledge gap and their crucial need. Addressing this gap is essential for guiding future clinical practice and optimizing patient care.},
}
RevDate: 2025-05-29
Beyond plastisphere transfer, deep corals are subject to dysbiosis when exposed to plastics.
Environmental pollution (Barking, Essex : 1987) pii:S0269-7491(25)00927-3 [Epub ahead of print].
Plastic pollution has been identified as a major threat to marine life and ecosystems, but their biological impacts are still largely unknown. Coral reefs, which are one of the most biodiverse ecosystems on earth that provide essential ecological and economical services, are now recognized to be impacted by plastic pollution from the surface to the deep. Here, we investigated the impact of colonized macro- and microplastics on the microbiome of the most emblematic cold-water coral, Lophelia pertusa. Studies at the associated bacterial level help better understand the early biological pathways that may lead to coral physiological alterations. Both macro- and microplastics induced early (7 days) microbial shifts for L. pertusa polyps, with specific exacerbated effects between plastic sizes observed after 47 days. In the case of stressed corals, we observed an increase of opportunistic and/or pathogenic bacteria that may be induced by different processes whether corals are exposed to macro- (barrier effect) or microplastics (ingestion). Our results however confirm that very few specific bacteria can be directly transferred from plastisphere to coral microbiome. We suggest that shift in coral microbiome was due to general dysbiosis from stress, and poorly from a transfer of microorganisms from the plastisphere. Considering the widespray distribution of macroplastics in the ocean that are continuously fragmented into microplastics, our conclusions suggest that plastics could seriously endangered the cold-water coral reefs.
Additional Links: PMID-40441277
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40441277,
year = {2025},
author = {Chapron, L and Meistertzheim, AL and Ghiglione, JF and Peru, E and Galand, PE and Lartaud, F},
title = {Beyond plastisphere transfer, deep corals are subject to dysbiosis when exposed to plastics.},
journal = {Environmental pollution (Barking, Essex : 1987)},
volume = {},
number = {},
pages = {126554},
doi = {10.1016/j.envpol.2025.126554},
pmid = {40441277},
issn = {1873-6424},
abstract = {Plastic pollution has been identified as a major threat to marine life and ecosystems, but their biological impacts are still largely unknown. Coral reefs, which are one of the most biodiverse ecosystems on earth that provide essential ecological and economical services, are now recognized to be impacted by plastic pollution from the surface to the deep. Here, we investigated the impact of colonized macro- and microplastics on the microbiome of the most emblematic cold-water coral, Lophelia pertusa. Studies at the associated bacterial level help better understand the early biological pathways that may lead to coral physiological alterations. Both macro- and microplastics induced early (7 days) microbial shifts for L. pertusa polyps, with specific exacerbated effects between plastic sizes observed after 47 days. In the case of stressed corals, we observed an increase of opportunistic and/or pathogenic bacteria that may be induced by different processes whether corals are exposed to macro- (barrier effect) or microplastics (ingestion). Our results however confirm that very few specific bacteria can be directly transferred from plastisphere to coral microbiome. We suggest that shift in coral microbiome was due to general dysbiosis from stress, and poorly from a transfer of microorganisms from the plastisphere. Considering the widespray distribution of macroplastics in the ocean that are continuously fragmented into microplastics, our conclusions suggest that plastics could seriously endangered the cold-water coral reefs.},
}
RevDate: 2025-05-29
CmpDate: 2025-05-29
Causal associations between gut microbiota and rheumatoid arthritis: A two-sample Mendelian randomization study.
Medicine, 104(22):e42596.
The gut microbiota has been implicated in the development of rheumatoid arthritis (RA), but whether these associations reflect causal relationships remains unclear. We conducted a two-sample Mendelian randomization analysis to investigate the potential causal effects of gut microbial taxa on RA risk. Summary-level data from the MiBioGen consortium (n = 13,266) and a large RA genome-wide association study (n = 97,173) were used. Multiple Mendelian randomization methods and sensitivity analyses were applied to ensure robustness. Four microbial taxa showed nominal associations with RA. Increased abundance of Catenibacterium, Desulfovibrio, and Ruminiclostridium 6 was associated with a higher risk of RA, while Lachnospiraceae (UCG008) appeared to have a protective effect. Although these associations did not meet Bonferroni-corrected significance, results were consistent across analytical methods with no evidence of pleiotropy or heterogeneity. This study provides genetic evidence supporting a potential causal link between specific gut microbes and RA risk. The findings highlight host immune modulation as a possible pathway connecting the gut microbiome to RA and identify candidate taxa for future mechanistic and therapeutic research.
Additional Links: PMID-40441229
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40441229,
year = {2025},
author = {Wei, F and Zhao, M and Sun, X and Ma, H and Yin, H and Shen, X},
title = {Causal associations between gut microbiota and rheumatoid arthritis: A two-sample Mendelian randomization study.},
journal = {Medicine},
volume = {104},
number = {22},
pages = {e42596},
doi = {10.1097/MD.0000000000042596},
pmid = {40441229},
issn = {1536-5964},
mesh = {*Arthritis, Rheumatoid/microbiology/genetics ; *Gastrointestinal Microbiome/genetics ; Humans ; Mendelian Randomization Analysis ; Genome-Wide Association Study ; },
abstract = {The gut microbiota has been implicated in the development of rheumatoid arthritis (RA), but whether these associations reflect causal relationships remains unclear. We conducted a two-sample Mendelian randomization analysis to investigate the potential causal effects of gut microbial taxa on RA risk. Summary-level data from the MiBioGen consortium (n = 13,266) and a large RA genome-wide association study (n = 97,173) were used. Multiple Mendelian randomization methods and sensitivity analyses were applied to ensure robustness. Four microbial taxa showed nominal associations with RA. Increased abundance of Catenibacterium, Desulfovibrio, and Ruminiclostridium 6 was associated with a higher risk of RA, while Lachnospiraceae (UCG008) appeared to have a protective effect. Although these associations did not meet Bonferroni-corrected significance, results were consistent across analytical methods with no evidence of pleiotropy or heterogeneity. This study provides genetic evidence supporting a potential causal link between specific gut microbes and RA risk. The findings highlight host immune modulation as a possible pathway connecting the gut microbiome to RA and identify candidate taxa for future mechanistic and therapeutic research.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
*Arthritis, Rheumatoid/microbiology/genetics
*Gastrointestinal Microbiome/genetics
Humans
Mendelian Randomization Analysis
Genome-Wide Association Study
RevDate: 2025-05-29
CmpDate: 2025-05-29
Investigating the causal links among gut microbiome features, inflammation-related proteins, and diverticular disease: Insights from a mediation Mendelian randomization study.
Medicine, 104(22):e42676.
The pathophysiological mechanisms underlying diverticular disease (DD) remain incompletely understood, and there is considerable debate regarding the roles of gut microbiome features and inflammation-related proteins in the development of the disease. In this study, we employed mediation Mendelian randomization (MR) analysis to investigate the causal relationships among these 3 factors. In this study, we conducted a MR analysis on the genome-wide association studies data of 412 gut microbiome features (207 microbial taxa and 205 pathways), 91 inflammation-related proteins, and DD. We employed the inverse-variance weighted (IVW) method as our primary screening approach, followed by a mediation MR analysis to explore potential causal relationships among these 3 aspects. Our findings were further reinforced by comprehensive heterogeneity analyses, horizontal pleiotropy testing, outlier detection, and "leave-one-out" sensitivity analysis. Through our screening process, we identified potential causal relationships between DD and 18 gut microbiome features, as well as 6 inflammation-related proteins. These include s_Oscillibacter_unclassified (IVW odds ratio (OR): 1.139; 95% confidence interval (CI): 1.044-1.241, P = .003), g_Bilophila (IVW OR: 1.107, 95% CI: 1.016-1.206, P = .020), T-cell surface glycoprotein CD5 levels (IVW OR: 1.065, 95% CI: 1.011-1.123, P = .019), and inosine 5'-phosphate biosynthesis I (IVW OR: 0.882, 95% CI: 0.800-0.973, P = .012), etc. In the mediation MR analysis, we found that the genetic predictors of g_Bilophila and inosine 5'-phosphate biosynthesis I could explain 23.956% and 24.630% of the variation in T-cell surface glycoprotein CD5 levels, respectively. This study detailed analysis of the links between gut microbiome features, inflammation-related proteins, and DD offers key insights into DD pathogenesis and prevention.
Additional Links: PMID-40441205
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40441205,
year = {2025},
author = {Zhou, J and Xu, Y and Wang, H and Wang, K and Chen, C},
title = {Investigating the causal links among gut microbiome features, inflammation-related proteins, and diverticular disease: Insights from a mediation Mendelian randomization study.},
journal = {Medicine},
volume = {104},
number = {22},
pages = {e42676},
doi = {10.1097/MD.0000000000042676},
pmid = {40441205},
issn = {1536-5964},
support = {No. JDY2023018//Jiangsu University Medical Education Collaborative Innovation Fund Project/ ; No. Z2021010//Medical Research Project of Jiangsu Health Commission/ ; },
mesh = {Humans ; *Gastrointestinal Microbiome/genetics ; Mendelian Randomization Analysis ; *Diverticular Diseases/microbiology/genetics ; *Inflammation/genetics ; Genome-Wide Association Study ; Mediation Analysis ; },
abstract = {The pathophysiological mechanisms underlying diverticular disease (DD) remain incompletely understood, and there is considerable debate regarding the roles of gut microbiome features and inflammation-related proteins in the development of the disease. In this study, we employed mediation Mendelian randomization (MR) analysis to investigate the causal relationships among these 3 factors. In this study, we conducted a MR analysis on the genome-wide association studies data of 412 gut microbiome features (207 microbial taxa and 205 pathways), 91 inflammation-related proteins, and DD. We employed the inverse-variance weighted (IVW) method as our primary screening approach, followed by a mediation MR analysis to explore potential causal relationships among these 3 aspects. Our findings were further reinforced by comprehensive heterogeneity analyses, horizontal pleiotropy testing, outlier detection, and "leave-one-out" sensitivity analysis. Through our screening process, we identified potential causal relationships between DD and 18 gut microbiome features, as well as 6 inflammation-related proteins. These include s_Oscillibacter_unclassified (IVW odds ratio (OR): 1.139; 95% confidence interval (CI): 1.044-1.241, P = .003), g_Bilophila (IVW OR: 1.107, 95% CI: 1.016-1.206, P = .020), T-cell surface glycoprotein CD5 levels (IVW OR: 1.065, 95% CI: 1.011-1.123, P = .019), and inosine 5'-phosphate biosynthesis I (IVW OR: 0.882, 95% CI: 0.800-0.973, P = .012), etc. In the mediation MR analysis, we found that the genetic predictors of g_Bilophila and inosine 5'-phosphate biosynthesis I could explain 23.956% and 24.630% of the variation in T-cell surface glycoprotein CD5 levels, respectively. This study detailed analysis of the links between gut microbiome features, inflammation-related proteins, and DD offers key insights into DD pathogenesis and prevention.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Humans
*Gastrointestinal Microbiome/genetics
Mendelian Randomization Analysis
*Diverticular Diseases/microbiology/genetics
*Inflammation/genetics
Genome-Wide Association Study
Mediation Analysis
RevDate: 2025-05-29
Targeted inhibition of pathobiont virulence factor mitigates alcohol-associated liver disease.
Cell host & microbe pii:S1931-3128(25)00182-9 [Epub ahead of print].
Alcohol-associated liver disease poses a global health burden with high mortality. Imbalances in the gut microbiota are important for disease progression. Using metagenomic sequencing of fecal samples from a multicenter, international cohort of patients with alcohol-associated hepatitis, we found that the presence of virulence factor KpsM, encoded in the genome of Escherichia coli (E. coli), correlated with patient mortality. Functional studies using gnotobiotic mouse models and genetic manipulation of bacteria demonstrated that kpsM-positive E. coli exacerbate ethanol-induced liver disease. The kpsM gene mediates the translocation of capsular polysaccharides to the cell surface. This enables kpsM-positive E. coli to evade phagocytosis by the scavenger receptor Marco on Kupffer cells in the liver, leading to bacterial spread. Importantly, inhibiting kpsM-dependent capsules with the small molecule 2-(4-phenylphenyl)benzo[g]quinoline-4-carboxylic acid (C7) attenuated ethanol-induced liver disease in mice. We show that precision targeting of the virulence factor KpsM is a promising approach to improve outcomes of patients with alcohol-associated hepatitis.
Additional Links: PMID-40441146
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40441146,
year = {2025},
author = {Yang, Y and Duan, Y and Lang, S and Fondevila, MF and Schöler, D and Harberts, A and Cabré, N and Chen, S and Shao, Y and Vervier, K and Miyamoto, Y and Zhang, X and Chu, H and Yang, L and Tan, C and Eckmann, L and Bosques-Padilla, F and Verna, EC and Abraldes, JG and Brown, RS and Vargas, V and Altamirano, J and Caballería, J and Shawcross, DL and Louvet, A and Lucey, MR and Mathurin, P and Garcia-Tsao, G and Bataller, R and Stärkel, P and Lawley, TD and Schnabl, B},
title = {Targeted inhibition of pathobiont virulence factor mitigates alcohol-associated liver disease.},
journal = {Cell host & microbe},
volume = {},
number = {},
pages = {},
doi = {10.1016/j.chom.2025.05.003},
pmid = {40441146},
issn = {1934-6069},
abstract = {Alcohol-associated liver disease poses a global health burden with high mortality. Imbalances in the gut microbiota are important for disease progression. Using metagenomic sequencing of fecal samples from a multicenter, international cohort of patients with alcohol-associated hepatitis, we found that the presence of virulence factor KpsM, encoded in the genome of Escherichia coli (E. coli), correlated with patient mortality. Functional studies using gnotobiotic mouse models and genetic manipulation of bacteria demonstrated that kpsM-positive E. coli exacerbate ethanol-induced liver disease. The kpsM gene mediates the translocation of capsular polysaccharides to the cell surface. This enables kpsM-positive E. coli to evade phagocytosis by the scavenger receptor Marco on Kupffer cells in the liver, leading to bacterial spread. Importantly, inhibiting kpsM-dependent capsules with the small molecule 2-(4-phenylphenyl)benzo[g]quinoline-4-carboxylic acid (C7) attenuated ethanol-induced liver disease in mice. We show that precision targeting of the virulence factor KpsM is a promising approach to improve outcomes of patients with alcohol-associated hepatitis.},
}
RevDate: 2025-05-29
Understanding oncobiosis in ovarian cancer: Emerging concepts in tumor progression.
Pathology, research and practice, 271:156026 pii:S0344-0338(25)00218-3 [Epub ahead of print].
Ovarian cancer is a leading cause of gynecologic cancer mortality and has recently been linked to microbial dysbiosis or oncobiosis. Tumorigenesis is a highly complex process, and recent research has revealed numerous new mechanisms showing how tumors interact with their surrounding microenvironment. The inclusion of microbiome studies has significantly advanced this field revealing the important role microbes play, not only in maintaining normal physiological functions of the human body but also in influencing oncogenic pathways. This expanding knowledge is deepening our understanding of tumor pathophysiology and is helping to create new diagnostic, prognostic, therapeutic and preventive strategies for specific cancers. This review explores the role of the microbiome in ovarian carcinogenesis, focusing on its interaction with the tumor microenvironment (TME) and its influence on inflammation, immune regulation and metabolic signaling. This review studied dysbiosis in several anatomical compartments such as the gut, oral cavity, lower and upper genital tracts and ovarian tissues, in relation to ovarian oncobiosis. Emerging clinical implications of these studies include the use of microbial profiles as diagnostic or prognostic biomarkers. Therapeutic strategies such as fecal microbiota transplantation and probiotics are also discussed for their ability to restore microbial balance and enhance treatment efficacy. This review highlights the importance of continued research to explore causal relationships between the microbiome and tumorigenesis, positioning microbiome studies as promising tools in ovarian cancer management and improving patient care.
Additional Links: PMID-40441086
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40441086,
year = {2025},
author = {Sharma, P and Das, S and Rituraj, R and Bhagyashree, B},
title = {Understanding oncobiosis in ovarian cancer: Emerging concepts in tumor progression.},
journal = {Pathology, research and practice},
volume = {271},
number = {},
pages = {156026},
doi = {10.1016/j.prp.2025.156026},
pmid = {40441086},
issn = {1618-0631},
abstract = {Ovarian cancer is a leading cause of gynecologic cancer mortality and has recently been linked to microbial dysbiosis or oncobiosis. Tumorigenesis is a highly complex process, and recent research has revealed numerous new mechanisms showing how tumors interact with their surrounding microenvironment. The inclusion of microbiome studies has significantly advanced this field revealing the important role microbes play, not only in maintaining normal physiological functions of the human body but also in influencing oncogenic pathways. This expanding knowledge is deepening our understanding of tumor pathophysiology and is helping to create new diagnostic, prognostic, therapeutic and preventive strategies for specific cancers. This review explores the role of the microbiome in ovarian carcinogenesis, focusing on its interaction with the tumor microenvironment (TME) and its influence on inflammation, immune regulation and metabolic signaling. This review studied dysbiosis in several anatomical compartments such as the gut, oral cavity, lower and upper genital tracts and ovarian tissues, in relation to ovarian oncobiosis. Emerging clinical implications of these studies include the use of microbial profiles as diagnostic or prognostic biomarkers. Therapeutic strategies such as fecal microbiota transplantation and probiotics are also discussed for their ability to restore microbial balance and enhance treatment efficacy. This review highlights the importance of continued research to explore causal relationships between the microbiome and tumorigenesis, positioning microbiome studies as promising tools in ovarian cancer management and improving patient care.},
}
RevDate: 2025-05-29
Transcriptomic strategy provides molecular insights into the growth and ginsenosides accumulation of Panax ginseng.
Phytomedicine : international journal of phytotherapy and phytopharmacology, 143:156834 pii:S0944-7113(25)00472-6 [Epub ahead of print].
BACKGROUND: Panax ginseng C. A. Meyer, a well-known phytomedicine has been widely used in traditional medicine for centuries. However, its quality and yield are heavily influenced by environmental conditions and cultivation years. For example, ginsenosides as the primary active component of ginseng, the concentration increased with the age of the roots and unevenly distributed across different tissues. Recently, transcriptomic technologies have provided powerful tools for revealing the relationship between gene expression and ginsenoside accumulation during ginseng growth, and researches in this field is continuously expanding, influencing the quality and sustainability of ginseng cultivation.
PURPOSE: Investigating the relationship between ginseng growth and the accumulation of active components may provide new insights for improving ginseng performance and medicinal value. This requires a systematic review and in-depth discussion of relevant research.
STUDY DESIGN AND METHODS: This article reviews the application of transcriptomic strategies in studying the molecular mechanisms of ginseng growth and ginsenoside accumulation. A literature search and analysis were conducted using keywords such as "Panax ginseng" and "transcriptomics/transcriptome," along with terms including "ginsenoside biosynthesis," "microbe/microorganism," "RNA-seq," "cultivation years," "rhizosphere," and "stress."
RESULT: Our study focuses on the transcriptome strategy provides molecular insights into the growth and ginsenosides accumulation of Panax ginseng, we summarized and discussed the dynamic changes in gene expression across cultivation years, specific-tissue, environmental stress, and imbalance of rhizosphere microbes during the ginseng growth and ginsenosides accumulation process. In addition, we also highlight future directions.
CONCLUSION: The cultivation years, specific-tissue, environmental stress, and rhizosphere microbiome imbalance of Panax ginseng are indirectly or directly involved in plant health, biomass production, and the synthesis of ginsenosides. Harnessing these factors to improve the quality and yield of ginseng holds great promise.
Additional Links: PMID-40440906
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40440906,
year = {2025},
author = {Zhan, Z and Zhang, J and Huang, W and Huang, J},
title = {Transcriptomic strategy provides molecular insights into the growth and ginsenosides accumulation of Panax ginseng.},
journal = {Phytomedicine : international journal of phytotherapy and phytopharmacology},
volume = {143},
number = {},
pages = {156834},
doi = {10.1016/j.phymed.2025.156834},
pmid = {40440906},
issn = {1618-095X},
abstract = {BACKGROUND: Panax ginseng C. A. Meyer, a well-known phytomedicine has been widely used in traditional medicine for centuries. However, its quality and yield are heavily influenced by environmental conditions and cultivation years. For example, ginsenosides as the primary active component of ginseng, the concentration increased with the age of the roots and unevenly distributed across different tissues. Recently, transcriptomic technologies have provided powerful tools for revealing the relationship between gene expression and ginsenoside accumulation during ginseng growth, and researches in this field is continuously expanding, influencing the quality and sustainability of ginseng cultivation.
PURPOSE: Investigating the relationship between ginseng growth and the accumulation of active components may provide new insights for improving ginseng performance and medicinal value. This requires a systematic review and in-depth discussion of relevant research.
STUDY DESIGN AND METHODS: This article reviews the application of transcriptomic strategies in studying the molecular mechanisms of ginseng growth and ginsenoside accumulation. A literature search and analysis were conducted using keywords such as "Panax ginseng" and "transcriptomics/transcriptome," along with terms including "ginsenoside biosynthesis," "microbe/microorganism," "RNA-seq," "cultivation years," "rhizosphere," and "stress."
RESULT: Our study focuses on the transcriptome strategy provides molecular insights into the growth and ginsenosides accumulation of Panax ginseng, we summarized and discussed the dynamic changes in gene expression across cultivation years, specific-tissue, environmental stress, and imbalance of rhizosphere microbes during the ginseng growth and ginsenosides accumulation process. In addition, we also highlight future directions.
CONCLUSION: The cultivation years, specific-tissue, environmental stress, and rhizosphere microbiome imbalance of Panax ginseng are indirectly or directly involved in plant health, biomass production, and the synthesis of ginsenosides. Harnessing these factors to improve the quality and yield of ginseng holds great promise.},
}
RevDate: 2025-05-29
Bacterial composition of dust deposited in Qatar: A seasonal study.
The Science of the total environment, 985:179766 pii:S0048-9697(25)01407-X [Epub ahead of print].
Dust storms in the Middle East threaten public health by deteriorating air quality and transporting microorganisms over vast distances. This study analyzes seasonal variations in dust-borne bacterial diversity on photovoltaic (PV) panels using 16S rRNA gene sequencing and bioinformatics to assess community composition and metabolic potential. Our findings suggest that seasonal ecological factors have potential effects on the composition of the airborne bacterial community. In Qatar, the high atmospheric CO2 levels associated with hydrocarbon refining had promoted the growth of hydrocarbon-degrading bacteria belonging to the phyla Campilobacterota, Proteobacteria, and Bacteroidota. High temperatures and photothermal reactions of summer conditions have favored sulfur-metabolizing bacteria. Conversely, milder temperatures, increased humidity, reduced wind speed, and a decline in summer-favoring bacteria had contributed to the increased abundance of the phyla Patescibacteria, Firmicutes, and Actinobacteriota during other seasons. This study had also identified dust borne pathogenic bacteria associated with human and plant diseases, highlighting the need for environmental surveillance to monitor microbial diversity and its shifts driven by ecological factors. This knowledge is crucial for public health, environmental protection, sustainable farming and advancing our understanding of microbial ecology.
Additional Links: PMID-40440849
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40440849,
year = {2025},
author = {Ramadoss, R and Nishad, AK and Moovarkumudalvan, B and Shomar, B},
title = {Bacterial composition of dust deposited in Qatar: A seasonal study.},
journal = {The Science of the total environment},
volume = {985},
number = {},
pages = {179766},
doi = {10.1016/j.scitotenv.2025.179766},
pmid = {40440849},
issn = {1879-1026},
abstract = {Dust storms in the Middle East threaten public health by deteriorating air quality and transporting microorganisms over vast distances. This study analyzes seasonal variations in dust-borne bacterial diversity on photovoltaic (PV) panels using 16S rRNA gene sequencing and bioinformatics to assess community composition and metabolic potential. Our findings suggest that seasonal ecological factors have potential effects on the composition of the airborne bacterial community. In Qatar, the high atmospheric CO2 levels associated with hydrocarbon refining had promoted the growth of hydrocarbon-degrading bacteria belonging to the phyla Campilobacterota, Proteobacteria, and Bacteroidota. High temperatures and photothermal reactions of summer conditions have favored sulfur-metabolizing bacteria. Conversely, milder temperatures, increased humidity, reduced wind speed, and a decline in summer-favoring bacteria had contributed to the increased abundance of the phyla Patescibacteria, Firmicutes, and Actinobacteriota during other seasons. This study had also identified dust borne pathogenic bacteria associated with human and plant diseases, highlighting the need for environmental surveillance to monitor microbial diversity and its shifts driven by ecological factors. This knowledge is crucial for public health, environmental protection, sustainable farming and advancing our understanding of microbial ecology.},
}
RevDate: 2025-05-29
Anti-obesity effects of Oleoylethanolamide: Modulation of mitochondrial bioenergetics, endocannabinoidome and gut microbiome.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 188:118201 pii:S0753-3322(25)00395-6 [Epub ahead of print].
The endocannabinoidome (eCBome) and gut microbiome play key roles in metabolism and obesity, and oleoylethanolamide (OEA), a lipid mediator within the eCBome, is known to reduce food intake and promote fat oxidation. This study investigated the effects of OEA administration on mice with diet-induced obesity, focusing on hepatic inflammation and mitochondrial function, the endocannabinoidome (eCBome), and the gut microbiome. Mice fed standard (STD) or high-fat (HFD) diets for 18 weeks were treated with either vehicle or OEA. Metabolic, inflammatory, oxidative stress and mitochondrial parameters were assessed, along with intestinal and hepatic levels of eCBome lipids and fecal microbiota and short chain fatty acid composition. In HFD-fed mice, OEA decreased body weight, food intake, and serum and liver inflammatory markers, limiting hepatic and body fat accumulation. OEA improved liver mitochondrial oxidative capacity, lipid metabolism and oxidative stress. It reduced intestinal levels of the endocannabinoid 2-arachidonoylglycerol. Effects on microbiota composition were mostly found in the STD-fed group. However, OEA increased the relative abundance of Akkermansia muciniphila more strongly in HFD-fed mice. These findings suggest that OEA may help counteract obesity-related metabolic dysfunction and inflammation, and gut microbiota unbalance, thus representing a promising candidate for future therapeutic strategies.
Additional Links: PMID-40440748
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40440748,
year = {2025},
author = {Cimmino, F and Silvestri, C and Trinchese, G and Petrella, L and Cavaliere, G and Fogliano, C and Piscitelli, F and Cristino, L and Avallone, B and Banni, S and Sihag, J and Di Marzo, V and Mollica, MP},
title = {Anti-obesity effects of Oleoylethanolamide: Modulation of mitochondrial bioenergetics, endocannabinoidome and gut microbiome.},
journal = {Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie},
volume = {188},
number = {},
pages = {118201},
doi = {10.1016/j.biopha.2025.118201},
pmid = {40440748},
issn = {1950-6007},
abstract = {The endocannabinoidome (eCBome) and gut microbiome play key roles in metabolism and obesity, and oleoylethanolamide (OEA), a lipid mediator within the eCBome, is known to reduce food intake and promote fat oxidation. This study investigated the effects of OEA administration on mice with diet-induced obesity, focusing on hepatic inflammation and mitochondrial function, the endocannabinoidome (eCBome), and the gut microbiome. Mice fed standard (STD) or high-fat (HFD) diets for 18 weeks were treated with either vehicle or OEA. Metabolic, inflammatory, oxidative stress and mitochondrial parameters were assessed, along with intestinal and hepatic levels of eCBome lipids and fecal microbiota and short chain fatty acid composition. In HFD-fed mice, OEA decreased body weight, food intake, and serum and liver inflammatory markers, limiting hepatic and body fat accumulation. OEA improved liver mitochondrial oxidative capacity, lipid metabolism and oxidative stress. It reduced intestinal levels of the endocannabinoid 2-arachidonoylglycerol. Effects on microbiota composition were mostly found in the STD-fed group. However, OEA increased the relative abundance of Akkermansia muciniphila more strongly in HFD-fed mice. These findings suggest that OEA may help counteract obesity-related metabolic dysfunction and inflammation, and gut microbiota unbalance, thus representing a promising candidate for future therapeutic strategies.},
}
RevDate: 2025-05-29
Guild-Level Response of the Gut Microbiome to Nutritional Signals: Advancing Precision Nutrition for Metabolic Health.
Annual review of nutrition [Epub ahead of print].
The gut microbiome functions as a hidden organ, providing essential ecosystem services to sustain human health. By identifying stably connected bacteria, we reveal two competing guilds (TCG) as the resilient core of the microbiome: the health-promoting foundation guild (FG) and the proinflammatory pathobiont guild (PG). FG members produce short-chain fatty acids (SCFAs), enhancing gut barrier integrity and systemic resilience, while PG members disrupt metabolism through endotoxins, indoles, and hydrogen sulfide. Together, the FG and PG mediate ∼85% of ecological interactions in a dynamic, seesaw-like relationship. As evolved nutrient sensors for coping with feast-famine cycles, these guilds align host metabolism with dietary patterns. Fiber-rich diets bolster FG activity, maintaining microbial balance and metabolic health, whereas fiber-deficient diets in modern-day society favor chronic PG dominance, driving inflammation and disease. Synthesizing clinical and experimental evidence, this review positions the TCG model as a transformative framework for precision nutrition, guiding strategies to restore microbial balance and address metabolic disorders.
Additional Links: PMID-40440482
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40440482,
year = {2025},
author = {Zhao, L},
title = {Guild-Level Response of the Gut Microbiome to Nutritional Signals: Advancing Precision Nutrition for Metabolic Health.},
journal = {Annual review of nutrition},
volume = {},
number = {},
pages = {},
doi = {10.1146/annurev-nutr-122424-022254},
pmid = {40440482},
issn = {1545-4312},
abstract = {The gut microbiome functions as a hidden organ, providing essential ecosystem services to sustain human health. By identifying stably connected bacteria, we reveal two competing guilds (TCG) as the resilient core of the microbiome: the health-promoting foundation guild (FG) and the proinflammatory pathobiont guild (PG). FG members produce short-chain fatty acids (SCFAs), enhancing gut barrier integrity and systemic resilience, while PG members disrupt metabolism through endotoxins, indoles, and hydrogen sulfide. Together, the FG and PG mediate ∼85% of ecological interactions in a dynamic, seesaw-like relationship. As evolved nutrient sensors for coping with feast-famine cycles, these guilds align host metabolism with dietary patterns. Fiber-rich diets bolster FG activity, maintaining microbial balance and metabolic health, whereas fiber-deficient diets in modern-day society favor chronic PG dominance, driving inflammation and disease. Synthesizing clinical and experimental evidence, this review positions the TCG model as a transformative framework for precision nutrition, guiding strategies to restore microbial balance and address metabolic disorders.},
}
RevDate: 2025-05-29
Toward accurate vaginal microbiome profiling: protocol, bioinformatics, and core microbiota characterisation.
Journal of assisted reproduction and genetics [Epub ahead of print].
PURPOSE: Rising demand for assisted reproductive technologies (ART) with limited improvements in success rates has driven interest in the impact of the vaginal microbiome on fertility outcomes. In order to fully examine the relationship between the vaginal microbiome and fertility outcomes, methodologies and technological developments must be standardised and benchmarked to provide the most accurate assessment of microbial population representation.
METHODS: This study sought to investigate the utility of 16S sequencing and bioinformatic approaches using nanopore sequencing to characterize core vaginal microbiota in a healthy Australian cohort of reproductive-age women.
RESULTS: Optimisation and comparison of different PCR strategies for whole 16S amplification was undertaken, along with the generation of bioinformatic analysis strategies. Initial qPCR identified the 27F-YM (MIX) primer as the most sensitive for C. trachomatis. However, nanopore sequencing revealed no detectable C. trachomatis across all six samples. Among the bioinformatic tools, Porechop with NanoCLUST most accurately identified microbial presence. Community state type (CST) I-characterised by Lactobacillus crispatus dominance-was identified as the most common CST (66%), aligning with patterns of a healthy vaginal microbiome.
CONCLUSION: The findings highlight a Lactobacillus-rich microbiome as the most common among healthy females; however, further refinement-potentially through a metagenomics approach-is recommended to address 16S rRNA primer limitations to enable improved accuracy of microbial detection for the vaginal microbiome.
Additional Links: PMID-40439988
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40439988,
year = {2025},
author = {Davidson, IM and Nikbakht, E and Haupt, LM and Dunn, PJ},
title = {Toward accurate vaginal microbiome profiling: protocol, bioinformatics, and core microbiota characterisation.},
journal = {Journal of assisted reproduction and genetics},
volume = {},
number = {},
pages = {},
pmid = {40439988},
issn = {1573-7330},
abstract = {PURPOSE: Rising demand for assisted reproductive technologies (ART) with limited improvements in success rates has driven interest in the impact of the vaginal microbiome on fertility outcomes. In order to fully examine the relationship between the vaginal microbiome and fertility outcomes, methodologies and technological developments must be standardised and benchmarked to provide the most accurate assessment of microbial population representation.
METHODS: This study sought to investigate the utility of 16S sequencing and bioinformatic approaches using nanopore sequencing to characterize core vaginal microbiota in a healthy Australian cohort of reproductive-age women.
RESULTS: Optimisation and comparison of different PCR strategies for whole 16S amplification was undertaken, along with the generation of bioinformatic analysis strategies. Initial qPCR identified the 27F-YM (MIX) primer as the most sensitive for C. trachomatis. However, nanopore sequencing revealed no detectable C. trachomatis across all six samples. Among the bioinformatic tools, Porechop with NanoCLUST most accurately identified microbial presence. Community state type (CST) I-characterised by Lactobacillus crispatus dominance-was identified as the most common CST (66%), aligning with patterns of a healthy vaginal microbiome.
CONCLUSION: The findings highlight a Lactobacillus-rich microbiome as the most common among healthy females; however, further refinement-potentially through a metagenomics approach-is recommended to address 16S rRNA primer limitations to enable improved accuracy of microbial detection for the vaginal microbiome.},
}
RevDate: 2025-05-29
Exploring the potential mechanism of tofacitinib therapy for ankylosing spondylitis through gut microbiome and plasma metabolomics.
Clinical rheumatology [Epub ahead of print].
OBJECTIVE: To explore the role of gut microbiota and plasma metabolites in the therapeutic mechanism of tofacitinib in ankylosing spondylitis (AS).
METHOD: Ten AS patients and ten matched healthy controls (HC) were enrolled in this study. 16S rRNA sequencing and LC-MS profiling was conducted to investigate the gut microbiota and plasma metabolite before and after tofacitinib therapy. An AS mouse model was established to validate the effect of tofacitinib in vivo via H&E staining, western blot, and ELISA.
RESULTS: Tofacitinib improved clinical symptoms in AS patients. Microbiota analysis revealed Microbiota analysis revealed reduced α-diversity (ACE, Chao1) and altered community structure in AS patients compared to HC, which partially normalized post-treatment. LEfSe identified 84 taxa biomarkers; Barnesiella, Coprobacter, Lachnospira, and Lactobacillus tended to return to normal after tofacitinib treatment. Plasma metabolomics uncovered 3 key metabolies, including choline metabolism, glycerophospholipid metabolism, and phenylalanine metabolism. Spearman analysis revealed that the gut microbiota were closely related to the changes in differential plasma metabolites. Combinated tofacitinib and trichostatin therapy attenuated inflammation, restored metabolism caused by AS in mice in vivo.
CONCLUSION: AS patients suffer from dysbiosis of gut microbiota, and the mechanism of tofacitinib treatment of AS may be related to the modulation of gut microbiota and alteration of plasma metabolites. Key Points • Tofacitinib improves clinical symptoms in patients with AS. • Tofacitinib regulates gut microbiota in AS patients. • Tofacitinib regulates plasma metabolites in patients with AS. • Tofacitinib regulates the choline metabolism.
Additional Links: PMID-40439987
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40439987,
year = {2025},
author = {Wang, X and Sun, C and Yang, X and Xu, G and Pei, L and Tang, L and Xu, S and Xie, C},
title = {Exploring the potential mechanism of tofacitinib therapy for ankylosing spondylitis through gut microbiome and plasma metabolomics.},
journal = {Clinical rheumatology},
volume = {},
number = {},
pages = {},
pmid = {40439987},
issn = {1434-9949},
abstract = {OBJECTIVE: To explore the role of gut microbiota and plasma metabolites in the therapeutic mechanism of tofacitinib in ankylosing spondylitis (AS).
METHOD: Ten AS patients and ten matched healthy controls (HC) were enrolled in this study. 16S rRNA sequencing and LC-MS profiling was conducted to investigate the gut microbiota and plasma metabolite before and after tofacitinib therapy. An AS mouse model was established to validate the effect of tofacitinib in vivo via H&E staining, western blot, and ELISA.
RESULTS: Tofacitinib improved clinical symptoms in AS patients. Microbiota analysis revealed Microbiota analysis revealed reduced α-diversity (ACE, Chao1) and altered community structure in AS patients compared to HC, which partially normalized post-treatment. LEfSe identified 84 taxa biomarkers; Barnesiella, Coprobacter, Lachnospira, and Lactobacillus tended to return to normal after tofacitinib treatment. Plasma metabolomics uncovered 3 key metabolies, including choline metabolism, glycerophospholipid metabolism, and phenylalanine metabolism. Spearman analysis revealed that the gut microbiota were closely related to the changes in differential plasma metabolites. Combinated tofacitinib and trichostatin therapy attenuated inflammation, restored metabolism caused by AS in mice in vivo.
CONCLUSION: AS patients suffer from dysbiosis of gut microbiota, and the mechanism of tofacitinib treatment of AS may be related to the modulation of gut microbiota and alteration of plasma metabolites. Key Points • Tofacitinib improves clinical symptoms in patients with AS. • Tofacitinib regulates gut microbiota in AS patients. • Tofacitinib regulates plasma metabolites in patients with AS. • Tofacitinib regulates the choline metabolism.},
}
RevDate: 2025-05-29
CmpDate: 2025-05-29
An aegerolysin-like protein from Heliothis virescens ascovirus 3h (HvAV-3h) shows immune suppression and antibacterial activity.
The Journal of general virology, 106(5):.
Aegerolysins are lipid-binding proteins associated with multiple functions, including membrane pore-formation, insecticidal toxicity and defence against predators. Whilst distributed over the kingdoms of the Tree of Life, ascoviruses are the only representative viruses that encode an aegerolysin-like protein. Ascoviruses are entomopathogenic and possess a large dsDNA genome. The present study aimed to functionally characterize the aegerolysin-like protein of Heliothis virescens ascovirus 3h (HvAV-3h), encoded by ORF85, and to explore its potential roles in the interaction between the ascovirus and its host. Our results demonstrate the importance of this species-specific protein to HvAV-3h replication in host cells. In vivo, silencing of this gene for 12-72 h significantly increased the expression of some innate immunity-associated genes, including Toll (114-fold), IMD (44.7-fold) and Hopscotch (22.9-fold). In parallel, we detected significant gradual increases in MyD88 and Relish and decreases in PIAS. Moreover, histopathological analyses of infected larval tissues indicated reduced tissue damage after 72 h of ORF85 gene silencing. The prokaryotic expression of the HvAV-3h aegerolysin, followed by feeding to third-instar Spodoptera exigua larvae for 24 or 48 h led to significant reductions in larval weight. Moreover, the in vitro treatment demonstrated a bactericidal action against Lysinibacillus xylanilyticus, a bacterial resident of some insect guts. Overall, our findings suggest that the protein encoded by ORF85 is associated with the pathogenicity of HvAV-3h and its ability to replicate in host cells. Additionally, aegerolysin may inhibit or kill specific bacterial species in the host microbiome during infection, potentially modulating the host immune response.
Additional Links: PMID-40439700
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40439700,
year = {2025},
author = {Zaghloul, HAH and Xiao, Z and Tang, J and Xiao, T and Gao, J and Hu, J and Huang, GH},
title = {An aegerolysin-like protein from Heliothis virescens ascovirus 3h (HvAV-3h) shows immune suppression and antibacterial activity.},
journal = {The Journal of general virology},
volume = {106},
number = {5},
pages = {},
doi = {10.1099/jgv.0.002107},
pmid = {40439700},
issn = {1465-2099},
mesh = {Animals ; *Ascoviridae/genetics/immunology ; *Viral Proteins/genetics/immunology/metabolism ; *Moths/virology/immunology ; *Anti-Bacterial Agents/pharmacology ; Immunity, Innate ; Larva/virology ; Host-Pathogen Interactions ; Virus Replication ; Fungal Proteins ; Hemolysin Proteins ; },
abstract = {Aegerolysins are lipid-binding proteins associated with multiple functions, including membrane pore-formation, insecticidal toxicity and defence against predators. Whilst distributed over the kingdoms of the Tree of Life, ascoviruses are the only representative viruses that encode an aegerolysin-like protein. Ascoviruses are entomopathogenic and possess a large dsDNA genome. The present study aimed to functionally characterize the aegerolysin-like protein of Heliothis virescens ascovirus 3h (HvAV-3h), encoded by ORF85, and to explore its potential roles in the interaction between the ascovirus and its host. Our results demonstrate the importance of this species-specific protein to HvAV-3h replication in host cells. In vivo, silencing of this gene for 12-72 h significantly increased the expression of some innate immunity-associated genes, including Toll (114-fold), IMD (44.7-fold) and Hopscotch (22.9-fold). In parallel, we detected significant gradual increases in MyD88 and Relish and decreases in PIAS. Moreover, histopathological analyses of infected larval tissues indicated reduced tissue damage after 72 h of ORF85 gene silencing. The prokaryotic expression of the HvAV-3h aegerolysin, followed by feeding to third-instar Spodoptera exigua larvae for 24 or 48 h led to significant reductions in larval weight. Moreover, the in vitro treatment demonstrated a bactericidal action against Lysinibacillus xylanilyticus, a bacterial resident of some insect guts. Overall, our findings suggest that the protein encoded by ORF85 is associated with the pathogenicity of HvAV-3h and its ability to replicate in host cells. Additionally, aegerolysin may inhibit or kill specific bacterial species in the host microbiome during infection, potentially modulating the host immune response.},
}
MeSH Terms:
show MeSH Terms
hide MeSH Terms
Animals
*Ascoviridae/genetics/immunology
*Viral Proteins/genetics/immunology/metabolism
*Moths/virology/immunology
*Anti-Bacterial Agents/pharmacology
Immunity, Innate
Larva/virology
Host-Pathogen Interactions
Virus Replication
Fungal Proteins
Hemolysin Proteins
RevDate: 2025-05-29
Mathematical Modeling and Association Analysis Deciphers the Impact of the Gut Microbiome on Cancer Immunotherapy.
Cancer research pii:762766 [Epub ahead of print].
The gut microbiome has emerged as a key regulator of response to cancer immunotherapy. However, a better understanding of the underlying mechanisms by which the microbiome influences immunotherapy is needed to identify strategies to optimize outcomes. To this end, we developed a mathematical model to obtain insights into the effect of the microbiome on the immune system and immunotherapy response. This model was based on i) gut microbiome data derived from preclinical studies, ii) mathematical modeling of the antitumor immune response, iii) association analysis of microbiome profiles with model-predicted immune profiles, and iv) statistical models that correlate model parameters with the microbiome. The model was used to investigate the complexity of murine and human studies on microbiome modulation. Comparison of model predictions with experimental observation of tumor response in the training and test datasets supported the hypothesis that two model parameters, the activation and killing rate constants of immune cells, are the most influential in tumor progression and are potentially affected by microbiome composition. Evaluation of the associations between the gut microbiome and immune profile indicated that the components and structure of the gut microbiome affect the activation and killing rate of adaptive and innate immune cells. Overall, this study contributes to a deeper understanding of microbiome-cancer interactions and offers a framework for understanding how microbiome interactions influence cancer treatment outcomes.
Additional Links: PMID-40439571
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40439571,
year = {2025},
author = {Hadjigeorgiou, AG and Harkos, C and Mishra, AK and Morad, G and Johnson, SB and Ajami, NJ and Wargo, JA and Munn, LL and Stylianopoulos, T and Jain, RK},
title = {Mathematical Modeling and Association Analysis Deciphers the Impact of the Gut Microbiome on Cancer Immunotherapy.},
journal = {Cancer research},
volume = {},
number = {},
pages = {},
doi = {10.1158/0008-5472.CAN-24-2232},
pmid = {40439571},
issn = {1538-7445},
abstract = {The gut microbiome has emerged as a key regulator of response to cancer immunotherapy. However, a better understanding of the underlying mechanisms by which the microbiome influences immunotherapy is needed to identify strategies to optimize outcomes. To this end, we developed a mathematical model to obtain insights into the effect of the microbiome on the immune system and immunotherapy response. This model was based on i) gut microbiome data derived from preclinical studies, ii) mathematical modeling of the antitumor immune response, iii) association analysis of microbiome profiles with model-predicted immune profiles, and iv) statistical models that correlate model parameters with the microbiome. The model was used to investigate the complexity of murine and human studies on microbiome modulation. Comparison of model predictions with experimental observation of tumor response in the training and test datasets supported the hypothesis that two model parameters, the activation and killing rate constants of immune cells, are the most influential in tumor progression and are potentially affected by microbiome composition. Evaluation of the associations between the gut microbiome and immune profile indicated that the components and structure of the gut microbiome affect the activation and killing rate of adaptive and innate immune cells. Overall, this study contributes to a deeper understanding of microbiome-cancer interactions and offers a framework for understanding how microbiome interactions influence cancer treatment outcomes.},
}
RevDate: 2025-05-29
A biotin-free diet attenuates the incidence of collagen-induced arthritis and alleviates microbial dysbiosis.
Food & function [Epub ahead of print].
Emerging evidence has shown that the gut microbiota and its products are important triggers in the pathogenesis of rheumatoid arthritis (RA). Biotin is a diet- and microbiome-dependent metabolite and an immune regulator; however, the role of biotin in RA remains unknown. In this study, we observed abnormal fecal biotin excretion in RA patients, which correlated with microbial alterations. Specifically, biotin content was inversely associated with gut microbial genera enriched in healthy controls, including Roseburia and Dorea. Meanwhile, it positively correlated with Oscillospira, which was highly enriched in RA individuals. Moreover, collagen-induced arthritis (CIA) mice fed a biotin-free diet had attenuated arthritis incidence with depressed differentiation of splenic CD3[+] T cells and restored microbial diversities. The biotin-free diet also increased bone mass and protected against inflammation-induced bone loss in CIA mice. Additionally, the biotin-free diet reshaped the host metabolic phenotype of amino acids and microbial composition. Notably, biotin deficiency ameliorated the augmentation of Oscillospira in CIA mice. Collectively, our results suggested a potential link between biotin deficiency, gut microbiota dysbiosis and CIA progression.
Additional Links: PMID-40439440
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40439440,
year = {2025},
author = {Su, X and Li, X and He, X and Zhou, S and Lyu, A and Cai, Z},
title = {A biotin-free diet attenuates the incidence of collagen-induced arthritis and alleviates microbial dysbiosis.},
journal = {Food & function},
volume = {},
number = {},
pages = {},
doi = {10.1039/d5fo01457c},
pmid = {40439440},
issn = {2042-650X},
abstract = {Emerging evidence has shown that the gut microbiota and its products are important triggers in the pathogenesis of rheumatoid arthritis (RA). Biotin is a diet- and microbiome-dependent metabolite and an immune regulator; however, the role of biotin in RA remains unknown. In this study, we observed abnormal fecal biotin excretion in RA patients, which correlated with microbial alterations. Specifically, biotin content was inversely associated with gut microbial genera enriched in healthy controls, including Roseburia and Dorea. Meanwhile, it positively correlated with Oscillospira, which was highly enriched in RA individuals. Moreover, collagen-induced arthritis (CIA) mice fed a biotin-free diet had attenuated arthritis incidence with depressed differentiation of splenic CD3[+] T cells and restored microbial diversities. The biotin-free diet also increased bone mass and protected against inflammation-induced bone loss in CIA mice. Additionally, the biotin-free diet reshaped the host metabolic phenotype of amino acids and microbial composition. Notably, biotin deficiency ameliorated the augmentation of Oscillospira in CIA mice. Collectively, our results suggested a potential link between biotin deficiency, gut microbiota dysbiosis and CIA progression.},
}
RevDate: 2025-05-29
An experimental test of the influence of microbial manipulation on sugar kelp (Saccharina latissima) supports the core influences host function hypothesis.
Applied and environmental microbiology [Epub ahead of print].
UNLABELLED: Kelp are valued for a wide range of commercial products and their role in kelp forest ecosystems, making kelp cultivation a rapidly expanding economic sector. Microbes associated with kelp and other macroalgae play a critical role in processes such as nutrient exchange, chemical signaling, and defense against pathogens. Thus, manipulating the microbiome to enhance macroalgal growth and resilience is a promising yet underexplored approach for sustainable kelp cultivation. The core microbiome hypothesis suggests that the bacteria that are consistently found on a host (the core microbes) are likely to have a disproportionate impact on host biology, making them an attractive target for microbiome manipulation. In this study, we surveyed wild Saccharina latissima and their surrounding environment to identify core bacterial taxa, compared them to cultivated kelp, and experimentally tested how cultured bacterial isolates affect kelp development. We found that core bacteria are nearly absent in cultivated juvenile sporophytes in nurseries, but eventually colonize them after outplanting to ocean farm sites. Bacterial inoculants had both positive and negative effects on kelp development. Notably, the strength of association of a bacterial genus with kelp in the wild positively correlated with its impact on gametophyte settlement and sporophyte development in kelp co-culture experiments, aligning with predictions from the core microbiome influences host function hypothesis. These findings affirm the feasibility of using microbial manipulations to improve current kelp aquaculture practices and provide a framework for developing these techniques.
IMPORTANCE: Microorganisms consistently associated with hosts are widely thought to be more likely to impact host biology and health. However, this intuitive concept has not been experimentally evaluated. This study formalizes this concept as the Core Microbiome Influences Host Function hypothesis and experimentally tests this hypothesis in sugar kelp (Saccharina). The distribution of bacteria on wild kelp and core microbes was first identified by compiling a broad dataset of the kelp microbiome sampled across space and time. Bacterial cultures were isolated from the surface of sugar kelp and individually grown in laboratory co-culture with sugar kelp spores to assess the ability of bacterial isolates to influence kelp growth and development. In support of the core influences host function hypothesis, isolates belonging to bacterial genera that are more strongly associated with wild sugar kelp are more likely to influence development in laboratory experiments.
Additional Links: PMID-40439420
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40439420,
year = {2025},
author = {Park, J and Kohn, E and Schenk, S and Davis, KM and Clark, JS and Parfrey, LW},
title = {An experimental test of the influence of microbial manipulation on sugar kelp (Saccharina latissima) supports the core influences host function hypothesis.},
journal = {Applied and environmental microbiology},
volume = {},
number = {},
pages = {e0030125},
doi = {10.1128/aem.00301-25},
pmid = {40439420},
issn = {1098-5336},
abstract = {UNLABELLED: Kelp are valued for a wide range of commercial products and their role in kelp forest ecosystems, making kelp cultivation a rapidly expanding economic sector. Microbes associated with kelp and other macroalgae play a critical role in processes such as nutrient exchange, chemical signaling, and defense against pathogens. Thus, manipulating the microbiome to enhance macroalgal growth and resilience is a promising yet underexplored approach for sustainable kelp cultivation. The core microbiome hypothesis suggests that the bacteria that are consistently found on a host (the core microbes) are likely to have a disproportionate impact on host biology, making them an attractive target for microbiome manipulation. In this study, we surveyed wild Saccharina latissima and their surrounding environment to identify core bacterial taxa, compared them to cultivated kelp, and experimentally tested how cultured bacterial isolates affect kelp development. We found that core bacteria are nearly absent in cultivated juvenile sporophytes in nurseries, but eventually colonize them after outplanting to ocean farm sites. Bacterial inoculants had both positive and negative effects on kelp development. Notably, the strength of association of a bacterial genus with kelp in the wild positively correlated with its impact on gametophyte settlement and sporophyte development in kelp co-culture experiments, aligning with predictions from the core microbiome influences host function hypothesis. These findings affirm the feasibility of using microbial manipulations to improve current kelp aquaculture practices and provide a framework for developing these techniques.
IMPORTANCE: Microorganisms consistently associated with hosts are widely thought to be more likely to impact host biology and health. However, this intuitive concept has not been experimentally evaluated. This study formalizes this concept as the Core Microbiome Influences Host Function hypothesis and experimentally tests this hypothesis in sugar kelp (Saccharina). The distribution of bacteria on wild kelp and core microbes was first identified by compiling a broad dataset of the kelp microbiome sampled across space and time. Bacterial cultures were isolated from the surface of sugar kelp and individually grown in laboratory co-culture with sugar kelp spores to assess the ability of bacterial isolates to influence kelp growth and development. In support of the core influences host function hypothesis, isolates belonging to bacterial genera that are more strongly associated with wild sugar kelp are more likely to influence development in laboratory experiments.},
}
RevDate: 2025-05-29
Biologic drug development for treatment and prevention of sexually transmitted infections.
Clinical microbiology reviews [Epub ahead of print].
SUMMARYSexually transmitted infections (STIs) represent a significant global health burden, with over one million new infections occurring daily. In some instances, the prevalence of antibiotic-resistant pathogens is rising, which exacerbates the challenge. STIs cause severe complications, including infertility, ectopic pregnancies, pre-term births, and heightened risks of HIV acquisition. These outcomes underscore the need for innovative therapeutic and prophylactic strategies. In this review, we provide a comprehensive analysis of the current state of biologic drug development targeting key STIs, focusing on Chlamydia trachomatis, Neisseria gonorrhoeae, herpes simplex virus type 2 (HSV-2), and Treponema pallidum. We examine the complexity of host-pathogen interactions that inform biologic drug design, such as multiple mechanisms of infection, immune evasion strategies, and pathogenic latency. We also explore the role of mucosal immunity, highlighting advances in resident memory T cells and cytokine-driven responses that guide therapeutic targeting, concentrating on Chlamydia trachomatis and Neisseria gonorrhoeae, where recent advances in vaccine development appear promising. We conduct a comprehensive survey of platforms, including vaccines, and explore modalities such as monoclonal antibodies and protein therapeutics. Additionally, we examine emerging technologies like nucleic acid-based therapies, microbiome modulation, and phage-based interventions, highlighting their potential against challenging pathogens like HSV-2 and Treponema pallidum. By examining these established and emerging approaches, this review prioritizes critical opportunities for innovation in biologic therapeutics, addressing unmet needs in STI management. It advocates for integrated strategies leveraging antigenic conservation, host immunity modulation, and novel delivery platforms to achieve durable prophylaxis and effective treatment for high-burden infections globally.
Additional Links: PMID-40439402
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40439402,
year = {2025},
author = {Gill, DS and Ram, S and Rice, PA},
title = {Biologic drug development for treatment and prevention of sexually transmitted infections.},
journal = {Clinical microbiology reviews},
volume = {},
number = {},
pages = {e0010724},
doi = {10.1128/cmr.00107-24},
pmid = {40439402},
issn = {1098-6618},
abstract = {SUMMARYSexually transmitted infections (STIs) represent a significant global health burden, with over one million new infections occurring daily. In some instances, the prevalence of antibiotic-resistant pathogens is rising, which exacerbates the challenge. STIs cause severe complications, including infertility, ectopic pregnancies, pre-term births, and heightened risks of HIV acquisition. These outcomes underscore the need for innovative therapeutic and prophylactic strategies. In this review, we provide a comprehensive analysis of the current state of biologic drug development targeting key STIs, focusing on Chlamydia trachomatis, Neisseria gonorrhoeae, herpes simplex virus type 2 (HSV-2), and Treponema pallidum. We examine the complexity of host-pathogen interactions that inform biologic drug design, such as multiple mechanisms of infection, immune evasion strategies, and pathogenic latency. We also explore the role of mucosal immunity, highlighting advances in resident memory T cells and cytokine-driven responses that guide therapeutic targeting, concentrating on Chlamydia trachomatis and Neisseria gonorrhoeae, where recent advances in vaccine development appear promising. We conduct a comprehensive survey of platforms, including vaccines, and explore modalities such as monoclonal antibodies and protein therapeutics. Additionally, we examine emerging technologies like nucleic acid-based therapies, microbiome modulation, and phage-based interventions, highlighting their potential against challenging pathogens like HSV-2 and Treponema pallidum. By examining these established and emerging approaches, this review prioritizes critical opportunities for innovation in biologic therapeutics, addressing unmet needs in STI management. It advocates for integrated strategies leveraging antigenic conservation, host immunity modulation, and novel delivery platforms to achieve durable prophylaxis and effective treatment for high-burden infections globally.},
}
RevDate: 2025-05-29
Polyphenol rewiring of the microbiome reduces methane emissions.
The ISME journal pii:8152721 [Epub ahead of print].
Methane mitigation is regarded as a critical strategy to combat the scale of global warming. Currently, about 40% of methane emissions originate from microbial sources, which is causing strategies to suppress methanogens-either through direct toxic effects or by diverting their substrates and energy-to gain traction. Problematically, current microbial methane mitigation knowledge lacks detailed microbiome-centered insights, limiting translation across conditions and ecosystems. Here we utilize genome-resolved metatranscriptomes and metabolomes to assess the impact of a proposed methane inhibitor, catechin, on greenhouse gas emissions for high-methane-emitting peatlands. In microcosms, catechin drastically reduced methane emissions by 72-84% compared to controls. Longitudinal sampling allowed for reconstruction of a catechin degradation pathway involving Actinomycetota and Clostridium, which break down catechin into smaller phenolic compounds within the first 21 days, followed by degradation of phenolic compounds by Pseudomonas_E from days 21 to 35. These genomes co-expressed hydrogen-uptake genes, suggesting hydrogenases may act as a hydrogen sink during catechin degradation and consequently reduce hydrogen availability to methanogens. In support of this idea, there was decreased gene expression by hydrogenotrophic and hydrogen-dependent methylotrophic methanogens under catechin treatment. There was also reduced gene expression from genomes inferred to be functioning syntrophically with hydrogen-utilizing methanogens. We propose that catechin metabolic redirection effectively starves hydrogen-utilizing methanogens, offering a potent avenue for curbing methane emissions across diverse environments including ruminants, landfills, and constructed or managed wetlands.
Additional Links: PMID-40439232
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40439232,
year = {2025},
author = {McGivern, BB and Ellenbogen, JB and Hoyt, DW and Bouranis, JA and Stemple, BP and Daly, RA and Bosman, SH and Sullivan, MB and Hagerman, AE and Chanton, JP and Tfaily, MM and Wrighton, KC},
title = {Polyphenol rewiring of the microbiome reduces methane emissions.},
journal = {The ISME journal},
volume = {},
number = {},
pages = {},
doi = {10.1093/ismejo/wraf108},
pmid = {40439232},
issn = {1751-7370},
abstract = {Methane mitigation is regarded as a critical strategy to combat the scale of global warming. Currently, about 40% of methane emissions originate from microbial sources, which is causing strategies to suppress methanogens-either through direct toxic effects or by diverting their substrates and energy-to gain traction. Problematically, current microbial methane mitigation knowledge lacks detailed microbiome-centered insights, limiting translation across conditions and ecosystems. Here we utilize genome-resolved metatranscriptomes and metabolomes to assess the impact of a proposed methane inhibitor, catechin, on greenhouse gas emissions for high-methane-emitting peatlands. In microcosms, catechin drastically reduced methane emissions by 72-84% compared to controls. Longitudinal sampling allowed for reconstruction of a catechin degradation pathway involving Actinomycetota and Clostridium, which break down catechin into smaller phenolic compounds within the first 21 days, followed by degradation of phenolic compounds by Pseudomonas_E from days 21 to 35. These genomes co-expressed hydrogen-uptake genes, suggesting hydrogenases may act as a hydrogen sink during catechin degradation and consequently reduce hydrogen availability to methanogens. In support of this idea, there was decreased gene expression by hydrogenotrophic and hydrogen-dependent methylotrophic methanogens under catechin treatment. There was also reduced gene expression from genomes inferred to be functioning syntrophically with hydrogen-utilizing methanogens. We propose that catechin metabolic redirection effectively starves hydrogen-utilizing methanogens, offering a potent avenue for curbing methane emissions across diverse environments including ruminants, landfills, and constructed or managed wetlands.},
}
RevDate: 2025-05-29
Microbial Dysbiosis in the Lung and Gut in Response to Inhalable Particulate Matters in Pneumoconiosis Patients and Animals.
Environmental science & technology [Epub ahead of print].
Pneumoconiosis is a progressive and life-threatening fibrotic lung disorder caused by the prolonged deposition of inhaled particulate matters (PMs); thus far, no cure is available. Emerging evidence has suggested that the resulting disordered respiratory microbiome is caused by disturbed lung architecture and homeostasis responding to inhalable PMs. Lung microbiome dysbiosis also contributes to injury to the lung and distant organs, such as the intestine, through the lung-gut axis. Current studies on the microbiome-disease interplay are still in their infancy, and sufficient understanding of microbial heterogeneity in pathological processes is lacking. Here we investigated the microbiome in the lung and gut of patients with pneumoconiosis in comparison to healthy individuals. Our findings indicated reciprocal causation between lung injuries and microbial dysbiosis under particle exposure; pulmonary Streptococcus and Stenotrophomonas, along with intestinal Ligilactobacillus and Blautia, may represent key microbial communities influencing pneumoconiosis progression. We defined close microbiota crosstalk between the lung and gut, as evidenced by their interaction networks, implying considerable effects on the gut microenvironment through either direct microbial translocation or other mechanisms such as inflammation-driven alterations. Animal experiments further corroborated the findings in humans. Collectively, our results highlight the potential involvement of the lung-gut axis microbial dysbiosis in pneumoconiosis pathogenesis and open a new avenue to develop microbiome-targeted diagnosis and treatment strategies.
Additional Links: PMID-40439217
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40439217,
year = {2025},
author = {Ma, H and Dong, Z and Zhang, X and Li, N and Liu, C and Zhou, X and He, J and Ma, J and Zhang, S and Kan, H and Liu, S},
title = {Microbial Dysbiosis in the Lung and Gut in Response to Inhalable Particulate Matters in Pneumoconiosis Patients and Animals.},
journal = {Environmental science & technology},
volume = {},
number = {},
pages = {},
doi = {10.1021/acs.est.5c00798},
pmid = {40439217},
issn = {1520-5851},
abstract = {Pneumoconiosis is a progressive and life-threatening fibrotic lung disorder caused by the prolonged deposition of inhaled particulate matters (PMs); thus far, no cure is available. Emerging evidence has suggested that the resulting disordered respiratory microbiome is caused by disturbed lung architecture and homeostasis responding to inhalable PMs. Lung microbiome dysbiosis also contributes to injury to the lung and distant organs, such as the intestine, through the lung-gut axis. Current studies on the microbiome-disease interplay are still in their infancy, and sufficient understanding of microbial heterogeneity in pathological processes is lacking. Here we investigated the microbiome in the lung and gut of patients with pneumoconiosis in comparison to healthy individuals. Our findings indicated reciprocal causation between lung injuries and microbial dysbiosis under particle exposure; pulmonary Streptococcus and Stenotrophomonas, along with intestinal Ligilactobacillus and Blautia, may represent key microbial communities influencing pneumoconiosis progression. We defined close microbiota crosstalk between the lung and gut, as evidenced by their interaction networks, implying considerable effects on the gut microenvironment through either direct microbial translocation or other mechanisms such as inflammation-driven alterations. Animal experiments further corroborated the findings in humans. Collectively, our results highlight the potential involvement of the lung-gut axis microbial dysbiosis in pneumoconiosis pathogenesis and open a new avenue to develop microbiome-targeted diagnosis and treatment strategies.},
}
RevDate: 2025-05-29
Unveiling Neonatal Pneumonia Microbiome by High-Throughput Sequencing and Droplet Culturomics.
Genomics, proteomics & bioinformatics pii:8152696 [Epub ahead of print].
Neonatal pneumonia is a leading cause of infant mortality worldwide; however, a lack of microbial profiling, especially of low-abundance species, makes accurate diagnosis challenging. Traditional methods can fail to capture the complexity of the neonatal respiratory microbiota, thereby obscuring its role in disease progression. We describe a novel approach that combines high-throughput sequencing with droplet-based microfluidic cultivation to investigate microbiome shifts in neonates with pneumonia. Using 16S ribosomal RNA (rRNA) gene sequencing of 71 pneumonia cases and 49 controls, we identified 1009 genera, including 930 low-abundance taxa, which showed significant compositional differences between groups. Linear Discriminant Analysis Effect Size analysis identified key pneumonia-associated genera, such as Streptococcus, Rothia, and Corynebacterium. Droplet-based cultivation recovered 299 strains from 94 taxa, including rare species and ESKAPE pathogens, thereby supporting targeted antimicrobial management. Host-pathogen interaction assays showed that Rothia and Corynebacterium induced inflammation in lung epithelial cells, likely via dysregulation of the PI3K-Akt pathway. Integrating these marker taxa with clinical factors, such as gestational age and delivery type, offers the potential for precise diagnosis and treatment. The recovery of diverse species can support the construction of a biobank of neonatal respiratory microbiota to advance mechanistic studies and therapeutic strategies.
Additional Links: PMID-40439157
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40439157,
year = {2025},
author = {Wang, Z and Cheng, X and Xu, Y and Wang, Z and Ma, L and Li, C and Jiang, S and Li, Y and Guo, S and Du, W},
title = {Unveiling Neonatal Pneumonia Microbiome by High-Throughput Sequencing and Droplet Culturomics.},
journal = {Genomics, proteomics & bioinformatics},
volume = {},
number = {},
pages = {},
doi = {10.1093/gpbjnl/qzaf047},
pmid = {40439157},
issn = {2210-3244},
abstract = {Neonatal pneumonia is a leading cause of infant mortality worldwide; however, a lack of microbial profiling, especially of low-abundance species, makes accurate diagnosis challenging. Traditional methods can fail to capture the complexity of the neonatal respiratory microbiota, thereby obscuring its role in disease progression. We describe a novel approach that combines high-throughput sequencing with droplet-based microfluidic cultivation to investigate microbiome shifts in neonates with pneumonia. Using 16S ribosomal RNA (rRNA) gene sequencing of 71 pneumonia cases and 49 controls, we identified 1009 genera, including 930 low-abundance taxa, which showed significant compositional differences between groups. Linear Discriminant Analysis Effect Size analysis identified key pneumonia-associated genera, such as Streptococcus, Rothia, and Corynebacterium. Droplet-based cultivation recovered 299 strains from 94 taxa, including rare species and ESKAPE pathogens, thereby supporting targeted antimicrobial management. Host-pathogen interaction assays showed that Rothia and Corynebacterium induced inflammation in lung epithelial cells, likely via dysregulation of the PI3K-Akt pathway. Integrating these marker taxa with clinical factors, such as gestational age and delivery type, offers the potential for precise diagnosis and treatment. The recovery of diverse species can support the construction of a biobank of neonatal respiratory microbiota to advance mechanistic studies and therapeutic strategies.},
}
RevDate: 2025-05-29
Infective endocarditis and oral health: a long-known threat, still a challenge.
Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace [Epub ahead of print].
Infective endocarditis (IE) remains a life-threatening condition associated with high morbidity and mortality, often influenced by the complex interplay between systemic and oral health. The increasing recognition of oral health as a risk modifier has led to greater focus on the oral microbiome, dental procedures, and periodontal disease as potential contributors to bacteremia and IE. This review critically examines the relationship between oral health and IE, exploring pathophysiological mechanisms, risk factors, and the evolving epidemiology of the disease. The discussion includes diagnostic challenges, particularly in culture-negative cases, and the emerging role of advanced imaging and molecular diagnostics in improving early detection. A central focus is placed on preventive strategies, highlighting the debate surrounding antibiotic prophylaxis (AP) in high-risk individuals and the potential role of periodontal therapy in reducing systemic inflammation and transient bacteremia. The review also addresses the growing concern of antimicrobial resistance and the necessity of balancing AP recommendations with antimicrobial stewardship. Additionally, this review identifies critical research gaps, including the need for longitudinal studies on the impact of oral health interventions on IE incidence and the importance of interdisciplinary collaboration between dental and medical professionals in optimizing patient care. By synthesizing current guidelines and emerging evidence, this review underscores the necessity of an integrated, multidisciplinary approach to mitigate the burden of IE and establish oral health as a key pillar of infection prevention.
Additional Links: PMID-40439013
Publisher:
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40439013,
year = {2025},
author = {Alsergani, M and Zaini, RH and Al Kholaif, N and Al Admawi, M and Savo, MT and Cozac, DA and Tansella, D and Aladani, BA and Di Michele, S and Pergola, V},
title = {Infective endocarditis and oral health: a long-known threat, still a challenge.},
journal = {Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace},
volume = {},
number = {},
pages = {},
doi = {10.4081/monaldi.2025.3497},
pmid = {40439013},
issn = {2532-5264},
abstract = {Infective endocarditis (IE) remains a life-threatening condition associated with high morbidity and mortality, often influenced by the complex interplay between systemic and oral health. The increasing recognition of oral health as a risk modifier has led to greater focus on the oral microbiome, dental procedures, and periodontal disease as potential contributors to bacteremia and IE. This review critically examines the relationship between oral health and IE, exploring pathophysiological mechanisms, risk factors, and the evolving epidemiology of the disease. The discussion includes diagnostic challenges, particularly in culture-negative cases, and the emerging role of advanced imaging and molecular diagnostics in improving early detection. A central focus is placed on preventive strategies, highlighting the debate surrounding antibiotic prophylaxis (AP) in high-risk individuals and the potential role of periodontal therapy in reducing systemic inflammation and transient bacteremia. The review also addresses the growing concern of antimicrobial resistance and the necessity of balancing AP recommendations with antimicrobial stewardship. Additionally, this review identifies critical research gaps, including the need for longitudinal studies on the impact of oral health interventions on IE incidence and the importance of interdisciplinary collaboration between dental and medical professionals in optimizing patient care. By synthesizing current guidelines and emerging evidence, this review underscores the necessity of an integrated, multidisciplinary approach to mitigate the burden of IE and establish oral health as a key pillar of infection prevention.},
}
RevDate: 2025-05-29
Gut Microbiota Dysbiosis and Its Role in the Development of Irritable Bowel Syndrome.
Cureus, 17(4):e83084.
The gut microbiota refers to the diverse community of symbiotic and pathogenic microorganisms inhabiting the host digestive tract. This microbiome plays a vital role in maintaining the integrity of the digestive system. Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder (FGID) characterized by chronic abdominal pain and altered bowel habits. Although the pathophysiology of IBS remains unclear, recent studies suggest that the disruption of the gut microbiota (dysbiosis) may play a significant role. This study aims to examine the role of the gut microbiota in the development of IBS, analyze factors influencing the gut microbiome, and explore the potential for microbiota-targeted therapies. Relevant literature published from 2014 until 2024 was sourced from Google Scholar, PubMed, and Scopus using the keywords "microbiome", "irritable bowel syndrome", "dysbiosis", "faecal transplantation", and "probiotics". This review revealed consistent evidence of gut microbiota dysbiosis in individuals with IBS, characterized by altered microbial diversity, composition, and metabolic function. Contributing factors included a reduced abundance of beneficial commensals, overgrowth of potentially pathogenic species, and disrupted host-microbiota interactions. This dysbiosis was also frequently associated with symptom severity and specific IBS subtypes. Emerging evidence further highlights the role of diet, stress, and genetic factors in modulating gut microbiota and influencing IBS development. The growing body of research supports a strong link between dysbiosis and the pathogenesis and symptomatology of IBS. Understanding the microbial underpinnings of IBS opens avenues for potential diagnostic biomarkers and innovative therapeutic interventions aimed at restoring a balanced gut microbiota. However, further research is needed to elucidate the underlying mechanisms and translate these insights into effective clinical strategies for the management of IBS. This review underscores the significance of gut microbiota in IBS and its potential as a target for future therapeutic interventions.
Additional Links: PMID-40438840
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40438840,
year = {2025},
author = {Saleem, MM and Masood, S and Rahmatullah, MM and Ayesha Imdad, I and Mohammed Aslam Sange, A and Nasr, D},
title = {Gut Microbiota Dysbiosis and Its Role in the Development of Irritable Bowel Syndrome.},
journal = {Cureus},
volume = {17},
number = {4},
pages = {e83084},
pmid = {40438840},
issn = {2168-8184},
abstract = {The gut microbiota refers to the diverse community of symbiotic and pathogenic microorganisms inhabiting the host digestive tract. This microbiome plays a vital role in maintaining the integrity of the digestive system. Irritable bowel syndrome (IBS) is a functional gastrointestinal disorder (FGID) characterized by chronic abdominal pain and altered bowel habits. Although the pathophysiology of IBS remains unclear, recent studies suggest that the disruption of the gut microbiota (dysbiosis) may play a significant role. This study aims to examine the role of the gut microbiota in the development of IBS, analyze factors influencing the gut microbiome, and explore the potential for microbiota-targeted therapies. Relevant literature published from 2014 until 2024 was sourced from Google Scholar, PubMed, and Scopus using the keywords "microbiome", "irritable bowel syndrome", "dysbiosis", "faecal transplantation", and "probiotics". This review revealed consistent evidence of gut microbiota dysbiosis in individuals with IBS, characterized by altered microbial diversity, composition, and metabolic function. Contributing factors included a reduced abundance of beneficial commensals, overgrowth of potentially pathogenic species, and disrupted host-microbiota interactions. This dysbiosis was also frequently associated with symptom severity and specific IBS subtypes. Emerging evidence further highlights the role of diet, stress, and genetic factors in modulating gut microbiota and influencing IBS development. The growing body of research supports a strong link between dysbiosis and the pathogenesis and symptomatology of IBS. Understanding the microbial underpinnings of IBS opens avenues for potential diagnostic biomarkers and innovative therapeutic interventions aimed at restoring a balanced gut microbiota. However, further research is needed to elucidate the underlying mechanisms and translate these insights into effective clinical strategies for the management of IBS. This review underscores the significance of gut microbiota in IBS and its potential as a target for future therapeutic interventions.},
}
RevDate: 2025-05-29
Skin and systemic infections in children with atopic dermatitis: review of the current evidence.
Frontiers in pediatrics, 13:1513969.
Atopic dermatitis is a chronic, pruritic inflammatory skin disorder that affects approximately 2%-42% of children worldwide. Its course is frequently complicated by secondary bacterial, viral, and fungal infections, which can exacerbate disease severity and hinder treatment outcomes. These infections are thought to arise due to a disrupted skin barrier, reduced antimicrobial peptide production, alterations in the skin microbiome, and Th2-dominant inflammatory response. Identifying the most prevalent and pathogenic microorganisms in patients with AD is critical for early diagnosis, effective management, and prevention of complications. This review provides an updated synthesis of current knowledge on the infectious agents implicated in AD pathogenesis, summarizing recent findings on the epidemiology, microbial interactions, and immune mechanisms involved. Furthermore, it provides an overview of the latest therapeutic strategies for managing AD and its associated infections. By integrating recent insights into pathogenesis and treatment, this study offers a comprehensive perspective on the evolving landscape of AD management in children.
Additional Links: PMID-40438776
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40438776,
year = {2025},
author = {Lomelí-Valdez, R and Orozco-Covarrubias, L and Sáez-de-Ocariz, M},
title = {Skin and systemic infections in children with atopic dermatitis: review of the current evidence.},
journal = {Frontiers in pediatrics},
volume = {13},
number = {},
pages = {1513969},
pmid = {40438776},
issn = {2296-2360},
abstract = {Atopic dermatitis is a chronic, pruritic inflammatory skin disorder that affects approximately 2%-42% of children worldwide. Its course is frequently complicated by secondary bacterial, viral, and fungal infections, which can exacerbate disease severity and hinder treatment outcomes. These infections are thought to arise due to a disrupted skin barrier, reduced antimicrobial peptide production, alterations in the skin microbiome, and Th2-dominant inflammatory response. Identifying the most prevalent and pathogenic microorganisms in patients with AD is critical for early diagnosis, effective management, and prevention of complications. This review provides an updated synthesis of current knowledge on the infectious agents implicated in AD pathogenesis, summarizing recent findings on the epidemiology, microbial interactions, and immune mechanisms involved. Furthermore, it provides an overview of the latest therapeutic strategies for managing AD and its associated infections. By integrating recent insights into pathogenesis and treatment, this study offers a comprehensive perspective on the evolving landscape of AD management in children.},
}
RevDate: 2025-05-29
The gut microbiota and aging: interactions, implications, and interventions.
Frontiers in aging, 6:1452917.
The human microbiota, a complex ecosystem of microorganisms inhabiting various body sites, particularly the gut, plays a crucial role in maintaining health and influencing disease susceptibility. Dysbiosis, characterized by alterations in microbial composition and diversity, has been implicated in numerous diseases, including those associated with aging. This review examines the complex relationship between gut microbiota and aging, highlighting the age-associated gut microbiota alterations, the factors contributing to these changes, the links between microbiota and age-related diseases, and the potential of interventions targeting the microbiome to extend lifespan and improve health outcomes in the elderly. Further research is needed to unravel the intricate mechanisms underlying the interplay between the microbiome and aging, paving the way for innovative strategies to promote healthy aging.
Additional Links: PMID-40438731
PubMed:
Citation:
show bibtex listing
hide bibtex listing
@article {pmid40438731,
year = {2025},
author = {Gyriki, D and Nikolaidis, CG and Bezirtzoglou, E and Voidarou, C and Stavropoulou, E and Tsigalou, C},
title = {The gut microbiota and aging: interactions, implications, and interventions.},
journal = {Frontiers in aging},
volume = {6},
number = {},
pages = {1452917},
pmid = {40438731},
issn = {2673-6217},
abstract = {The human microbiota, a complex ecosystem of microorganisms inhabiting various body sites, particularly the gut, plays a crucial role in maintaining health and influencing disease susceptibility. Dysbiosis, characterized by alterations in microbial composition and diversity, has been implicated in numerous diseases, including those associated with aging. This review examines the complex relationship between gut microbiota and aging, highlighting the age-associated gut microbiota alterations, the factors contributing to these changes, the links between microbiota and age-related diseases, and the potential of interventions targeting the microbiome to extend lifespan and improve health outcomes in the elderly. Further research is needed to unravel the intricate mechanisms underlying the interplay between the microbiome and aging, paving the way for innovative strategies to promote healthy aging.},
}
▼ ▼ LOAD NEXT 100 CITATIONS
ESP Quick Facts
ESP Origins
In the early 1990's, Robert Robbins was a faculty member at Johns Hopkins, where he directed the informatics core of GDB — the human gene-mapping database of the international human genome project. To share papers with colleagues around the world, he set up a small paper-sharing section on his personal web page. This small project evolved into The Electronic Scholarly Publishing Project.
ESP Support
In 1995, Robbins became the VP/IT of the Fred Hutchinson Cancer Research Center in Seattle, WA. Soon after arriving in Seattle, Robbins secured funding, through the ELSI component of the US Human Genome Project, to create the original ESP.ORG web site, with the formal goal of providing free, world-wide access to the literature of classical genetics.
ESP Rationale
Although the methods of molecular biology can seem almost magical to the uninitiated, the original techniques of classical genetics are readily appreciated by one and all: cross individuals that differ in some inherited trait, collect all of the progeny, score their attributes, and propose mechanisms to explain the patterns of inheritance observed.
ESP Goal
In reading the early works of classical genetics, one is drawn, almost inexorably, into ever more complex models, until molecular explanations begin to seem both necessary and natural. At that point, the tools for understanding genome research are at hand. Assisting readers reach this point was the original goal of The Electronic Scholarly Publishing Project.
ESP Usage
Usage of the site grew rapidly and has remained high. Faculty began to use the site for their assigned readings. Other on-line publishers, ranging from The New York Times to Nature referenced ESP materials in their own publications. Nobel laureates (e.g., Joshua Lederberg) regularly used the site and even wrote to suggest changes and improvements.
ESP Content
When the site began, no journals were making their early content available in digital format. As a result, ESP was obliged to digitize classic literature before it could be made available. For many important papers — such as Mendel's original paper or the first genetic map — ESP had to produce entirely new typeset versions of the works, if they were to be available in a high-quality format.
ESP Help
Early support from the DOE component of the Human Genome Project was critically important for getting the ESP project on a firm foundation. Since that funding ended (nearly 20 years ago), the project has been operated as a purely volunteer effort. Anyone wishing to assist in these efforts should send an email to Robbins.
ESP Plans
With the development of methods for adding typeset side notes to PDF files, the ESP project now plans to add annotated versions of some classical papers to its holdings. We also plan to add new reference and pedagogical material. We have already started providing regularly updated, comprehensive bibliographies to the ESP.ORG site.
ESP Picks from Around the Web (updated 28 JUL 2024 )
Old Science
Weird Science
Treating Disease with Fecal Transplantation
Fossils of miniature humans (hobbits) discovered in Indonesia
Paleontology
Dinosaur tail, complete with feathers, found preserved in amber.
Astronomy
Mysterious fast radio burst (FRB) detected in the distant universe.
Big Data & Informatics
Big Data: Buzzword or Big Deal?
Hacking the genome: Identifying anonymized human subjects using publicly available data.